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DYNAMICS OF PROTEIN INTERACTIONS WITH NEW BIOMIMETIC INTERFACES: 




Nonspecific blood protein adsorption on the surfaces is the first event that occurs within 
seconds when a biomaterial comes into contact with blood. This phenomenon may ultimately lead 
to significant adverse biological responses. Therefore, preventing blood protein adsorption on 
biomaterial surfaces is a prerequisite towards designing blood-compatible artificial surfaces.  
This project aims to address this problem by engineering surfaces that mimic the inside 
surface of blood vessels, which is the only known material that is completely blood-compatible. 
The inside surface of blood vessels presents a carbohydrate-rich, gel-like, dynamic surface layer 
called the endothelial glycocalyx. The polysaccharides in the glycocalyx include polyanionic 
glycosaminoglycans (GAGs). This polysaccharide-rich surface has excellent and unique blood 
compatibility. We developed a technique for preparing and characterizing dense GAG surfaces 
that can serve as models of the vascular endothelial glycocalyx. The glycocalyx-mimetic surfaces 
were prepared by adsorbing heparin- or chondroitin sulfate-containing polyelectrolyte complex 
nanoparticles (PCNs) to chitosan-hyaluronan polyelectrolyte multilayers (PEMs). 
We then studied in detail the interactions of two important blood proteins (albumin and 
fibrinogen) with these glycocalyx mimics. Surface plasmon resonance (SPR) is a common 
ensemble averaging technique for detection of biomolecular interactions. SPR was used to quantify 
the amount of protein adsorption on these surfaces. Moreover, single-molecule microscopy along 
iii 
 
with advanced particle tracking were used to directly study the interaction of single molecule 
proteins with synthetic surfaces. Finally, we developed a groundwork for a kinetic model of long-
term protein adsorption on biomaterial surfaces. 
In the first chapter, we thoroughly summarize the important blood-material interactions 
that regulate blood compatibility, organize recent developments in this field from a materials 
perspective, and recommend areas for future research. In the second chapter, we report preparation 
and characterization of dense GAG surfaces that can serve as models of the vascular endothelial 
glycocalyx. In the third chapter, we investigate how combining surface plasmon resonance, X-ray 
spectroscopy, atomic force microscopy, and single-molecule total internal reflection fluorescence 
microscopy provides a more complete picture of protein adsorption on ultralow fouling 
polyelectrolyte multilayer and polymer brush surfaces, over different regimes of protein 
concentration. In the fourth chapter, the interactions of two important proteins from blood (albumin 
and fibrinogen) with glycocalyx-mimetic surfaces are revealed in detail using surface plasmon 
resonance and single-molecule microscopy. Finally in the fifth chapter, the long-term protein 
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CHAPTER 1: THE QUEST FOR BLOOD-COMPATIBLE MATERIALS: RECENT 





The development of blood-compatible materials represents a grand challenge in 
biomaterials science. Blood is a complex fluid containing many types of living cells, functional 
proteins, and other signaling molecules, which work together to protect the circulatory system 
from injury, pathogens, and foreign materials. Blood-contacting biomaterials include the 
components of cardiovascular implants (such as stents, shunts, and valves) and extracorporeal 
circuit components (such as tubing, membranes, and pumps). The engineered materials used in 
these applications are distinctly unlike the biological tissues that make up the cardiovascular 
system in their physical, chemical, and biological properties, leading to undesirable—and 
sometimes catastrophic—blood-material interactions. The pursuit of blood-compatible materials 
challenges nearly every aspect of materials design, including composition, mechanical properties, 
structure across multiple length scales, tribology, surface physical-chemistry, and biochemical 
functionalization. Materials have been designed to bind or reject specific blood proteins, interact 
favorably with specific cell types, or to interact with particular biochemical pathways in blood. 
This review summarizes the important blood-material interactions that regulate blood 
compatibility, organizes recent developments in this field from a materials perspective. 
                                                            
1 This work was published in Materials Science & Engineering R and is reproduced in modified form here with 
permission [1]. M. Hedayati was responsible for the most of the literature review, data collection, organization, 
writing, and editing. M. Neufeld provided commentary on NO section, writing, reviewing, and editing.  M. Reynolds 




1.1.1 The blood-material interface in medical devices 
Worldwide, millions of blood-contacting medical devices are used annually [2]. These 
include implants, such as stents and heart valves, components of extracorporeal life support 
systems (i.e., catheters, tubing, and membranes used in blood oxygenators) and materials used for 
blood collection, storage and sensing. Some of these applications require only momentary or 
incidental blood contact while other applications involve long-term blood contact (days to years). 
For implanted cardiovascular devices and components of life-support systems, undesirable blood-
material interactions such as blood clotting (thrombosis) and inflammation can lead to catastrophic 
failure. The success of all of these life-saving technologies is therefore critically dependent upon 
the ability to manage and prevent these complications.  
There is a widespread recognition that preventing thrombosis and inflammation on the 
surfaces of biomaterials is an important challenge. The clinical literature testifies that managing 
thrombosis and inflammation risks through pharmaceuticals is essential for the treatment of 
patients with cardiovascular implants and extracorporeal circuits. For the cardiovascular 
interventionist, these risks are often worth taking: trading a potentially life-threatening or 
debilitating condition (such as a blocked artery or congenital valve disorder) for a risk that can be 
mediated pharmaceutically represents a cost-benefit trade off. Anticoagulant therapy causes other 
risks and side effects, requires patient compliance, and is not 100% effective. While the systemic 
treatment of anticoagulants and antiplatelet therapies may reduce the thrombosis risk, an 
alternative localized approach that prevents clotting on synthetic surfaces without systemic effects 
is ideal for future iterations of blood-contacting devices. The clinical literature also recognizes that 
there is a huge unmet need for blood-contacting medical devices that reduce the need for 
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continuous systemic anticoagulant therapy. To identify strategies and develop rational designs for 
materials with enhanced blood compatibility, it is essential to understand why these outcomes 
occur when synthetic materials are in contact with blood and why these outcomes do not occur in 
the healthy vasculature.   
Materials scientists and engineers working in the field of blood-contacting materials tend 
to view this challenge differently than clinicians. The questions “what is blood doing to my 
material?” and “what is this material doing to my patient’s blood?” result in two very different 
approaches for solving this problem. Materials scientists have the opportunity to address the 
perennial challenge of blood-compatible materials from a materials design paradigm which 
optimizes the features and functions of the material to suit both the long-term performance criteria 
and the multiple environmental challenges that the material will encounter. Materials scientists can 
also design functional and responsive materials that dynamically interact with the biological 
environment.  
Blood is a particularly complex biological fluid, containing as many as 4,500 different 
proteins and peptides, as well as cells that participate in complex and dynamic biological 
phenomena, including blood clotting and inflammation responses. In healthy blood vessels, 
hemostasis is the process by which bleeding is stopped through the formation of a blood clot. 
Hemostasis is essential for maintaining the health of the cardiovascular system by preventing blood 
loss and by initiating repair of damaged blood vessels. Inflammation is an essential response of 
the innate immune system, enabling the blood to respond quickly to harmful foreign objects and 
pathogens. These two remarkably robust processes, blood clotting and inflammation, present 




1.1.2 Materials at the blood-material interface 
Early attempts to develop blood-compatible materials date to at least the middle ages, 
centuries before the molecular and cellular mechanisms of clotting and inflammation were 
understood [3,4]. As early as the 1800s, Freund and Haycraft independently discovered that a 
surface coated with paraffin wax lengthens blood coagulation time compared to glass [5–7]. They 
discovered that blood failed to clot upon removal and placement in a tube coated with paraffin wax 
or when directly added to a solution of paraffin oil [5–7]. However, if the blood contacted a surface 
that lacked the oily coating, coagulation was induced. These rudimentary observations of blood-
material incompatibility by Freund and Haycraft were caused by the same factors which result in 
blood-device incompatibilities in current clinical practice.  
Today, the materials used in blood-contacting applications include a wide variety of 
organic and inorganic materials, metals, polymers, and ceramics. These materials have a wide 
variety of composition, surface chemistry and structure. Table 1.1 summarizes cardiovascular and 
blood-contacting devices and their common materials of construction. 
Table 1.1. Common materials used in blood-contacting medical devices. 
catheters hydrophilic and hydrophobic polyurethanes (PU), silicone rubber, 
polyethylene 
tubing PU, Tygon™, silicone rubber 
vascular grafts polytetrafluoroethylene (PTFE), Dacron® 
stents stainless steel, nitinol 
oxygenator fibers silicone, polymethyl pentene, polypropylene 




Despite decades of modern research in blood-contacting materials (preceded by centuries 
of early failures), we know of no material that is completely blood-compatible for long-term 
contact with flowing whole blood, other than the inside surfaces of healthy blood vessels [8]. All 
blood-contacting materials used in medical devices initiate undesirable blood-material 
interactions, such as thrombosis and inflammation [9,10]. Even supposedly ‘inert’ or ‘passive’ 
surfaces will initiate these responses when in contact with whole blood [11–13]. A key limitation 
of synthetic materials is that they lack the ability to dynamically integrate with and respond to the 
biological system through molecular signals, to regulate blood-material interactions. Development 
of blood compatible-materials will require that the biomaterials scientist acknowledge these 
limitations, and where possible, mitigate them through new materials technologies. The next 
sections review some of the key biological responses. 
1.2. Thrombosis and inflammation 
Thrombosis and inflammation are initiated by the adsorption of proteins onto biomaterials 
surfaces. Protein adsorption modifies the surface chemistry, often creating a biologically active 
surface that can specifically interact with blood cells, including platelets and leukocytes. These 
cells are key initiators of negative blood-material interactions. Platelets are involved thrombosis 
and leukocytes are primarily responsible for inflammation. While these processes occur on 
different time scales, they are related as shown in Figure 1.1 and discussed below. The mechanisms 
of inflammation and blood clotting are not completely independent of one another, leading some 
authors to consider them as a combined phenomenon [14], or as distinct phases in an overall 
foreign body reaction [15]; regardless of how they are described, these two mechanisms interact 




Figure 1.1. Relationships in the coagulation cascade (top) and inflammation (bottom). The 
coagulation cascade is made up of intrinsic (blue), extrinsic (green), and common (violet) 
pathways. Inflammation processes are shown at the bottom (red). Attachment, activation and 
aggregation of platelets, and their associated contributions to thrombus formation are shown in 
black. The material is shown here as initiating the intrinsic pathway, which is the way this is 
commonly understood in the biomaterials literature. Nonetheless, the presence of a foreign 
material can also initiate the extrinsic pathway, for example by inflammatory responses leading to 
TF production [16].   
1.2.1 Costs, consequences, and complicated management of thrombosis 
Thrombosis, or the formation of blood clot, is a common mode of failure for cardiovascular 
implants and extracorporeal circuits. The adverse clinical effects of thrombosis include thrombotic 
occlusion in grafts, obstruction of stents, embolic complications, and may necessitate the life-long 
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use of anticoagulants [17,18]. A thrombus that dislodges from a biomaterial surface and enters the 
circulation can occlude blood flow by forming an embolism. Particularly for stents and heart 
valves, thrombosis and embolism represent high risks for stroke, heart attack, and mortality, and 
frequently necessitate repeating the procedure or replacing the implant altogether [19,20]. For this 
reason patients with cardiovascular implants must take anticoagulants and/or antiplatelet drugs 
indefinitely, leading to complications such as bleeding disorders [21].  
Extracorporeal circuits are used in hemodialysis and blood oxygenation. Frequently, these 
are used in life support systems for critically ill and injured patients that are facing immanent 
respiratory and/or cardiac failure [22]. Managing thrombosis and bleeding complications for 
patients on extracorporeal life support adds an additional layer of complexity to the treatment of 
patients who are already suffering from severe injury or illness [8]. In a retrospective study of adult 
patients on extracorporeal life support, over 50% of patients had a serious bleeding-related event, 
with 13.6% being a thrombosis complication [23].  In another retrospective analysis of over 2000 
pediatric patients receiving extracorporeal life support, thrombosis occurred in over 30% of cases 
correlating to a substantial decrease (33%) in survival [24].  
Despite these risks, in the past four decades the use of cardiovascular implants and 
extracorporeal life support has grown dramatically. This growth has been accompanied by 
continuous improvements in device design and in surgical and managerial procedures that improve 
outcomes and reduce risks of complications. Notably, this growth has also been facilitated by the 
development of strategies to manage the risk of thrombosis. The early use of stents was 
accompanied by high doses of anticoagulant therapeutics, but still resulted in very high rates of 
thrombosis (~25%), as well as bleeding complications (~9%) [19]. While these rates have been 
reduced through improvements in stent design, the risk of thrombosis still necessitates long-term 
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systemic anticoagulant and/or antiplatelet therapy. For patients who are in a hospital setting, 
anticoagulants such as intravenous heparin are administered for the management of thrombosis in 
procedures involving blood-contacting devices [25]. While anticoagulants can provide 
symptomatic relief, their associated complications make them undesirable as a permanent solution. 
As an example, the use of heparin can lead to low platelet counts (thrombocytopenia) and produce 
internal hemorrhaging that requires platelet transfusions to maintain patient vitality [23,25–27]. 
For patients on extracorporeal life support due to other injury or illness, bleeding complications 
can be particularly threatening, were found to be even more common than thrombosis in pediatric 
patients (38%), and were also associated with a 40% decrease in survival [24]. These studies 
demonstrate that there is a need to balance the materials interactions with the blood and the goal 
of patient survival or desired outcomes.  
1.2.2 Biological mechanisms of blood clotting 
Thrombosis is a multistep sequence of events, illustrated in Figure 1.2, resulting in the 
formation of a blood clot (thrombus) [16,28]. The typical sequence of events that results in 
thrombus formation upon device implantation proceeds as follows: (1) protein adsorption, (2) 
platelet adhesion and activation, (3) coagulation cascade activation and (4) thrombus formation 
[29]. Upon implantation of a blood-contacting biomaterial, two distinct pathways can act in 
parallel or separately to trigger clot formation (Figure 1.1) [2,29,30]. These include platelet 
adhesion and activation and activation of the coagulation cascade which together forms the overall 
thrombus. The specific interactions of cells and proteins with surfaces and their roles in thrombus 




Figure 1.2. Simplified representation of the sequence of events leading to thrombus formation on 
the surface of blood-contacting biomaterials.   
 
1.2.2.1 Platelets 
Platelets are anuclear, disc-shaped cells circulating with a concentration of about 250,000 
cells μl−1 [31]. Their primary role is hemostasis—preventing blood loss following a blood vessel 
injury. Prevention of blood loss is accomplished through the formation of a thrombus or blood 
clot, when blood is in contact with surfaces and tissues other than a healthy luminal wall of a blood 
vessel. In addition to stopping blood loss, the thrombus also serves as a provisional matrix for 
subsequent tissue repair. The special role of platelets in thrombosis is why platelets are sometimes 
referred to as “thrombocytes”.  
Platelets ordinarily circulate in a quiescent state, suspended in blood, where they co-exist 
with dissolved blood proteins, such as fibrinogen and von Willebrand factor (vWF) [32]. Platelet 
quiescence is maintained in part by the action of signals in the blood produced by endothelial cells 
lining the blood vessel, including prostaglandin I2 (PGI2) and nitric oxide (NO) [33,34]. Because 
platelets have no nucleus, they cannot alter gene expression in response to soluble or surface-
bound signals. Nonetheless, platelets are preprogrammed to respond quickly to surface-bound and 
soluble protein signals presented on a surface, initiating a sequence of events essential to blood 
clotting. Platelet activation can occur in fractions of a second, leading to the formation of a blood 
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clot in less than five minutes [21]. Surface-induced platelet activation occurs when platelets adhere 
to surface-adsorbed plasma proteins, such as vWF or fibrinogen, or tissue-specific proteins [31]. 
Activation is accompanied by platelets rapidly changing their shape, through cytoskeletal 
rearrangement [31]. Platelet activation is characterized by a morphological change from discoidal 
(inactivated) to spherical with the appearance of appendages, known as pseudopods, which 
promote platelet contact and adhesion [35]. Partially activated platelets exhibit multiple short 
(shorter than the cell body) dendrites or long dendrites (longer than the cell body). Fully activated 
platelets are flattened and spread on the surface of a biomaterial [36,37]. Examples of platelet 
adhered to biomaterials in various stages of activation are shown in (Figure 1.3).  
 
Figure 1.3. Examples of human platelets in various stages of activation, after a 2 hour incubation 
of human platelets in plasma on titanium and modified substrates. From left to right, platelets on 
a titanium substrate are spread and fully activated. Platelets on titanium anodized to present titania 
nanotubes (TiO2NT) are aggregated, but not fully activated. Platelets on TiO2NT coated with 
heparin-containing polyelectrolyte multilayers (TiO2NT+PEM) are round with few short 
extensions, and are not aggregated. On a similar surface containing an NO-donor chemistry 
(TiO2NT+PEM+NO), very few platelets attach. Attached platelets remain round and do not 
advance to a further stage of activation. Reproduced with permission from [37], copyright 2016, 
American Chemical Society. 
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Although platelets circulate in an inactive state, they constantly surveil the endothelium for 
sites of damage or injury. Platelet interactions with surfaces are mediated by cell surface 
glycoproteins (GP) [31]. Initial platelet binding to a surface can be mediated by GPIb (often in the 
GPIb-IX or GPIb-IX-V complexes) interacting with vWF [38]. Elongated vWF on surfaces 
displays exposed, positively charged vWF-A1 domains which bind to a negatively charged ligand 
binding domain on GP1b [32]. The GP1b-vWF bond has a shear-dependent bond strength that 
results in transient binding, enabling platelets to “roll” on vWF-activated surfaces [39,40]. GP1b 
binding to vWF-A1 and shear-induced rolling produces tensile forces that unfold GP1b, thereby 
mechanically transducing a signal, which ultimately results inactivation of GPIIb-IIIa [32].  
GPIIb-IIIa is an integrin (integrin αIIbβ3) and is the most abundant receptor on platelet 
surfaces [38]. It undergoes a conformational change upon platelet activation, enabling it to bind to 
the arginine-glycine-aspartic acid peptide sequence (RGD), found in proteins such as adsorbed 
fibrin(ogen) [41,42]. Additional adhesion ligands GPIa-IIa (integrin αIIβ1), and GPVI enable 
rolling platelets to form strong adhesive contacts with collagen on surfaces [32,38]. GPIIb-IIIa 
binding to fibrin(ogen) and to vWF is important for platelet adhesion to surfaces, and also enables 
fibrin(ogen) to link platelets to one another within platelet aggregates [16,41,42]. Mechanical 
signal transduction also occurs through GPIIb-IIIa, initiating signaling that causes rearrangement 
of the cytoskeleton, enabling filopodia and lamellipodia formation, and promoting granule 
secretion [32]. This interaction has been shown to be stronger on stiff substrates than on more 
compliant substrates. The resulting shape changes of the platelet are identifiable markers of platelet 
activation.  
The interaction between the GP receptors and their ligands induces activation through the 
release of phospholipase C, leading to an increase in platelet cytoplasmic Ca2+ concentration. An 
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increase in the cytoplasmic Ca2+ concentration leads to secretions of the granular contents (dense, 
alpha, and lysosomal granules) and subsequent shape change of the platelet [2,29,30,35]. The 
secreted granules contain both adhesion molecules, and cytokines. The secreted granules then 
release their contents, which include Ca2+, platelet factor (PF), fibrinogen, vWF and coagulation 
factors (F) FXI and FVII. Fibrinogen and vWF provide positive feedback by further activating 
additional platelets and inducing platelet aggregation [2]. Activated platelets also release 
additional pro-thrombotic signals, including PF3 and PF4. These interactions are shown on the left 
side of Figure 1.1.  
Platelet adhesion and activation can be influenced significantly by surface topographic 
features. This requires a rational design approach that considers the feature geometry and inter-
feature spacing, and not just an average surface roughness. When the adhesion area (the area 
accessible to a cell) is smaller than a critical value, platelets may not be able to attach, spread, or 
activate on a micro- and/or nanostructured surfaces. For example, Koh et al. utilized poly(lactic-
co-glycolic acid) pillars of various dimensions and proposed that interspacing, width and height 
significantly influence platelet adhesion and activation. Their proposed optimal range of 
topographical dimensions of the pillars is: height = 300–800 nm, width =100–200 nm, interspacing 
< 200 nm [43]. Platelet adhesion and activation on arrays of groove and pillar patterns with various 
dimensions on TiO2 surfaces has also been investigated [44]. In this work, groove patterns resulted 
in much higher levels of platelet adhesion and activation than pillar patterns. In addition, platelets 
can bridge over spacing between adjacent patterns when inter-feature spacing is smaller than 1.5 
µm. Moreover, when inter-feature spacing is larger than 3 µm, platelets cannot bridge but fully 
contact the entire surface, including the bottom, top, and side-walls of the pattern. Therefore the 
optimal spacing range for reducing platelet adhesion is between 1.5 µm and 3 µm.  
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1.2.2.2 The coagulation cascade 
In addition to the activation of platelets, thrombus formation involves the blood coagulation 
cascade which leads to the formation of a fibrin clot [2,29,30,45]. The coagulation cascade consists 
of a series of proenzyme activations where one activated factor then activates another inactive 
precursor factor. The coagulation cascade is initiated by either the “intrinsic pathway” or the 
“extrinsic pathway”. As illustrated in (Figure 1.1), these two pathways converge at the activation 
of factor X (FX) to the active form, FXa. The conversion of FX to FXa and the subsequent steps 
make up the “common pathway”.  
Traditionally biomaterials scientists have considered the intrinsic pathway to be the most 
important mechanism because the intrinsic pathway is initiated by FXII activation (to FXIIa) upon 
adsorption to a material surface. The extrinsic pathway, on the other hand, is activated by damage 
to tissues, leading to expression of tissue factor (TF) on the surfaces of cells. However, tissue 
damage can also result directly from the deployment of a cardiovascular implant. Furthermore, TF  
can also be initiated by a biomaterial that induces inflammatory responses, as TF is a product of 
inflammation (shown at the bottom of Figure 1.1) [16]. Therefore, both the intrinsic and the 
extrinsic pathway are important initiators of coagulation in response to blood-contacting materials 
[16].  
In the intrinsic pathway, FXII adsorbs to a surface and becomes activated. This activation 
can be enhanced by immunoglobulin and albumin [46]. FXIIa, along with other cofactors, activates 
FXI to FXIa, which subsequently activates FIX to FIXa [2,29,30,45,47]. FIXa then initiates the 
common pathway by activation of FX to FXa. In the extrinsic pathway, damaged cells express TF 
which forms a complex on the surfaces of cells with activated FVII (FVIIa). This FVIIa-TF 
complex can also activate FX to FXa, also initiating the common pathway [2,29,30,45,47]. 
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In the common pathway, prothrombin is converted to thrombin, which cleaves the small 
fibrinopeptides A and B from the N-termini of the Aα and Bβ chains in fibrinogen, as discussed 
below, to form the polymerizable fibrin [48,49]. Fibrin then polymerizes into fibrin fibers which 
form a crosslinked network, making up the primary structure of the blood clot. The fibrin(ogen) 
network also promotes platelet aggregation by providing adhesive links between platelets. 
Thrombin also provides positive feedback to both the intrinsic and common pathways; thrombin 
promotes the activation of FXIa and another coagulation factor not shown in Figure 1.1—FVIII 
[16]. FVIII binds to FIXa and FX, promoting FX activation [16,50]. Thrombin also promotes the 
activation of FV to FVa which accelerates FXa-mediated conversion of prothrombin to thrombin 
[16]. The central role of thrombin in activating fibrinogen and in providing positive feedback to 
the coagulation cascade make thrombin inhibition an important strategy for reducing blood 
clotting. 
Under normal conditions, the vascular endothelium prevents thrombus formation and 
maintains homeostasis through a variety of factors. These include platelet inhibitors such as PGI2, 
adenosine diphosphatase (ADPase), matrix metalloproteinases, and the free radical molecule NO 
[47]. Heparan sulfate is a glycosaminoglycan (GAG) presented on the surfaces of endothelial cells 
lining the blood vessel wall. Heparan sulfate binds and activates an important anticoagulant, 
antithrombin III (ATIII), which inhibits thrombin, FXa, and FIXa [51]. Heparin is structurally 
similar to heparan sulfate, and has similar activity, making heparin a useful anticoagulant.   
1.2.3 Inflammation 
Leukocytes or white blood cells are far less abundant in blood, than platelets, at a 
concentration of about 4000 cells μl−1. This leukocyte fraction includes several important cell types 
that mediate blood-material interactions, notably neutrophils and monocytes. The monocytes can 
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differentiate into macrophages, which are important mediators of inflammation. Neutrophils and 
macrophages are both phagocytes, which specialize in eliminating damaged tissue, foreign 
materials, and pathogens, both by phagocytosis (ingestion) and by secretion of various 
antimicrobial, digestive, and reactive species. The interactions of these cell types with materials in 
contact with blood can ultimately lead to a negative response known as the foreign body reaction.  
Neutrophil adhesion to biomaterials may be promoted by adsorbed fibrinogen [52]. Upon surface 
adhesion, neutrophils change the environment by releasing proteolytic enzymes, reactive oxygen 
species (ROS), and TF [52]. ROS can chemically modify biomaterials surfaces and cause local 
tissue damage [53]. Neutrophils also secrete pro-inflammatory cytokines such as the interleukin 
(IL) IL-8, macrophage chemoattractant protein, and macrophage inflammatory protein-1β [15]. 
The activity of neutrophils at a site of a foreign body response is identified as the acute 
inflammation phase which typically lasts just a few days. 
Neutrophils and macrophages may be recruited to the site of a biomaterial by activated 
platelets’ release of FVII and FXI and by PF4 (Figure 1.1) [15]. Leukocytes use membrane-
associated proteins called pattern recognition receptors to identify pathogens and damaged tissue. 
Biomaterials implanted in the cardiovascular system, such as stents, shunts, catheters and heart 
valves can all cause injury to surrounding tissue, leading to activation of pattern recognition 
receptors. There is some evidence that some pattern recognition receptors, such as toll-like 
receptor-4 (TLR-4) can also be stimulated directly by synthetic biomaterials [54]. TLR-4 has been 
implicated in determining the response of monocytes/macrophages to materials both in vivo and 
in vitro [55,56].  
Monocytes circulate in the blood and are recruited to sites of tissue injury and inflammation 
[57]. Their homing to sites of injury is achieved through chemoattractant signals such as the 
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macrophage chemoattractant proteins and macrophage inflammatory proteins [15]. 
Monocytes/macrophages express integrins that enable their attachment to both vWF and 
fibrin(ogen) in the thrombus or provisional matrix [15]. They also express integrins that bind to 
the complement C3b fragment, and to immunoglobulin that may be adsorbed to biomaterials 
surfaces [58]. Their activity at the site of biomaterials is associated with the chronic phase of the 
foreign body reaction which can last weeks to months. Monocytes differentiate into macrophages 
whereupon they may either promote inflammation, or contribute to its resolution depending upon 
the local microenvironmental cues (Figure 1.1) [57]. The M1 or pro-inflammatory response is 
characterized by secretion of pro-inflammatory cytokine signals, such as IL-1, IL-6, IL-8, and 
tumor necrosis factor-α (TNF-α) [15]. The M2 phenotype is generally considered to be anti-
inflammatory, and is characterized by anti-inflammatory cytokine production (e.g. IL-4 and IL-
10) [59]. The M2 phenotype is complex, and several subsets of macrophages have been identified, 
including those which participate in wound healing and remodeling [60]. The adoption of either 
the M1 or the M2 phenotype is classically referred to as macrophage polarization, though there is 
recent evidence that macrophages can exhibit both pro- and anti-inflammatory activity 
simultaneously [59].  
Macrophage phenotype has been implicated as an important predictor of tissue healing 
around implants [61]. Macrophages will attempt to phagocytose foreign materials including 
implanted biomaterials. For implanted devices with dimensions much larger than the cell body, 
this phagocytosis is not possible, leading to a state called “frustrated phagocytosis” [58]. Frustrated 
phagocytosis is thought to be the primary initiator of macrophage fusion, leading the formation 
multinucleated foreign body giant cells (FBGC), characteristic of the foreign body reaction. 
Regardless of their polarization, both M1 and M2 macrophages can contribute to FBGC formation 
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[59]. These cells then produce enzymes, ROS (including superoxide anion, hydrogen peroxide, 
hydroxyl radicals and singlet oxygen) and reactive nitrogen species (RNS)  that can degrade 
biomaterials, and otherwise alter their surface chemistry [15,59,62,63]. 
Recent work has hypothesized that materials can be designed with features to guide 
macrophage polarization. For example, based on the observation that the M1 macrophages are 
rounded, while M2 macrophages are elongated, McWhorter et al. used micropatterned 
presentation of the adhesion ligand fibronectin, to induce macrophage elongation, leading to 
modulation of polarization (Figure 1.4) [64]. More recently, surface treatments on titanium have 
generated significant interest [65–67]. Macrophage phenotype on titanium is of particular interest 
in the field of orthopedic materials, as macrophage signaling has impacts on bone cell 
differentiation and matrix deposition. The foreign body reaction to orthopedic implants can lead 
to poor apposition of implants to host bone, implant loosening, and other complications. The 
interactions of macrophages with titanium can also be important for cardiovascular implants, as 
stents and heart valve components are also made from titanium or titanium alloys (Table 1.1). In 
one study, titanium surfaces that were smooth or were treated to present micron-scale surface 
roughness exhibited a pro-inflammatory phenotype, unless the surface was treated to be 
hydrophilic, in which case an anti-inflammatory phenotype was induced [65]. Other studies have 
shown that nanotexturing on titanium produced by anodization or other techniques can induced 
M2 polarization [66] or reduce pro-inflammatory phenotypes compared to smooth titanium [67]. 
These studies demonstrate that better understanding of the mechanisms whereby surface properties 
influence macrophage polarization will lead to improved control over inflammatory responses. 
One working hypothesis is that surface chemistry can be used to alter the composition of adsorbed 
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protein layers, which in turn could modify the integrins with which macrophages interact with the 
surface leading to differential signaling [68]. 
 
Figure 1.4. Elongation of cells by micropatterning drives macrophage polarization. (a) Schematic 
of method used to micropattern cells by microcontact printing of arrays of fibronectin lines of 
various widths. (b) Phase contrast images of unpatterned cells and cells patterned on 50-μm and 
20-μm wide lines. (Scale bar: 50 μm.) (c) Quantification of cell area of unpatterned cells and cells 
patterned on 50-μm and 20-μm wide lines. (d) Quantification of elongation factor of unpatterned 
cells and cells patterned on 50-μm and 20-μm wide lines. (e) Representative Western blot of iNOS 
(a marker of inflammatory phenotype), arginase-1 (a marker of anti-inflammatory phenotype), and 
α-tubulin of unpatterned and patterned cells and quantification across three separate experiments. 
Error bars indicate the SEM for three separate experiments. *p < 0.05 compared with unpatterned 
cells as determined by the Student’s t-test. ns, not significantly different. Reproduced with 





1.2.4. Red blood cells and hemolysis 
Red blood cells, or erythrocytes, are the most abundant cells in blood, with 4 to 6 × 106 
cells μl−1 [62]. Therefore, understanding their interactions with blood-contacting biomaterials is 
essential. Unlike the other cell types described above, red blood cells do not typically directly 
attach and spread on biomaterials. Blood contact with materials, however, can induce hemolysis 
or the rupture of red blood cells. Hemolysis is often associated with the shear forces induced by 
abnormal blood flow [69]. Abnormal flow conditions can occur in blood-contacting device 
components, such as the centrifugal and roller pumps used in extracorporeal blood circuits, but 
they also occur in and around cardiovascular implants, such as heart valves and stents [69,70].  
Hemolysis results in the contents of erythrocytes being released into the blood stream and 
abnormally high plasma hemoglobin levels (hemoglobinemia). Severe cases can lead to anemia 
[71]. Hemoglobinemia can be diagnostic of problems with cardiovascular implants and 
extracorporeal circuits, and has been associated with mortality and other complications [72,73]. 
Device design geometry, placement, and other complicating health conditions, but not the 
materials per se, are typically the root causes of severe cases. Nonetheless, materials surface 
structure and physical chemistry can also have a strong influence on promoting or reducing 
hemolysis [70,74]. Taken together, the biomaterials scientist must be aware of the materials-related 
causes and consequences of hemolysis. 
1.3. Protein interactions with biomaterials 
When a biomaterial comes into contact with blood, nonspecific blood protein adsorption 
on the surface occurs within seconds. These proteins have a wide range of size, concentration, 
biological function, and chemical activity that determine their mode of adsorption and their rates 
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of transport to the surface [75]. The initial adsorption is assumed to be reversible. Reversible 
adsorption can occur through interactions resulting in low affinity with the surface. Over time, 
irreversible adsorption may occur due to multiple cooperative protein-surface interactions, protein-
protein intermolecular interactions, or protein unfolding. As a result, small proteins with higher 
concentration and low surface affinity, such as albumin, adsorb quickly and reversibly and may be 
later displaced by larger proteins with high surface affinity, like fibrinogen, leading to a change in 
the nature of the adsorbed proteins over time [41,76]. This competitive phenomenon is known as 
the Vroman effect, and leads to protein adsorption exchange on the surface over time [77,78]. 
Blood clotting on the surface of biomaterials is mainly affected by the type of proteins adsorbed 
and their structural changes (folded versus unfolded) rather than the total amount of adsorbed 
protein. As a result, the blood compatibility of biomaterials is frequently evaluated by resistance 
to nonspecific protein adsorption. Albumin, fibrinogen, vWF, fibronectin, and vitronectin are 
among the most important blood proteins that mediate blood clotting on biomaterials [41].  
Proteins mainly interact with the surface of biomaterials through electrostatic interactions, 
van der Waals forces, hydrogen bonds, and hydrophobic dehydration. These interactions can lead 
to reversible or irreversible adsorption. Reversibly adsorbed proteins do not undergo large 
conformational changes and therefore do not permanently modify the physical chemistry of the 
surface. Irreversible adsorption often results in the unfolding of the protein (changes in the 
secondary and tertiary structure) which affect the protein's biological functions and permanently 
modify the surface physical chemistry. Often the unfolded protein exposes functional protein 
domains that lead to activation of coagulation or of an immune or inflammatory response [79]. As 
such, protein denaturation on artificial surfaces is generally considered unfavorable. The 
irreversibly adsorbed proteins enable the subsequent adsorption of circulating platelets and 
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monocytes, which can then attach and activate [80–82]. Platelets can bind to the specific peptide 
regions within adsorbed proteins via cell membrane receptors and induce platelet adhesion and 
aggregation, as described above [83]. This activation results in blood clot formation. The 
monocytes differentiate into macrophages, which initiate the inflammatory response and foreign 
body response. These important cell-mediated biological responses are ultimately regulated by the 
adsorbed proteins. Understanding the behavior of protein interactions with biomaterials is an 
essential prerequisite to developing rational strategies for blood compatible materials.  
1.3.1 Fibrinogen 
Fibrinogen is a 340 kD, rod-shaped, dimeric glycoprotein, approximately 47 nm long and 
6 nm in diameter, with a plasma concentration of 2-4 mg ml-1. Each dimer of fibrinogen is 
composed of three distinct chains, designated as the Aα, Bβ and γ chains [84]. Fibrinogen has two 
important roles in blood clotting: 1) mediating platelet adhesion and 2) providing a structural 
component to blood clots. Fibrinogen adsorption is a key mediator of cell-surface interactions, 
promoting both platelet and monocyte adhesion [85]. At low shear rates fibrinogen serves as a 
major surface-adsorbed protein mediating platelet adhesion, activation, and aggregation, while its 
role is less significant at high shear rates [86,87]. Adsorption-induced unfolding of fibrinogen 
exposes platelet binding motifs that are otherwise not accessible to platelet receptors in the folded 
state of this protein [88]. The degree of adsorption-induced conformational change of fibrinogen 
can have a greater effect on platelet adhesion than the amount of adsorbed fibrinogen [89]. Non-
activated platelets bind through an integrin receptor αIIbβ3 (GPIIb/IIIa) to receptor recognition sites 
(RGD) on adsorbed fibrinogen [85,90,91]. The second important role of fibrinogen is in forming 
crosslinked fibrin fiber networks. When the coagulation cascade is activated, fibrinogen is 
converted to fibrin monomers through thrombin-mediated cleavage of small fibrinopeptides A and 
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B from the N-termini of the Aα and Bβ chains [48,49]. The fibrin monomers then polymerize and 
cross-link to form the network of fibrin fibers. This fibrous mesh on the surface of biomaterials 
provides a scaffold for cell adhesion during blood coagulation, trapping platelets and red blood 
cells to form thrombus [92–94]. 
1.3.2 Albumin 
Albumin is a 66 kD globular protein with dimensions approximately 14 nm × 4 nm. It is 
the most abundant protein in plasma at a concentration of approximately 40 mg ml-1. Additionally, 
albumin is an amphiphilic protein with high surface activity. Since albumin lacks specific 
sequences for binding platelet receptors, platelets adhere minimally to adsorbed albumin on 
surfaces. Its high surface activity also makes albumin widely used for blocking other blood 
proteins, such as fibrinogen, from adsorbing to the surfaces of biomaterials [95–98]. However, 
some studies have suggested that platelets may bind to adsorbed albumin through a non-canonical 
interaction, whereby RGD-specific receptors bind to R residues on denatured albumin [99–101]. 
This binding increases with increasing degree of albumin unfolding on the surface. Beyond a 
critical level of albumin unfolding platelet adhesion occurs very similar to the mechanism of 
platelet adhesion on adsorbed fibrinogen [99]. As such, using albumin to block adsorption of other 
serum proteins may not be sufficient to reduce or prevent platelet adhesion and activation. 
Preadsorption of albumin must be done in a manner that preserves the folded protein state. 
Moreover, fully-folded albumin may be only weakly adsorbed. To overcome the Vroman effect in 
displacing albumin with other proteins, albumin should be covalently bound to the surface when 




vWF is a large multimeric glycoprotein consisting of monomers ranging in size from 500 
to 10,000 kD with a plasma concentration of approximately 10 µg ml-1. vWF plays a central role 
in platelet adhesion and aggregation especially under high shear rates [102–104].  vWF plays a 
role as a carrier protein for FVIII, protecting FVIII from degradation [105,106]. In circulating 
blood, vWF multimers remain non-adhesive and adopt a globular conformation [107,108]. In the 
globular conformation, platelet GPIb binding sites in the vWF A1 domain are shielded [107,108]. 
Above a critical shear rate (?̇?𝛾 > 5000 s-1) vWF undergoes an abrupt transition from the collapsed 
to a stretched conformation (Figure 1.5) [109–112]. The stretched conformation has a length of 
approximately 15 µm that aggregates to form a protein network [109–112]. The shear-induced 
transition to the stretched conformation enables stretched vWF to recruit platelets by revealing the 
binding sites for the GPIb. High shear rates occur at sites of vascular injury or atherosclerotic 
stenoses [113]. High shear rates can also occur at the surfaces of cardiovascular implants and 
extracorporeal blood circuit components such as centrifugal pumps and extracorporeal 
oxygenation membranes [113,114]. The wall shear rates in the human circulatory system can range 




Figure 1.5. Dynamic conformational change of vWF under shear. (a) Cartoon (Upper) and 
selected fluorescence (Lower) images of a video sequence of vWF below and above the critical 
shear rate of a few thousand s−1. Above ?̇?𝛾crit, the protein is in an elongated conformation. The little 
yellow spots on the protein are meant to represent a variety of known binding sites. Adhesion of 
vWF (b) Below the critical shear rate ?̇?𝛾crit, only few vWF coils adhere to the collagen coated 
surface. (c) vWF adhered at high shear rates forms a spider web like network, which represents a 
very adhesive substrate for blood platelets. Reproduced with permission from [109], copyright 
2007, National Academy of Sciences. 
 
The platelet-vWF interaction is stabilized by activation of platelet integrin αIIbβ3 leading to 
platelet aggregation [110,111,116]. Designing surfaces that prevent vWF adsorption is a necessary 
prerequisite for materials that have contact with blood at high shear rate, since evidence suggests 
that at high shear rates platelet adhesion is more highly correlated to vWF adsorption than to 
fibrinogen adsorption on some model surfaces [117–119]. While many studies report fibrinogen 
and albumin adsorption on biomaterials surfaces, we know of no studies aimed at developing 
specifically vWF-resistant surfaces. The central role of this blood protein under flow in regulating 





The complement system is comprised of more than 50  proteins that interact with immune 
cells in blood to help them identify and clear pathogens [14]. Complement activation is a series of 
reactions that leads to the promotion of inflammatory responses of immune cells [120,121]. 
Complement activation can occur via three different pathways [14]. When antibodies bind to 
antigens in the blood, the “classical” pathway is initiated. Lectin proteins binding to pathogen-
associated mannose glycans activate complement through the “lectin” pathway. The “alternative” 
pathway is initiated by the spontaneous hydrolysis of a complement protein C3 into two fragments. 
One of these fragments, C3b, accumulates on pathogenic cells, signaling complement activation. 
While it is well-known that biomaterials in contact with blood can activate complement, leading 
to inflammatory responses, the mechanisms of biomaterials-associated complement activation are 
not entirely clear [16,120]. Direct binding of complement proteins, the nonspecific adsorption of 
antibodies (leading to the classical activation mechanism) and the accumulation of C3b (leading 
to the alternative activation mechanism) have all been proposed as possible initiators of 
complement activation by biomaterials surfaces [15]. Though some experiments suggest that 
hydrophobic surfaces are more reactive with respect to activating the complement system, both 
hydrophobic and hydrophilic surfaces (containing either negatively charged or nucleophilic 
groups) can contribute to complement activation [15,62]. The interactions of blood-contacting 
biomaterials with elements of the complement system is a less frequently investigated 
phenomenon but is an important blood-material interaction. 
1.3.5 Driving forces of protein adsorption and denaturation 
Both nonspecific protein adsorption and protein denaturation play key roles in thrombosis, 
inflammation and complement activation on the surfaces of materials. A vast amount of the 
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literature on blood-compatible materials is focused on the first of these challenges—reducing 
protein adsorption. A surface that adsorbs less than 5 ng cm-2 of protein in a controlled experiment  
is said to be “ultra low-fouling” [122].   Surface modification is an efficient approach to make the 
biomaterials “stealthy” with regard to nonspecific protein adsorption [123]. However, even a small 
amount of adsorbed proteins on a surface can initiate changes in the surface chemistry and 
ultimately lead to significant adverse biological responses [124,125]. Comparatively few studies 
have investigated how surfaces can be designed to address the second of these challenges—
preventing protein denaturation. To set the stage for understanding recent advances in the design 
of blood-compatible materials, this sub-section reviews the driving forces for protein adsorption 
and denaturation.  
Irreversible protein adsorption is often modeled as a series of multiple steps, following a 
path towards lower Gibbs free energy (G).  The minimum in G can be achieved by a decrease in 
the enthalpy (H) and/or an increase in the entropy (S) at constant temperature.  
∆G = ∆H - T∆S                                                                                                                                (1) 
Proteins in solution are stabilized by interactions between peptide residues that include 
hydrogen bonds, ionic bonds, and internal hydrophobic-hydrophobic interfaces. Their solvent-
exposed surfaces are typically hydrophilic, and may also have bound water molecules and 
associated small counterions (Figure 1.6). Similarly, the surfaces to which proteins adsorb may 
also have bound water and counterions. Protein adsorption to a surface liberates these bound small 
counterions and water molecules from both the protein and the surface in a region near the protein-
surface interaction, resulting in an increase in entropy. As a protein subsequently denatures, its 
internal stabilizing interactions must be broken, often leading to the exposure of hydrophobic 
regions to the solvent. These processes are endothermic (resulting in a positive ∆H and a positive 
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contribution to ∆G) [75,126]. These may be accompanied by the formation of new bonds between 
the protein and the surface, which are exothermic, but the net enthalpy change of protein adsorption 
is typically still positive. However, the liberation of counterions and water molecules as well as 
conformational changes in the protein result in a positive ∆S [127]. Protein denaturation on a 
surface is therefore assumed to be entropically driven, with the increase in entropy being more 
than sufficient to overcome unfavorable enthalpy of adsorption, resulting in a net decrease in Gibbs 
free energy [128].  
Protein adsorption depends upon both the dynamics and equilibrium of the entire system, 
and protein adsorption at solid liquid interfaces is governed by properties of both the solution and 
the interface. In the liquid phase, protein properties, buffer composition, pH, ionic strength and 
temperature affect the processes of protein adsorption. At the solid interface, surface chemistry, 
surface energy, and surface topography impact the protein-surface interaction.  
 
Figure 1.6. Schematic of the thermodynamics of protein adsorption on a biomaterial surface. Both 
the protein and the surface may have formally charged groups on their surfaces, and may have 
bound counterions (anions shown in red, and cations shown in blue), as well as bound water. 
Hydrophobic interactions that stabilize the protein structure are shown as black lines in the interior 
of the protein. The initial reversible interaction of the protein with the surface may have a positive 
ΔS (due to release of bound water and ions from the protein and surface interfaces), and a positive 
ΔH (due to rearrangement of the protein structure). Irreversible denaturation and binding of the 
protein to the surface is characterized by a large positive ΔS (due to many water molecules and 
counterions desorbing into solution, and due to rearrangement of the protein secondary and tertiary 
structure) and a relatively small (close to 0) ΔH as intermolecular protein interactions are 
exchanged for new interactions within the protein or between the protein and the surface. 
1.3.5.1 Protein characteristics influencing adsorption 
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The unique structure of each protein influences its adsorption behavior on surfaces. 
Important structural features include size, solvent-accessible surface area, structural stability, net 
charge, configuration, and amino acid composition. Proteins are high molecular weight 
macromolecules composed of 20 naturally occurring amino acids. The folded protein surfaces 
consist of different local patches characterized by positively charged, negatively charged, 
hydrophobic, and hydrophilic moieties that are dictated by the primary, secondary, and tertiary 
protein structure [129]. Proteins are broadly classified as “soft” if they readily unfold upon 
adsorption on surfaces, or “hard” if they are more stable and mobile. Important blood proteins such 
as albumin, fibrinogen, and immunoglobulin G (IgG) are considered soft, whereas hard proteins 
include small enzymes, such as lysozyme.  
1.3.5.2 Solution characteristics influencing protein adsorption 
The solution pH is another parameter that controls protein adsorption through two different 
mechanisms. Proteins contain weak ionic groups (amines and carboxylic acids) which are sensitive 
to pH. The isoelectric point is the pH at which the surface net charge of the protein is zero. At pH 
> pI the proteins are negatively charged in solution and at pH < pI they are positively charged. 
Proteins exhibit higher adsorption at their isoelectric point (when pH = pI) due to minimized 
protein-protein repulsions. Electrostatic interactions are another major contributor to protein 
adsorption on biomaterials controlled by pH [130]. Formal charges of opposite sign on the surface 
and the protein create electrostatic attractions, increasing transport rates to the surface, and can 
form ionic bonds that stabilize surface-adsorbed proteins.  
The amount of adsorbed proteins on surfaces generally increases at higher temperature due 
to both thermodynamic and kinetic effects. From a thermodynamics perspective, increased 
temperature increases both conformational and configurational entropy in the bulk solution 
29 
 
[98,131–133] and increases the liberation of water molecules and ions from solid-liquid and 
protein-liquid interfaces [126]. Kinetically, at higher temperatures,  protein diffusion is accelerated 
leading to higher protein transport to the surface [75].   
Buffer composition and ionic strength can strongly affect protein adsorption behavior on 
solid surfaces by altering protein solubility [134,135]. The effects of specific ions can be 
understood by their classification according to the Hofmeiseter series [136]. Kosmotropes (e.g., 
HPO42-, Mg2+, SO42-) are highly hydrated and bind water more tightly, reducing the solubility of 
non-polar groups, and thereby accelerating protein precipitation [137]. On the other hand, 
chaotropes (e.g., NH4+, I-, NO3-) are weakly hydrated and decelerate protein precipitation [137]. 
Phosphate buffered saline (PBS) at physiological pH is the most commonly used buffer for protein 
adsorption studies on solid surfaces. PBS usually contains NaCl, KCl, KH2PO4, and NaH2PO4.  
1.3.5.3 Surface characteristics influencing protein adsorption 
Surface properties also play a decisive role in the protein-surface interactions. The 
chemistry [138], topography [139], and surface energy [140] all influence the extent of protein 
adsorption and possible conformational changes. Researchers have developed materials that to 
some degree are resistant to nonspecific protein adsorption to enhance blood compatibility of 
surfaces. Since there is still no biomaterial with absolute resistance to protein adsorption, new 
materials and surface treatments that eliminate nonspecific protein adsorption for various 
applications including blood-compatible materials are currently under development. 
For nearly 20 years the rules articulated by Whitesides and co-workers [141] have guided 
much of the research on preventing protein adsorption through surface chemistry. By surveying 
structure-property relationships of well-defined self-assembled monolayers (SAMs), this group 
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discerned four surface properties that can reduce protein adsorption:  (1) hydrophilicity of the 
surface (polar functional groups); (2) the presence of hydrogen-bond acceptors; (3) the absence of 
hydrogen-bond donors and (4) neutral overall electrical charge of the surface. The first three of 
these properties are all related to retaining bound water on the surface. Hydrophilicity is generally 
quantified by water contact angle measurements (θCA). Hydrophilic surfaces (θCA < 90°) are 
hypothesized to resist protein adsorption since hydrogen bonding to water is so strong that protein 
cannot displace water from the interface. Hydrophobic surfaces (θCA > 90°) have low surface 
energy and more readily release water molecules, inducing protein adsorption. Subsequent protein 
denaturation can result in inner hydrophobic protein domains interacting with the surface, while 
their outer hydrophilic domains are exposed to the solution, further stabilizing the adsorbed state. 
The fourth property—net charge neutrality—can reduce both kinetic and thermodynamic effects 
leading to protein adsorption. Charge neutrality reduces electrostatic attractions that facilitate 
protein attraction to the interface. Charge neutrality also may reduce the number of counterions 
that can be released upon protein adsorption thereby reducing the overall ∆S of adsorption. Taken 
together, these “rules” suggest that hydrophilic uncharged chemistries probably are among the best 
candidates for designing protein-resistant surfaces. The question still remains, however, as to 
whether protein-resistant surfaces provide long-term blood compatibility. 
Surface topography is another important factor that influences protein adsorption and 
subsequent cell behaviors [142–145]. Texture, at the microscale and nanoscale, including features 
with both vertical and lateral topographical dimensions, increases specific surface area and alters 
surface energy [146]. These changes may affect the amount of protein adsorption and the 
conformation of adsorbed protein. Nanoscale topographical features may be more important than 
features at larger length scales for influencing the interactions of individual protein molecules with 
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surfaces as they are measured at the same length scale as protein dimensions. While several studies 
reviewed below characterize the effects of surface topography on protein adsorption, there is still 
no universal set of rules that describe how these features should be chosen to optimize 
performance.  
Studies of protein adsorption on nanostructured model surfaces including titanium, TiO2, 
tantalum, and platinum have been reported with the goal of discerning the effects of nanostructure 
on protein-surface interactions. Fibrinogen adsorption to tantalum and albumin adsorption to 
platinum are both increased with increasing nanoscale roughness [147,148] while albumin 
adsorption to tantalum is less affected by surface roughness [147]. One report of albumin and 
fibrinogen adsorption on titanium found that nanoscale features in the range from about 20 to 200 
nm have no effect on the amount of adsorbed protein [149]. The conformation of adsorbed proteins 
is also potentially affected by nanoscale surface features. For example, fibrinogen adsorbs with an 
altered conformation on nanopatterned diamond-like carbon and TiO2 compared to planar surfaces 
of the same chemistry [143]. It is apparent that the local features on nanostructured surfaces may 
influence the surface properties such as surface chemistry and surface energy [150] but the overall 
effects of these surface properties on the extent, orientation, and conformation of adsorbed proteins 
is not completely understood. 
1.4. Strategies for improving blood compatibility of biomaterials 
Over the last three decades, research thrusts in biomaterials and surface science have aimed 
to address the interactions of biomaterials surfaces with blood components, reviewed above. This 
has led to advances in our understanding of thrombosis and inflammation on biomaterials and the 
connections between thrombosis and inflammatory responses.  Understanding how the physical 
chemistry of surfaces influences blood-surface interactions is leading to new advances in blood-
32 
 
compatible materials. To combat thrombus formation on artificial blood-contacting surfaces, 
research has focused on several different materials and surface modification approaches. Various 
strategies such as incorporation of hydrophilic polymers, bioactive components, bioinspired 
surfaces, surface endothelialization, and NO release have been proposed. These strategies can be 
optimized to reduce protein adsorption, control coagulation, and mitigate platelet adhesion and 
activation, and inflammation. Strategies to reduce protein adsorption have received the greatest 
amount of attention in this field; studies aimed at understanding how surface properties affect 
blood cells is also leading to exciting new materials design opportunities. This section highlights 
the current state of these strategies to improve blood compatibility through materials design.  
1.4.1 Polymer brushes 
Polymer brushes on solid interfaces represent a unique surface architecture with features 
that can be engineered to control protein-surface and cell-surface interactions [151–154]. Polymer 
brushes present a thin film that modifies surface properties such as chemistry, nanotopography, 
and wettability. These surface properties in turn can be tuned to reduce protein adsorption and cell 
attachment under physiological conditions. Covalently attached polymer brushes can be prepared 
by either a “grafting to” or a “grafting from” method [152]. In general “grafting to” (attaching pre-
formed polymer chains to a surface) results in lower grafting density than “grafting from” 
(initiating the polymerization from the surface). However, “grafting to” decouples the 
polymerization from the brush formation step, affording the opportunity for better control over the 
polymerization, for example, to achieve lower polydispersity.  
1.4.1.1 Physical structure and chemistries of polymer brushes 
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The physical structure of surface-anchored polymer brushes can be characterized by 
grafting density and brush thickness [155]. The conformations of the polymer chains attached to a 
surface are broadly classified as “pancake,” “mushroom,” “brush,” and “highly stretched brush” 
(Figure 1.7). These conformations are defined based on the reduced tethered density, Σ = σπRg2, 
that determines three regimes. Where Rg is radius of gyration of a tethered chain at specific 
experimental conditions of solvent and temperature, and the brush grafting density (σ) is 
determined by σ = (hρNA)/Mn. (h is dry brush thickness, ρ is bulk density of the polymer, NA is 
Avogadro’s number, and Mn is the number average molecular weight). The transition from the low 
grafting density “mushroom” regime to the “brush” regime occurs when Σ > 1 and the “highly 
stretched brush” regime is characterized by Σ > 5 (Figure 1.7) [151,156]. Many researchers have 
demonstrated polymer brushes that suppress nonspecific protein adsorption [157].  
 
Figure 1.7. Schematic of the conformations that polymer chains tethered to a surface may adopt, 
as classified based on the polymer chain configuration in relation to the surface and as constrained 
by the polymer graft density. 
Poly(ethylene glycol) (PEG)/poly(ethylene oxide) (PEO) brushes are widely used to create 
a steric barrier, shielding the surface from fouling by nonspecific protein adsorption. PEG or PEO 
brushes are often used as a standard for comparison of new surface chemistries and new polymer 
architectures. Other materials used for preparing protein-resistant and blood-compatible polymer 
brushes include modified poly(methacrylates) [158], modified poly(acrylamides) [159,160], and 
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poly(2-oxazoline)s (POX) [161,162]. When new materials are developed, the initial studies are 
usually done to demonstrate how the brush properties affect protein adsorption. Functional 
biological responses, such as cell and bacterial adhesion, platelet activation, and thrombus 
formation are assumed to be regulated by initial protein adsorption. However, comparatively few 
studies investigate these important downstream biological responses in detail. The literature 
reviewed in this section focuses on results that are particularly relevant for blood-contacting 
materials, beginning with protein resistance of PEG/PEO brushes. 
 
1.4.1.2 Mechanisms of protein resistance  
The ability of nontoxic and non-immunogenic PEG/PEO brushes to suppress protein 
adsorption has been attributed to ‘‘steric’’ repulsion from high mobility of polymer chains, 
hydrogen bonding with water to form a hydration shells, and very low electrostatic interactions 
between protein and the PEG/PEO layer [163–165]. In the highly-stretched brush conformation, 
protein adsorption is prevented primarily by a kinetic barrier; the brush slows protein diffusion to 
the underlying surface, and confinement retards local brush mobility [166,167]. Tethered polymer 
chains that interact favorably with the surface may also prevent protein adsorption 
thermodynamically, via site-blocking, by competing for the surface [166,168]. The differences 
between these kinetic and thermodynamic barrier mechanisms is difficult to verify experimentally. 
Nonetheless, the relative effects of these two mechanisms is important for the long-term 
performance of protein resistance. Surfaces that resist protein adsorption primarily through kinetic 
barriers will not perform well in long-term applications. However, for short-term applications, they 
may perform more favorably. Therefore, the time scale for the application of the surface in contact 
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with blood should be considered when designing protein-resistant and blood-compatible polymer 
brushes.  
1.4.1.3 Tuning PEG/PEO brushes to optimize protein and cell resistance 
Many studies have shown grafting density, brush thickness, and polymer molecular weight 
have essential impact on extent, orientation, and overall rate of protein adsorption as well as 
affinity for unfolded proteins [169–172]. Polymer brush hydrophobicity also can be tuned to 
optimize protein resistance. Hydrophobicity of the brush can be modified by selection of the 
terminal functional group on a PEG/PEO chain, and by selection of polymer chain and substituent 
functional groups. Important recent findings also show that hydrophobicity of PEG/PEO brushes 
is dictated by their structural properties. 
Grafting density can modulate the hydrophobicity of the brush. Therefore, resistance to 
protein adsorption and stabilization of protein conformation are not necessarily improved 
monotonically by increasing grafting density. The optimum grafting density and brush thickness 
depends upon the PEG/PEO molecular weight [170,171]. The correlation between the protein 
adsorption and the amount of water contained within different polymer brushes was investigated 
recently. The water content inside the polymer brushes strongly impacts the extent of protein 
adsorption; brushes having the highest water content more efficiently resist protein adsorption 
[173]. Molecular dynamics simulations have revealed that hydration of PEO brushes depends on 
the accessibility of water inside the grafted layer. Therefore at lower grafting densities PEO is 
well-hydrated (σ < 1.5 chains nm-2) with the exception of the close vicinity of the substrate [174]. 
By increasing the grafting density (with highest σ = 4.18 chains nm-2), however, the polymer 
volume fraction increases and the PEO grafted layer becomes dehydrated [174]. The relative 
degree of hydration may impact the local hydrophobicity of the brush. Recently, it has been shown 
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that by increasing PEG grafting density (from 0.16 to 0.34 chains nm-2) the rate of fibronectin 
adsorption decreases, but adsorbed fibronectin unfolds more readily and the unfolded fibronectin 
remains on the surface for longer residence times relative to folded molecules (Figure 1.8) [171]. 
The same authors later showed that PEG brushes are spatially heterogeneous, presenting nanoscale 
hydrophobic niches on the surface, and that these hydrophobic niches increase with the surface 
grafting density of the polymer chains (Figure 1.8) [175]. This phenomenon may explain 
denaturation of surface-adsorbed proteins at high grafting density. Interestingly, static contact 
angle of both low and high grafting density PEG surfaces was identical despite the existence of 
nanoscale hydrophobic niches, indicating the inability of conventional macroscopic measurements 




Figure 1.8. (a) Single-molecule observations provide detailed local information about nanoscale 
hydrophobicity in PEG brushes. Super-resolution maps generated from accumulated NBD-X 
trajectories for both high and low grafting density PEG brush surfaces (6 × 105 and 1 × 106 
trajectories, respectively). The color scale indicates the differences in local hydrophobicity based 
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on the parameter HI. (b) and (c) The apparent surface residence time of unfolded molecules 
increased with grafting density, confirming that the apparent increase of unfolded molecules at 
high grafting densities was due to an increase in surface residence time. Complementary 
cumulative surface residence time distributions for molecules that were (b) always folded and (c) 
always unfolded on bare fused silica and various PEG brushes, as annotated. Each distribution was 
fit to an exponential mixture model (black lines). Reproduced with permission from [171,175], 
copyright 2016 and 2018, American Chemical Society. 
Many researchers have studied how the brush thickness, molecular weight, and chain 
terminus chemistry of PEG/PEO brushes affect nonspecific blood protein adsorption. PEG/PEO 
brushes have also been used to reduce adsorption of a wide variety of proteins, bacteria, platelets 
and cells  [176–181]. Emilsson et al. [182] presented a new grafting-to method that uses Na2SO4 
in the solvent, allowing for high grafting density to be achieved. They grafted different molecular 
weights of both methoxy- and hydroxyl-terminated PEG and investigated irreversible binding of 
10× diluted serum. Surface plasmon resonance (SPR) data clearly showed that 2, 5, and 10 kDa 
methoxy-terminated PEG brushes, with thicknesses between 6 and 25 nm provide good serum 
resistance that exceeds the performance of oligo(ethylene glycol) (OEG) monolayers. A trend of 
reduced protein adsorption with increasing brush height was observed from 2 kDa to 10 kDa PEG 
brushes. For higher molecular weight (20 kDa and 30 kDa) the protein resistance is reduced, and 
these PEG brushes do not out perform OEG monolayers. The best performance was achieved for 
hydroxyl-terminated 10 kDa PEG, which corresponded to 4 ng cm-2 adsorbed proteins. They 
concluded that their strongly stretched PEG brushes provide a kinetic barrier to blood protein 
adsorption rather than an equilibrium barrier. In a similar study, grafting densities from 0.26 to 
1.60 chains nm-2 were obtained in different concentrations of Na2SO4 from 5 kDa methoxy-
terminated PEG [183]. This study found that increasing PEG graft density reduced BSA adsorption 
to below the detection limit using quartz crystal microbalance measurements [183].  
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Riedel et al. also prepared different brushes using a grafting-from method, to identify 
proteins responsible for blood plasma fouling on PEG- and OEG-based surfaces [158]. In their 
work, mixed alkane thiol SAMs were compared to PEG brushes (-COOH, -OH, and -OCH3 
terminated) and to brushes made from methacrylate polymers with grafted OEG side chains (-OH 
and -OCH3 terminated). The poly(methacrylate-g-OEG) graft copolymer brushes are much thicker 
than the PEG brushes, and result in less deposited blood proteins compared to PEG brushes. The 
authors concluded that closely packed brush structure prevents the penetration of the fibrinogen, 
human serum albumin (HSA), and IgG into the brush layers regardless of the hydrophilic or 
hydrophobic end groups on the graft copolymer brushes. On PEG-OH and PEG-COOH polymer 
brushes, however, HSA, and IgG proteins were detected. SPR data also confirmed that the mass 
of plasma deposited on the surfaces decreased in the order SAM > PEG > poly(methacrylate-g-
OEG) brushes.  
An important outstanding issue with PEG-/PEO-based brushes is the durability of their 
antifouling properties in physiological and oxidative environments [184,185]. PEG/PEO may be 
oxidized by exposure to air and physiological environments, over hours to days, altering the 
chemistry and structure of the brush [186–188]. When in long-term contact with biological 
systems, enzymes, ROS and RNS may alter the chemistry of biomaterials, including PEG/PEO, 
reducing their ability to resist protein adhesion [189]. Development of alternative chemical 
structures with improved durability is an important direction for future research. 
1.4.1.4 POXs and poly(2-oxazine)s 
POXs provide access to a different polymer chemistry and have become a prominent 
PEG/PEO alternative, because of their biocompatibility [161,162]. These hydrophilic polymers 
contain hydrogen bond acceptors and bear no formally charged groups, consistent with the 
40 
 
Whitesides criteria, described in section 3.5.3. Furthermore, the hydrophilicity and mechanical 
properties can be tuned by simply changing the side chain of the monomer, and their antifouling 
properties can be retained for longer periods than PEG/PEO [162,184]. The longer term stability 
of their antifouling properties may be related to higher resistance to oxidation compared to 
PEG/PEO [190]. Poly(2-alkyl-2-oxazoline)s (PAOXAs), in particular the poly(2-methyl-2-
oxazoline) (PMOXA) and poly(2-ethyl-2-oxazoline) (PEOXA), have been emerging as very 
promising candidates to modulate the interfacial, chemical,  and mechanical properties for 
enhancing antifouling properties [191–194]. Several studies have reported the grafting of 
PAOXAs to PU  (PU-g-PEOXA)s [195], poly(methylacrylic acid) (PMAA-g-PMOXA) [196], 
poly(ethylenimine) (PEI-g-PMOXA) [197], poly(L-lysine) (PLL-g-PMOXA) [198] as well as 
brush copolymers of 4-vinylpyridine (PMOXA-r-4VP) [199] that to some extent showed 
resistance to protein adsorption, platelet attachment, and other cell attachment.  
A recent study by Tang et al. investigated a series of poly[oligo(2-alkyl-2-
oxazoline)methacrylate] (POAOXMAs)  brushes by grafting from the surface of SPR chips [200]. 
They characterized the amount of protein adsorption using bovine serum albumin (BSA), 
fibronectin, and fetal bovine serum (FBS) on POX-based brushes and PEG-thiol monolayers. They 
investigated the effects of surface hydrophilicity/hydrophobicity and brush thickness on protein 
adsorption. All brush films performed significantly better compared to the PEG monolayer. The 
poly[oligo(ethylene glycol)methacrylate] (POEGMA) (13 nm thick, water contact angle = 53°), 
and  poly[oligo(2-ethyl-2-oxazoline)methacrylates] (POEOXMA-Me, 21 nm thick, water contact 
angle = 58°) showed only very little adsorption from all protein solutions studied. However, when 
the POEOXMA-Me thickness is reduced to 12 nm, more BSA and serum were adsorbed [200].  
This result could be because of the slightly increased hydrophobicity of POEOXMA-Me, 
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compared to POEGMA. For poly[oligo(2-methyl-2-oxazoline)methacrylates] (POMOXMA-Me, 
water contact angle = 28°) with 12 nm thickness, adsorption was low for BSA and fibronectin. 
FBS adsorption for POMOXMA-Me had intermediate values of protein adsorption compared to 
POEGMA and POEOXMA-Me. The authors concluded that adsorption of small molecules from 
serum is based on diffusion into spaces between polymer brushes rather than brush hydrophilicity 
[200].  
In another recent study, Morgese et al. generated poly(2-methyl-2-ozazine) (PMOZI) 
grafted to PLL (PLL-g-PMOZI) on SiO2 surfaces and compared the interfacial physicochemical 
properties of brushes with PLL-g-PEG, PLL-g-PMOXA, and PLL-g-PEOXA (Figure 1.9) [201]. 
PMOXA and PMOZI brushes showed the most hydrophilic character. They tested the protein 
resistant of PLL-g-X films, exposing them to 10% human serum (HS) and FBS for 1 hour. All the 
brushes significantly reduced protein adsorption compared to the bare SiO2 surface. PMOZI and 
PEOXA brushes were the most, and the least antifouling films form HS and FBS despite the fact 
that the hydrophilicity of PMOZI and PMOXA are very similar. The authors believed that the 
differences in antifouling activity stem from the higher flexibility of PMOZI chains that generates 
an efficient entropic barrier with respect to PAOXA counterparts (additional methylene group). 
PMOZI brushes also presented a very strong barrier towards cell (chondrocyte) attachment. After 
a 24 h incubation there was no cell attachment (Figure 1.9). The percentage of cell attachment on 
surfaces decreased in the order SiO2 > PLL-g-PEOXA > PLL-g-PEG> PLL-g-PMOXA brushes. 
The authors concluded that the combination of high hydration and enhanced chain flexibility 




Figure 1.9. (a) Surface functionalization with brush-forming graft copolymers of different side-
chain compositions. All of the brushes significantly reduced the amount of adsorbed protein both 
from HS and FBS compared to the bare SiO2 surface. Protein adsorption from (b) 10% HS and (c) 
10% FBS on PLLg-X films measured by variable angle spectroscopic ellipsometry after 1 h of 
exposure. (d) Amount of adsorbed proteins as a function of polymer brush hydration (H2O/ 
monomer). (e) Representative immunofluorescence micrographs highlighting chondrocytes 
adhered on the different films are reported in (first row) (without 10% FBS) and (second row) 
(with 10% FBS). Reproduced with permission from [201], copyright 2018, John Wiley and Sons. 
1.4.1.5 Other synthetic approaches        
Other synthetic approaches are also widely used to prepare polymer brushes that reduce 
nonspecific protein adsorption and subsequent thrombus formation. Polymer brushes from 
poly(amides), poly(thiophenes), poly(acrylamides), and poly(methacrylates) can also be tuned to 
reduce adsorption of a single protein, proteins from human blood serum or plasma, and/or bacteria 
adhesion and/or cell attachment [202–208]. Poly[N-(2-hydroxypropyl) methacrylamide] 
(poly(HPMA)) and poly(carboxybetaine acrylamide) (poly(CBAA)) brushes  grafted from gold 
surfaces exhibit very low protein adsorption, reduce the adhesion of leukocytes, erythrocytes, and 
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reduce thrombosis formation in short-term (< 1 h) studies [159,160]. When these polymer brushes 
are translated to polycarbonate (PC) substrates, they drastically reduce fouling from full human 
blood plasma compared to the bare PC for short contact time (10 min) under flow [209]. In another 
study from this group, uniform polymer brushes of poly(2-hydroxyethyl methacrylate) (PHEMA) 
and poly(methacrylate-g-OEG) were grafted from chitosan hydrogel surfaces to produce coatings 
for implantable biosensing devices [210]. The polymer brushes exhibited better resistance to 
protein fouling from single protein solutions and from diluted human blood plasma in a short-term 
study compared with bare chitosan hydrogel. They also prevent the adhesion and activation of 
platelets and leukocytes after 60 min contact.  
This body of work affirms that the underlying mechanisms whereby polymer brushes 
reduce protein adsorption on materials surfaces can be elucidated, and that these mechanisms can 
be linked to tunable brush properties, such as brush density, hydrophobicity/hydrophilicity, and 
molecular weight. Many of the fundamental studies on polymer brushes have been conducted on 
model surfaces optimized for interrogation by particular high-resolution analytical techniques (e.g. 
gold surfaces used for SPR). The translation of these polymer brushes to materials already used in 
blood-contacting applications, with control over brush properties is a technological challenge for 
some material types. While polymer brushes provide promising surface types for resisting protein 
adsorption, their stability for long-term blood-contacting applications remains an important open 
question. Future studies should continue to develop rational design principles for blood-compatible 
polymer brushes and should anticipate the need for long-term stability, particularly in a potentially 
oxidative environment created by a local inflammatory or foreign body response. To that end the 
interactions of promising polymer brush surfaces with specific cell types involved in blood clotting 
and inflammation should also be further investigated.     
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1.4.2 Zwitterionic interfaces 
Although polymer brushes reviewed above can be tuned to suppress nonspecific protein 
adsorption and subsequent fouling from whole blood, chemical stability decreases in the presence 
of metal ions and oxygen which significantly reduces their antifouling properties. Zwitterionic 
interfaces are an attractive alternative to polymer brushes for preventing protein adsorption. 
Zwitterionic materials possess both anionic and cationic groups with overall neutral charge. Two 
primary classes of zwitterionic materials have been most widely studied: (1) betaines that carry 
both cationic and anionic groups on the same monomer unit such as carboxybetaines and 
sulfobetaines and (2) polyampholytes which are copolymers, carrying a 1:1 ratio of positively and 
negatively charged groups on two different monomer units [211].  
1.4.2.1 Mechanism of protein resistance 
Surface modification of biomaterials with zwitterions to inhibit fouling can be achieved 
either by adsorbing as a two-dimensional monolayer (2-D) or by creating three-dimensional 
polymer brushes (3-D). Both 2-D and 3-D zwitterionic surfaces prevent protein adsorption by 
enthalpic and entropic mechanisms. The antifouling ability of both types of coatings is mainly 
attributed to formation of a hydration shell via ion-dipole interactions with water, which are much 
stronger than hydrogen bonds, creating a stronger enthalpic resistance to protein adsorption than 
similar PEG/PEO surfaces or other types of polymer brushes [212]. Moreover, since zwitterion 
surfaces contain paired positively and negatively charged groups covalently attached to each other, 
there is no release of small counterions to provide an entropic driving force for protein adsorption 
(compare Figure 1.6) [213]. Zwitterionic polymer brushes (3-D), have the benefit of an excluded 
volume effect that works as an additional entropy penalty preventing proteins from approaching 
the surface [211].  
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1.4.2.2 Tuning zwitterionic surfaces to optimize blood compatibility 
Zwitterionic biomaterials have gained special attention for designing blood-compatible 
surfaces because of their resistance to nonspecific protein adsorption, platelet adhesion and 
activation, cell attachment, and thrombus formation [214–224]. Yang et al. reported that protein 
adsorption from undiluted HS and plasma on poly(carboxybetaine) brushes is undetectable at both 
25 °C and 37 °C by SPR for approximately 1 h exposure [225]. This group also grafted zwitterionic 
copolymers containing anionic and zwitterionic blocks of poly(11-mercaptoundecyl sulfonic 
acid)-b-poly(sulfobetaine methacrylate) (PSA-b-PSBMA) onto a positively charged surface with 
controlled surface density [226]. The resulting zwitterionic copolymer brushes reduce protein 
adsorption to approximately 0 ng cm-2 using fibrinogen solution, and < 10 ng cm-2 in 100% HS 
and plasma. They also reported zero blood platelet adhesion and blood cell attachment in a short-
term experiment.  
PU materials are widely used in medical devices that have contact with blood despite their 
poor blood compatibility. Several studies report reduced biofouling on zwitterion-modified PU 
surfaces compared to commercially available PU [227–229]. In particular PU modified with 
zwitterionic chemistries can reduce biofouling from blood. In a recent study, PU was modified 
with three types of zwitterionic brushes to improve biofouling properties [230]. All three types of 
zwitterionic brushes reduced the blood protein adsorption, platelet adhesion, and cell attachment 
on the PU surface. One of the few studies demonstrating long-term blood-compatibility used 
poly(sulfobetaine) to modify the inner and outer surfaces of PU-based peripherally inserted central 
catheters (PICCs) (Figure 1.10) [231]. Modified catheters significantly reduce thrombus 
accumulation after 60 days of exposure to serum compared to unmodified and commercial 
catheters that were used less than one day in serum. This demonstrates the long-term protection 
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against thrombus formation (Figure 1.10). Significant reductions of protein, mammalian cell, and 
microbial cell attachment in vitro and in vivo were also observed on modified PICCs compared to 
commercial PICCs.  
 
Figure 1.10. (a) PolySB modification of PICC (peripherally inserted central catheters) surface. 
PolySB is bound to the surface of the PICC to form a conformal polymer surface. The zwitterionic 
polySB modification coordinates both free and bound water molecules to create a hydrophilic 
surface. (b) PolySB-modified PICC has reduced thrombus accumulation. Catheters were exposed 
to bovine blood in a flow loop system. Image shows variations in thrombus accumulation with 
different PICCs. (c) PolySB-modified and commercial PICCs were exposed to serum for 60 days. 
Adherent platelet data from serum-exposed polySB-modified PICCs were normalized to serum-
exposed commercial PICCs. (d) Accumulated thrombus was removed from serum-exposed 
polySB-modified and commercial PICCs and weighted. Weight data were normalized to the 
commercial PICCs (60 days in serum). For (c) and (d) actual average percentage of values are 
indicated above each bar. Reproduced with permission from [231], copyright 2012, The American 
Association for the Advancement of Science. 
Improvements in hemocompatibility of membrane oxygenators have facilitated the 
increased use of extracorporeal membrane oxygenation in recent years [232]. Several studies have 
demonstrated reduced blood protein adsorption, platelet adhesion, and/or cell attachment on 
membranes modified with zwitterionic materials [233–238]. Wang et al. coated the surfaces of a 
polypropylene hollow fiber membrane oxygenator and its connecting tubes with a zwitterionic 
copolymer bearing hydrophobic N-butyl and crosslinkable trimethoxysilyl side chains (PMBT) 
[239]. This modification significantly reduces fibrinogen adsorption, platelet adhesion and 
activation, and blood cell attachment. Moreover, thrombus formation is significantly reduced on 
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the modified membrane, compared to the unmodified membrane using whole canine blood 
circulated for 2 hours (Figure 1.11).   
 
Figure 1.11. Zwitterionic copolymer PMBT coated oxygenator membrane has reduced thrombus 
accumulation. Optical microscope and SEM images of the bare (a1, a2 and a3, a4) and PMBT 
copolymer coated (b1, b2 and b3, b4) polypropylene hollow-fiber membranes after circulation 
with dog blood for 2 h. Reproduced with permission from [239], copyright 2016, Elsevier. 
Modification of surfaces with zwitterionic chemistries is a promising strategy for 
improving blood compatibility of blood-contacting materials. While a relatively small number of 
zwitterionic chemistries have been studied in detail, these model chemistries have demonstrated 
that reduced protein adsorption can be correlated to improved performance in both long-term and 
whole blood studies, as shown above. The general strategy of using zwitterions could be expanded 
to other chemistries that are scalable and manufacturable to improve the prospects of these types 
of surfaces. 
1.4.3 Bioactive surfaces 
Surface immobilization of bioactive molecules or biopolymers including polysaccharides, 
peptides, enzymes, and antibodies has attracted considerable attention for designing antifouling 
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surfaces. This section discusses heparinized surfaces, surfaces modified with direct thrombin 
inhibitors and immunomodulators, and surfaces modified with other biopolymers. 
1.4.3.1 Heparin and heparin mimics  
Heparin coatings to improve blood compatibility of surfaces have been in clinical 
application for over 30 years. For example, the CBAS (which stands for Carmeda bioactive 
surface) of Carmeda AB® was developed from early work of Larm et al. [240], in which heparin 
is covalently bonded to the substrate. This surface has been used in a variety of blood-contacting 
applications including extracorporeal circulation devices (Medtronic plc), ventricular assist 
devices (Berlin Heart GmbH), vascular stents, stent grafts, and vascular grafts (W.L. Gore & 
Associates, Inc.) [241].  
Heparin is a naturally occurring GAG that possess structural similarity to heparan sulfate. 
Heparan sulfate is a key component of the glycocalyx presented by the endothelial cells lining the 
inside surfaces of blood vessels. Heparin inhibits FXIa, FIXa, FXa, and thrombin, thereby 
inhibiting blood clot formation [8]. For long-term blood compatibility of heparinized biomaterials, 
heparin can be immobilized by surface conjugation. The immobilized which binds ATIII through 
an active pentasaccharide sequence [242]. For example, heparin was bound to aminated poly(1,8-
octanediol-co-citrate) (POC) onto POC-modified ePTFE vascular grafts material and remained 
bioactive up to 28 days [243]. The modified grafts were shown to significantly reduce platelet 
adhesion and clot formation during that period. Several studies have also reported that heparin 
immobilization to poly(lactic acid) (PLA) membrane surfaces improves hemocompatibility of 
dialysis membranes [244,245]. In another study, small-diameter nanofibrous vascular grafts using 
a thermoplastic polycarbonate-urethane (PCU) were electrospun and fabricated [246]. The surface 
was modified via plasma treatment and subsequent covalent conjugation with heparin (Figure 
49 
 
1.12). The patency of heparin-conjugated PCU grafts was investigated by implanting grafts with 
an inner diameter of 1 mm and approximate length of 1.0 cm in the left common carotid artery of 
rats. Compared to untreated grafts, much more surrounding tissue around the heparin-modified 
grafts was observed with visible microvessels indicative of vascularization after 4 weeks (Figure 
1.12). Moreover, anti-thrombogenic activity of the immobilized heparin prevented occlusion as a 
consequence of thrombosis in the synthetic grafts. Cross-section staining for CD163, which is a 
marker of M2 (anti-inflammatory) macrophages, showed some positive cells in the tissue 
surrounding both the plasma-control and plasma-heparin grafts after 4 weeks in vivo, indicating 






Figure 1.12. Structural characterization of nanofibrous PCU vascular graft, explantation of the 
grafts, and inflammatory response of PCU plasma-control and plasma-heparin grafts after 4 weeks 
in vivo. SEM images taken from (a) side and (b) top view of an electrospun PCU vascular graft. 
Structure of nanofibers in the (c) inner (luminal) and (d) outer surface of the vascular graft before 
the plasma treatment; structure of nanofibers in the (e) inner and (f) outer surface of the vascular 
graft after the plasma treatment. (g) Nanofibrous PCU vascular grafts of various inner diameters 
(i.e. 1-mm and 6-mm) were fabricated to demonstrate the versatility of the electrospinning method. 
(h) Bending of a 6 mm-diameter PCU graft to confirm desired mechanical property. Scale bar = 
500 μm in a, b; scale bar = 30 µm in c, d, e, f. (i) 4-week plasma-control graft in situ taken 
immediately prior to explantation. (k) 4-week plasma-heparin graft in situ taken immediately prior 
to explantation. White arrows indicate noticeable microvessels and vascularization in the 
surrounding tissue of the grafts. Immunostaining for CD163 (j and l) of the cross-sections obtained 
from the vascular graft of the plasma-control and plasma-heparin grafts after 4 weeks in vivo was 
performed. White arrows indicate cells positive for CD163, within the graft wall. White dashed 
lines delineate the border of the graft wall. Cell nuclei were stained using DAPI (blue). Scale bar 
= 100 μm. Reproduced with permission from [246], copyright 2017, Elsevier. 
Heparin immobilization with other biomolecules on the surface of biomaterials to inhibit 
thrombus formation and accelerate endothelialization is another promising method for developing 
blood-compatible materials. Co-immobilization of heparin and fibronectin on the surface of 
titanium reduces fibrinogen denaturation, platelet activation and aggregation, improves blood 
compatibility, and increases ATIII binding density compared to unmodified titanium [247,248]. 
Modified surfaces also exhibit improved endothelial cell compatibility compared to Ti surfaces. 
Recently, RGD and heparin were grafted onto PTFE surfaces coated with dopamine (PTFE-DA) 
via a thin layer of PEI to promote endothelial cell affinity and to improve blood-compatibility of 
PTFE (Figure 1.13) [249]. While RGD-modified PTFE-DA increased platelet adhesion, the 
addition of heparin co-immobilization dramatically decreased platelet adhesion and improved 




Figure 1.13. (a) SEM images of platelets attached to PTFE, P-PTFE (plasma-treated PTFE), DA-
PTFE (Dopamine-coated P-PTFE), RGD-PTFE (RGD-grafted PTFE), and R/H-PTFE 
(RGD/heparin-grafted PTFE). (b) Water contact angle results of different PTFE samples. (c) 
Fluorescence images of HUVECs cultured on different PTFE substrates for 7 days. Live cells were 
stained with calcein-AM (green) and dead cells were stained with EthD-1 (red). Reproduced with 
permission from [249], copyright 2018, The Royal Society of Chemistry. 
Since the ability of immobilized heparin to preserve ATIII is a key attribute to retain its 
anticoagulant activity, chemical conjugation should retain this important functional activity 
[250,241]. However, heparin coating on the surface of biomaterials has a number of limitations. 
Heparin is known to bind to many plasma proteins other than ATIII, including fibrinogen, which 
reduces heparin efficacy over time and which may increase protein adsorption [251]. More 
importantly, at least one specific anticoagulant function of heparin is dependent on a 
pentasaccharide sequence to activate ATIII, but only one-third of commercial heparin molecules 
contains this sequence [241]. As an alternative to heparin coating, immobilization of an 
antithrombin-heparin covalent complex (ATH), which restricts access for the binding of other 
plasma proteins and has at least one pentasaccharide sequence, was proposed to increase 
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anticoagulant activity [252,253]. Immobilized ATH on gold surfaces reduces fibrinogen 
adsorption and binds significantly higher amounts of ATIII from plasma compared to heparinized 
surfaces [253]. Moreover, this group also showed that ATH immobilization on poly(dimethyl 
siloxane) (PDMS) modified with polydopamine (PDA) (PDMS–PDA–ATH) has the ability to 
inactivate FXa well beyond the surface without ATH (PDMS–PDA), suggesting that the activity 
on this surface is mainly due to the specific inhibition of FXa by the heparin moiety of the ATH 
[254].  
Another alternative to heparin is synthetic and semi-synthetic heparin-mimicking 
polymers. These are attractive alternatives for preparing blood-compatible surfaces. Compared to 
heparin, they have better defined chemical structures, higher purity, and greater stability, with 
comparable anticoagulant activity [255]. Heparin mimics are designed to contain sulfate, 
sulfamide, and carboxylate groups. For biomedical membranes, for example, modification with 
heparin-mimics is of tremendous interest, enabling reduced blood protein adsorption, platelet 
adhesion and aggregation, and improved blood compatibility [256–259]. Modification with 
heparin mimics is also used to modify other blood-contacting materials. In a study by Chen et al. 
vinyl-functionalized PU was modified with copolymers of 2-methacrylamido glucopyranose and 
sodium 4-vinylbenzenesulfonate, to include both saccharide and sulfonate groups (Figure 1.14) 
[260]. The optimum of 2:1 ratio of sulfonate to saccharide surface resulted in reduced fibrinogen 
and HSA adsorption from human plasma, suppressed platelet and human umbilical vein smooth 
muscle cell (HUVMSC) density, and increased HUVEC density (Figure 1.14). This optimum ratio 
also resulted in the longest plasma clotting time compared to bare PU and other fabricated surfaces. 
The authors concluded that by regulating the content of sulfonate and saccharide, a multifunctional 
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surface with anticoagulant properties and the ability to endothelialize and inhibit intimal 
hyperplasia could be achieved.  
 
Figure 1.14. (a) Schematic depicting procedure for the preparation of PU-P(SS-co-MAG) 
surfaces. (b) Adsorption of Fg (fibrinogen) and HSA (human serum albumin) from human plasma 
to unmodified PU and PU surfaces grafted with PSS (sodium 4-vinylbenzenesulfonate), PMAG 
(2-methacrylamido glucopyranose), and P(SS-co-MAG). (c) Density of adherent platelets. (d) 
Fluorescence images of HUVECs on surfaces after 48 h culture. (e) Fluorescence images of 
HUVSMCs on the surfaces after 48 h culture. The cells were co-stained for nuclei (DAPI; blue) 
and F-actin (Phalloidin-FITC; green). Reproduced with permission from [260], copyright 2018, 
American Chemical Society. 
1.4.3.2 Direct thrombin inhibitors and immunomodulators 
Unlike heparin, direct thrombin inhibitors including hirudin, hirudin derivatives, 
argatroban, and other peptides directly block the thrombin active site. Hirudin is a small protein 
and is the most potent known natural direct thrombin blocker [261]. It has been used as a 
biomolecule for modification of some biomaterials [262,263]. For example, hirudin 
immobilization reduces clotting on the surface of PLA membranes [264]. A major limitation of 
hirudin modification over heparin immobilization is that hirudin acts through a one-to-one 
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stoichiometry, with each hirudin molecule on a surface irreversibly inhibiting only one thrombin 
molecule. This stoichiometric limitation results in short-term anticoagulant activity of hirudin-
modified surfaces [265]. Hirudin alternatives such as bivalirudin have been developed that, unlike 
hirudin, bind thrombin reversibly. Bivalirudin was covalently conjugated on polymerized 
allylamine coated 316L stainless steel to develop blood-compatible surfaces [265]. The resulting 
surfaces extend clotting times, inhibit platelet adhesion and activation, reduce fibrinogen 
adsorption, and significantly enhance endothelial cell adhesion, proliferation, and migration.  
Argatroban is a synthetic direct thrombin inhibitor that reversibly binds to both free and 
clot-associated thrombin. Furthermore, argatroban is able to inhibit several procoagulant factors 
(FV, FVIII, FXIII) and platelet aggregation [266]. Argatroban chemically immobilized on the 
surface of polyurethane–silicone polymer (CarboSil®) was applied as a surface coating to the inner 
lumen of poly(vinyl chloride) (PVC) extracorporeal circuit tubing [267].  Thrombosis was 
evaluated using a 4 h rabbit extracorporeal circuit model and demonstrated significantly less 
thrombus formation compared to the control CarboSil®, as measured by the thrombosis area.  
Immobilization of immunomodulatory molecules such as CD47 and CD200 on the surface 
of biomaterials is a strategy to reduce inflammation. These proteins are recognizable by immune 
cells via specific inhibitory receptors. When these immunomodulatory molecules bind to their 
cognate receptor, they function as a molecular marker of self that reduces the material-induced 
inflammatory response [268]. Immunomodulation with CD47, a ubiquitously expressed cell 
membrane protein, has become a promising approach to develop blood-compatible, immune 
evasive biomaterials. Stachelek and coworkers have shown immobilization of recombinant CD47 
on PVC and PU surfaces reduces inflammation, human neutrophil activation, and platelet adhesion 
and activation, compared to unmodified surfaces [269,270]. In a follow-up study from this group, 
56 
 
immobilization of CD47 on metallic stent surfaces was shown to significantly reduce 
inflammatory cell attachment without impeding endothelial cell retention and expansion [271]. 
Moreover, stents functionalized with an active peptide from the extracellular domain of CD47 
prevented thrombus deposition and reduced restenosis by 30% in a rat model. In a recent study, 
multi-immobilization of heparin, stromal cell-derived factor-1α (SDF-1α), and CD47 on the 
surface of PTFE was performed to improve blood-compatibility, endothelialization and anti-
inflammatory properties of vascular grafts [272]. The multi-functionalized PTFE exhibited 
reduced blood clotting (heparin impact), increased the recruitment of endothelial progenitor cells 
(SDF-1α impact), and reduced the inflammatory immune responses of monocytes-macrophages 
(CD47 impact) compared to the bare PTFE.  
1.4.3.3 Drug release 
The release of small-molecule drugs or other therapeutics is another way to impart specific 
biological functions to materials. Antithrombogenic drugs can be incorporated into blood-
contacting materials to inhibit thrombosis for the duration of the drug release [273,274]. To 
improve blood compatibility of materials via controlled drug release, this approach has been 
primarily implemented by combining antithrombogenic agents with the erosion of a biodegradable 
polymer. Antithrombotic agents include biopolymers, such as heparin, peptides, such as 
bivalirudin, and small molecules, such as dipyridamole (DPA) and aspirin [275–278]. For 
example, covalent incorporation of the DPA into biodegradable polycaprolactone-based PU has 
been investigated, for use in heart valves [279]. In vitro characterization indicates that DPA is 
homogeneously distributed in the materials and is released slowly throughout the polymer 
degradation process for 130 days. After incubation of the synthetic materials in platelet rich plasma 
for 2 h, significantly reduced levels of platelet adhesion and activation were observed compared 
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to the control surfaces without drug. Moreover, the modified PUs support cell adhesion and 
proliferation for two types of human vascular cells: HUVEC and HUVSMC. In another similar 
and consistent study, a series of randomly crosslinked PU (PU-DPA) were prepared using 
polycaprolactone (PCL), hexamethylene diisocyanate (HDI) and DPA through a one-step/one-pot 
synthesis method (Figure 1.15) [280]. DPA content was tuned by varying the molar ratio of DPA 
to PCL to achieve various PU-DPA ratios. The results obtained for hemolysis showed that all of 
the surfaces were observed to cause less than 2% of hemolysis and there existed a trend of reduced 
hemolysis with the increase in DPA amount in the PU. Furthermore, increasing amounts of DPA 
incorporated into the PU resulted in reduced platelet adhesion; substantially reduced platelet 
adhesion was observed only for PU-DPA (70:30) compared to unmodified PU, which is in 
agreement with the amounts of lactate dehydrogenase (LDH) released by the adhered platelets 
(Figure 1.15). Furthermore, a platelet study was conducted after 14 days of enzymatic degradation 
of PU-DPA materials. Significantly reduced platelet adhesion was reported on the enzyme-




Figure 1.15. PU-DPA synthesis and hemocompatibility assessment of PU-DPA films. (a) 
Synthesis scheme of PU-DPA from polycaprolactone (PCL) diol, hexamethylene diisocyanate 
(HDI) and an antithrombogenic drug, dipyridamole (DPA). (b) Digital images to show the color 
change with PU-DPA films after DPA incorporation. (c) SEM images to show platelet deposition 
and morphology on PU-DPA films. (d) Percentage of red blood cell lysis after 2 hour exposure of 
whole blood with PU-DPA films (n = 4). DI water- and saline-diluted blood served as positive and 
negative controls, respectively. Glass is used for a comparison for blood testing studies. (e) amount 
of LDH released by triton-treated platelets after adhering on to PU-DPA films in 1 hour incubation 
at 37 °C. Reproduced with permission from [280], copyright 2018, The Royal Society of Chemistry. 
To create longer and more effective antithrombotic agent release, several bio-responsive 
polymer hydrogels have been developed based on a controlled and on-demand release system 
[281–285]. Hydrogels have the ability to be used as smart materials that respond to changes in the 
physiological environment [286]. The signal feedback-controlled system can be designed to be 
responsive to the levels of thrombin triggering antithrombotic agent release in a thrombin-
responsive mode which further quenches the blood coagulation cascade. For example, a hydrogel 
system with thrombin-sensitive peptide sequences has been developed to prevent clotting [283]. 
A high level of blood thrombin causes cleavage of the gel, leading to heparin release to inactivate 
thrombin, reducing blood clotting. Heparin release also prevents additional thrombin-cleavage of 
the gel, making the system capable of on-demand delivery. The synthetic bio-responsive hydrogel 
was exposed to freshly drawn whole blood without any soluble anticoagulant. Blood was protected 
from clotting for a 1 h time period. Whereas blood in contact with the non-responsive gels and 
clinically applied PTFE vascular graft materials with and without immobilized heparin completely 
coagulated in the same time period. In another feedback-controlled anticoagulation system, a 
thrombin-responsive patch that can be inserted in the skin was designed to prevent undesired blood 
clot formation [284]. In this hydrogel, a thrombin cleavable peptide acts as a linker during the 
conjugation of heparin to the main chain of hyaluronic acid (HA). The heparin release profile is 
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sensitive to thrombin concentration. The in vivo studies in a mouse model demonstrated effective 
protection from acute thrombosis.  
1.4.3.4 Other biopolymers 
Natural biopolymers have attracted considerable interest due to their similarity to human 
tissues, and their diverse repertoire of inherent biological functions. The use of biopolymers can 
take advantage of potential biocompatibility and biodegradability. Furthermore, there are many 
existing strategies whereby biopolymers can be biologically or synthetically modified to introduce 
new chemical and biological functions. The functionality and diversity of biopolymers therefore 
make them attractive candidates for antifouling and blood-compatible materials. 
Polysaccharide-based materials have been used extensively to suppress bacterial adhesion, 
blood protein adsorption, platelet adhesion and activation, and blood coagulation [287]. A variety 
of methods including surface conjugation, physical adsorption, and layer-by-layer (LbL) assembly 
have been investigated for developing antifouling surfaces.  
HA, a linear polysaccharide with multiple biological functions, is one of the prominent 
polysaccharides that has been used for designing antifouling surfaces. HA is a major component 
of the extracellular matrix of many tissues, and is a primary GAG found in the endothelial surface 
layer (ESL) that lines blood vessels [51]. HA can be immobilized by modifying surfaces with PDA 
to provide HA binding sites. Such HA-PDA modified surfaces can reduce platelet activation and 
aggregation, thrombosis, and inflammation [288,289]. HA-PDA modification improves blood 
compatibility of PDMS-based implants [290]. An appropriate ratio of HA to PDA has been shown 
to considerably reduce platelet adhesion and activation on modified PDMS substrates, indicating 
an enhanced hemocompatibility compared to native PDMS, and to PDMS coated with HA or PDA 
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alone [290]. Moreover, the surface modification inhibits inflammation, and reduces cytotoxicity 
compared to unmodified PDMS.  
HA and other biopolymers can also be deposited into thin films using LbL assembly. LbL 
of natural biopolymers has become a popular technique to modify and functionalize the surface of 
biomaterials. LbL assembly is performed by sequentially adsorbing polymers that have 
complementary interacting groups onto a substrate to produce a thin film [291,292]. Often these 
are polyanion-polycation pair. The polyelectrolytes may be polysaccharides, synthetic polymers, 
nanoparticles, proteins, lipids, or DNA. In addition to ionic complementarity, the intermolecular 
interactions stabilizing each bilayer can also include covalent bonding, hydrogen bonding, host-
guest interactions, and hydrophobic interactions, depending upon the chemistries of the materials 
chosen [293,294]. This method is attractive for its simplicity and scalability. The LbL method can 
be implemented by exposing a surface to alternating solutions containing the complementary 
chemistries, by spraying, dip-coating or other methods. The diversity of candidate materials 
enables a wide variety of biological functions to be introduced into the film, such as 
endothelialization [295], fibrinolytic activity [296], antimicrobial activity [297–299], antiplatelet 
activity [300] , and antifouling [301].  
The antifouling activity of the multilayered films is dictated by the nature of the polymers, 
assembly conditions, homogeneous or heterogeneous topography, and number of layers as well as 
electrostatic charge of the terminal layer. LbL films formed from strong polycation-polyanion pairs 
usually fail to prevent protein adsorption, since they display a net charge on their surface, which 
can accelerate the migration of protein towards the surface. Charged surfaces may also bind small 
counterions which can be released, providing an entropic driving force for protein adsorption 
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(compare Figure 1.6). Therefore, multilayered films should be designed in a way that neutralize 
the surface net charge, to achieve fouling resistance [302]. 
In our lab, we have developed several different polyelectrolyte multilayers from 
biopolymers and shown that by adjusting the pH, molarity, number of layers, and chemistry of the 
terminal layer we are able to control the structure, thickness, and physical chemistry of 
polysaccharide-based surfaces at the nanometer length scale [303–306]. Other groups also use 
biopolymers to modify and functionalize surfaces via LbL techniques to design blood-compatible 
biomaterials, demonstrating promising ability to reduce protein adsorption and biofouling 
[302,307–313]. In a study by Meng et al. chitosan-heparin polyelectrolyte multilayers on coronary 
artery stents accelerated the re-endothelialization and improved blood-compatibility of stent 
surfaces tested both in vitro and in vivo [314]. Five-bilayer heparin-collagen LbL coatings on 
ePTFE in the presence or absence of anti-CD133 antibodies were able to accelerate 
endothelialization, reduce platelet activation and aggregation, and prolong the blood coagulation 
time [300]. 
Recently, LbL assembly has been used to fabricate self-healing antifouling surfaces [315]. 
Sun and coworkers fabricated antifouling coatings by LbL assembly of PEGylated poly(ethylene 
imine) (bPEI-PEG) and HA for 40.5 deposition cycles [316]. The bPEI–PEG/HA multilayer film 
was then crosslinked by PEG bis(carboxymethyl) to make it stable. The fabricated film exhibits 
highly effective antifouling ability for inhibiting long-term BSA adsorption and cell attachment. 
This ability of the film was attributed to the presence of the PEG-rich surface and the extremely 
soft nature of the film. Moreover, the films exhibit rapid self-healing in response to multiple 
damages, such as cuts and scratches. The self-healing property was attributed to mobility of bPEI–
PEG and HA polyelectrolytes and their reversible electrostatic and hydrogen bonding interactions. 
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Biological activation of surfaces with naturally derived polymers, synthetic analogs, or 
drugs enables the introduction of specific and tunable biochemical functions. This can be an 
effective method for improving the blood-compatibility of materials, and has led to some clinical 
and commercial success. Biological activation with biopolymers may lead to the introduction of 
multiple biological functions, including susceptibility to biodegradation. Materials designed for 
controlled release of a drug must be judiciously designed to release the drug at a controlled rate, 
and with awareness that the bioactive drug reservoir will eventually be depleted, leading to loss of 
activity. This may only be an effective strategy for long-term applications in cases where the drug 
is intended to impact a temporary phenomenon, such as re-endothelialization or tissue healing. For 
the long-term application of blood-contacting materials, biological activation may be most 
effective when it is combined with other strategies to synergistically improve multiple aspects of 
blood-compatibility.  
1.4.4 Bioinspired surfaces 
Bioinspired superhydrophobic and lubricant-infused surfaces have been developed as an 
effective platform for designing anti-biofouling surfaces. The functionality of these surfaces is 
inspired by the complex hierarchical structures and chemical composition of natural materials, 
such as the lotus leaf and Nepenthes pitcher plants (Figure 1.16). Lotus leaf is well-known for its 
low adhesion, self-cleaning, and superhydrophobicity properties imparted by the cooperative 
influence of hierarchical microstructures and nanostructures and low-surface energy waxes 
[317,318]. Unlike lotus leaf, the Nepenthes pitcher plant surface locks in a layer of liquid water to 
create a low friction repellent surface that is able to prevent the attachment of insects [319,320]. 
Inspired by these biological surfaces, researchers have recently begun to design and fabricate 
biomimetic superhydrophobic and lubricant-infused surfaces with many kinds of synthetic 
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materials, including polymers, ceramics, and metals to develop low biofouling, blood-repellent 
surfaces [321–324]. 
 
Figure 1.16. (a) Image of a lotus leaf in nature. (b) SEM image of the micro-structure of lotus leaf. 
(c) Illustration of design principal and contact modes of a superhydrophobic surface in air. (d) 
Image of a pitcher plant in nature. (e) SEM image of the platelet-shaped wax crystals of slippery 
surfaces in Nepenthes alata. (f) Illustration of design principal and contact modes of liquid-1-
repellent surface based on the liquid-2 layer in air. (a,c,d, and f) Reproduced with permission from 
[325], copyright 2015, American Chemical Society. (b) Reproduced with permission from [326], 
copyright 2016, Elsevier. (e) Reproduced with permission from [327], copyright 2010, The 





1.4.4.1 Superhydrophobic (SH) surfaces 
SH surfaces are being explored in recent years for their potential use in blood-compatible 
materials since they have demonstrated self-cleaning, nonwetting, and anti-biofouling properties 
[328]. SH surfaces by definition have a water contact angle (θCA) exceeding 150° and contact angle 
hysteresis (the difference between the advancing and receding contact angle) less than 10° [329]. 
Superhydrophobicity is achieved by combination of appropriate surface roughness (nanoscale 
and/or microscale) with low-surface-energy materials (Figure 1.16). The theoretical models of 
wetting states on these textured surfaces can be explained by the Wenzel and Cassie-Baxter models 
[150]. Surface roughening leads to increasing the solid–liquid interfacial surface area. In the 
Wenzel state, liquid droplets fully wet the surface by entering into all cavities. As a result, based 
on the Wenzel equation, intrinsically hydrophilic materials (θCA < 90°) become more hydrophilic, 
and intrinsically hydrophobic materials (θCA > 90°) become more hydrophobic with increased 
surface roughness [330]. In the Cassie–Baxter state (or Cassie state), in contrast, the liquid droplets 
sit on top of rugosities and on air trapped inside surface features, resulting in smaller contact area 
between the liquid and the solid interface. Reduced effective area between blood and biomaterials 
caused by topographical features, in addition to their low surface energy can improve the design 
of SH blood-repellent surfaces.  
SH surfaces reduce blood protein adsorption, platelet adhesion and platelet activation, and 
therefore reduce blood coagulation. In the SH Cassie state, as long as the entrapped air is 
maintained at the interface, it can limit the available liquid-biomaterial surface area and thereby 
decrease the total area available for protein binding. Air trapped within the interstices of TiO2 
nanotube-microtemplated surfaces exhibit suppression of BSA and FBS binding when air is 
present in the SH regions  [331].  However, once air is displaced by sonication, proteins bind to 
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the SH domains [331]. In another study, the air trapped within the interstices of the SH fibular 
ePTFE significantly reduced adsorption of HSA compared to commercially available ePTFE 
[332].  
The stability of the Cassie state is a key factor for the protein resistance of SH surfaces. 
However, it has been shown that proteins are able to even adsorb to the small solid interfaces of 
SH surfaces and increase the surface energy of the biomaterial [333]. Increased surface energy 
promotes the penetration of water into interstices, causing a transition from the Cassie to the 
Wenzel state, and eventual displacement of the air-bubble layer. Moreover, when this transition 
occurs, the formerly SH surface is rendered non-superhydrophobic. The entire effective surface 
area is intrinsically hydrophobic, which promotes protein adsorption. Therefore, the Cassie-to-
Wenzel transition increases effective surface area resulting in more protein adsorption compared 
to a flat surface of the same material [334]. As a result, maximizing underwater stability of the 
Cassie state of SH surfaces over long time scales is important when designing SH surfaces for 
long-term contact with blood.  
SH surfaces can reduce platelet adhesion and activation [335,336], by a similar mechanism 
proposed for reduced protein binding. The Cassie state decreases the total area available for cell 
adhesion on SH surfaces. SH titania nanotubes reduce platelet adhesion and activation on 316L 
stainless steel [337], and are superior to other nontextured titania and nanoflower-textured titania 
surfaces [338]. SH titania surfaces can significantly reduce platelet adhesion and activation but 
only when the SH surfaces have a robust Cassie–Baxter state [338]. In another study laser ablation 
was used to alter the wettability of stainless steel with defined pattern geometry to investigate how 
surface morphology, surface roughness, and SH character of the surfaces affect platelet adhesion 
[339]. SH cauliflower-like surfaces with a stable Cassie–Baxter state (stable on immersion in water 
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up to six days) were shown to be highly resistant to platelet adhesion compared to other SH surface 
patterns, including triple pattern topography that had a high contact angle but less stable Cassie–
Baxter state.  
Since SH surfaces demonstrate promising results in reducing blood protein adsorption and 
platelet adhesion and activation, they are being explored for their potential application in 
developing blood-compatible biomaterials. In recent years, several SH surfaces have been 
developed with a nanoscale topography and hydrophobic surface chemistry to demonstrate their 
short-term blood-repellency [338,340–342]. The potential use of a SH coating (a commercial 
Ultra-Ever Dry spray coating) on a Jude Medical Bileaflet mechanical heart valve (BMHV) was 
investigated by Bark and coworkers [343]. The SH coating with a receding contact angle of 160° 
was able to reduce blood cell adhesion in a static environment compared to pyrolytic carbon 
(receding contact angle of 47°), the base material for BMHVs. Recently, a sand-casting technique 
was used to prepare a SH blood-repellent surfaces (blood contact angle of 150° and roll-off angle 
of 10° for 10 µl porcine blood) composed of silicone and functionalized SiO2 nanoparticles (Figure 
1.17) [344]. The multi-scale micro-structure provided trapped air-bubble layer on the casted 
surface to maintain a robust Cassie–Baxter state. The fabricated surface reduces water drag force 
by up to 72%  compared to PDMS and can withstand harsh durability tests, such as high-speed 
(9.7 m s-1) water jetting and extensive high-pressure sandpaper abrasion. 10 µl of blood dispensed 
onto the casted sample rolls off quickly leaving no trace of blood on the surface, which is a sign 




Figure 1.17. Top. Illustration of the sand-casting processes, showing particle aggregation and 
transfer of SiO2 nanoparticles from the SiO2 mold to the final casted item. Bottom. (a) Blood 
repelling properties of the sand-casted SHP sample compared with materials commonly used to 
make blood pumps, PDMS and polycarbonate. (a) Blood contact angle of the casted SHP sample, 
(b) blood rolling off the casted sample without leaving stains, (c) blood contact angle of PDMS, 
(d) blood flowing off the PDMS surface while leaving stains, (e) blood contact angle of 
polycarbonate, and (f) blood remains adhered to the polycarbonate surface. Reproduced with 
permission from [344], copyright 2018, The Royal Society of Chemistry.  
1.4.4.2 Lubricant-infused surfaces 
Lubricant-infused surfaces are a new emerging class of bioinspired materials that create a 
stable dynamic surface which repel immiscible fluids and display ultralow adhesion to 
micro/nanoporous solid substrates (Figure 1.16). Aizenberg and co-workers reported the first type 
of these surfaces, which they named slippery liquid-infused porous surfaces (SLIPS) [345]. These 
materials are fabricated by infusion of viscous oils into porous surfaces, rendering the surface with 
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low sliding angles for various complex liquids [346]. To fabricate a liquid-infused slippery surface 
several criteria for both solid substrate and infused liquid should be met [347]. The solid substrate 
must have the capacity for entrapment of a lubricating liquid within a micro/nanoporous structure 
to enable it to be firmly locked into the pores and mask the surface roughness. Several different 
materials in recent years such as polyamide-6 (PA6) [348], poly(ethylene terephthalate) (PET), 
poly(methyl methacrylate) (PMMA), PC [349], and titanium [350] have been used to design 
hierarchical micro/nanoporous structured substrates for lubricant-infused surfaces. In addition, the 
solid substrate must have a surface chemistry matching the chemical composition of the lubricating 
liquid to create an appropriate surface energy match between two phases. The stability of SLIPS 
also relies on a mobile lubricant layer which must wet the solid substrate and be immiscible with 
the repelled liquids. The long-term stability of the lubricating liquid is also essential since lubricant 
layer depletion leads to the loss of the slippery characteristics of these surfaces. Various lubricating 
liquids including silicone oils [349], perfluorodecalin [351], Krytox [352], and almond oil [353] 
have been used as infused liquid in several reports.  
The ability of SLIPS to repel complex biological fluids such as blood for designing blood-
repellent surfaces was introduced by the Aizenberg group (Figure 1.18, top). They showed that 
SLIPS composed of a tethered perfluorocarbon layer and a medical-grade liquid film of 
perfluorodecalin on different surfaces prevent fibrin attachment, reduce platelet adhesion and 
activation, and are stable under blood flow in vitro (Figure 1.18, top)  [351,354]. Since the initial 
report of these surfaces, many different approaches have been used to design, fabricate, and utilize 
lubricant-infused surfaces as blood-repellent materials that reduce biofouling [353,355–357]. 
ePTFE-perfluorocarbon SLIPS, for example, prevent biofouling while preserving the viability and 
bactericidal function of macrophages in vitro [358]. SLIPS also show low innate immune 
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responses and reduced inflammatory capsule formation in vivo, in a murine model [358]. SLIPS 
composed of hydrophobic silica nanoparticles infused with sesame oil showed blood repellent 
properties. These blood-repellent SLIPS can improve imaging when used as a covering for 
endoscope lenses in a mouse model [359].  
To incorporate both aspects of blood compatibility and targeted cell binding, biofunctional 
lubricant-infused surfaces (BLIS) have been proposed. BLIS are proposed to yield surfaces that 
prevent nonspecific adhesion of biomolecules and cells, while capturing target species in complex 
fluids such as blood (Figure 1.18, bottom) [360]. BLIS were fabricated by creating SAMs of 
organosilanes with optimized ratios of aminopropyl triethoxysilane (APTES) and 
trichloro(1H,1H,2H,2H-perfluorooctyl)silane (TPFS). APTES provides amine groups for 
conjugating biomolecules, and TPFS serves as the substrate for immobilizing 
perfluoroperhydrophenanthrene lubricant on the surface. These BLIS prevent nonspecific 
fibrinogen adsorption and platelet adhesion to the same extent as 100% TPFS-treated samples 
(Figure 18, bottom). They also exhibit good blood repellency properties, evidenced by immediate 
sliding of a blood droplet. Moreover, a long-term cell adhesion study showed that BLIS promote 
endothelialization and cell growth, and that no significant difference was seen in the cell 
confluency and viability in BLIS compared with 100% APTES-treated samples after 5 days 
(Figure 1.18, bottom). 
The development of new chemistries and structures for superhydrophobic and lubricant-
infused surfaces is an exciting and active area of research that could lead to advances in blood-
compatible materials. Methods for preparing superhydrophobic surfaces through texturing, in 
particular, can be readily scaled to enable manufacturing methods. Outstanding challenges include 




Figure 1.18. Top. TLP-coated (tethered-liquid perfluorocarbon) surfaces repel whole human 
blood. (a) Schematic of blood repellency on TLP surfaces showing the TP (tethered 
perfluorocarbon) bound to a substrate through plasma activation and silane treatment, which then 
allows a stable film of LP (perfluorodecalin) to adhere to the surface. (b) Surfaces without TP or 
LP (–TP/–LP; control) show adhesion of a blood droplet (50 μl, 3.2% sodium citrate) on the 30 
degree angled surface, low velocity and residence over 5 s (upper panels). When TLP is applied 
to the surface, a blood droplet (50 μl, 3.2% sodium citrate) is immediately repelled and slides down 
the surface at an incline of 30 degrees within 0.3 s (lower panels). Scale bars, 1 cm. (c) 
Thrombogenicity of TLP surfaces. Photographs of filtered thrombi after blood was pumped in a 
closed loop at 3 L/h for 2 h in control (upper image) and TLP medical-grade PVC (lower image), 
and photographs of control (left) or TLP (right) cardioperfusion tubing sterilized with ethylene 
oxide after it had been exposed to porcine blood for 2 min. Scale bars, 5 mm. Reproduced with 
permission from [351], copyright 2014, Springer Nature.  
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Bottom. Investigating the blood, protein interaction, platelet and cell adhesion with optimized 
biofunctional lubricant-infused surfaces. (d) SEM images taken from samples incubated with 
human whole blood indicate that samples treated with mixed silanes or 100% TPFS have excellent 
blood repellency properties, and no clot or blood cell adhesion was observed on them. (e) Left. 
Fluorescence intensity of FITC−fibrinogen adhered to treated substrates. Right. Number of 
platelets/mm2 adhered to surfaces. (f) Long-term cell experiments conducted on anti-CD34- and 
anti-CD144-treated samples and the investigation of cell phenotype and cytocompatibility of the 
treated surfaces. Samples were functionalized with (left) anti-CD34 and (right) anti-CD144 
antibodies and incubated with HUVECs for 5 days. The positive immunofluorescence staining for 
Alexa Fluor 488-conjugated VE-cadherin confirms the HUVEC phenotype for adherent cells. Both 
endothelial cell-specific antibodies promoted cell adhesion and endothelialization. The 100% 
TPFS-lubricated samples inhibited the nonspecific binding of cells and had significantly less 
adherent cells after 5 days compared to other treated substrates. The scale bars are 100 μm. 
Reproduced with permission from [360], copyright 2018, American Chemical Society. 
1.4.5 Glycocalyx-mimetic surfaces 
The inside surface of healthy blood vessels is the only known material that is completely 
blood-compatible when in long-term contact with flowing whole blood. By mimicking key 
features of the blood vessel wall, it may be possible to elucidate the structure-function relationships 
that could guide the development of new blood-compatible materials. In particular, mimicking the 
physical chemistry and topography of the luminal surface of healthy blood vessels has been 
proposed as a biomimetic strategy that could yield promising blood compatibility. The luminal 
surface of blood vessels is covered with a monolayer of endothelial cells. This endothelium surface 
is multifunctional, providing both blood-compatible properties and regulating the coagulation 
cascade once there is a vascular lesion [361]. The endothelial cells on the blood vessel wall present 
a carbohydrate-rich, gel-like, dynamic surface layer called the endothelial glycocalyx. The 
endothelial glycocalyx is connected to the endothelium mainly through proteoglycans, and to a 
lesser extent, through glycoproteins [51]. The ESL is composed of membrane-bound mesh of 
proteoglycans, GAGs, HA, glycoproteins, and plasma proteins [51,362,363]. Proteoglycans are 
composed of a core protein that carries one or more covalently attached GAG chains [364]. 
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Heparan sulfate, chondroitin sulfate (CS), dermatan sulfate (DS), keratan sulfate, and HA are five 
types of GAGs. The most common GAG in the ESL is heparan sulfate (roughly 50–90%), followed 
by CS and DS [51]. With the exception of HA, all GAGs are covalently connected to the protein 
core of proteoglycans. The thickness of the ESL varies throughout the vasculature, with reported 
thicknesses ranging from 200 to 4000 nm [51].  
Since the ESL is located between the endothelium and flowing blood, it has several 
fundamental functions that impart blood compatibility [51,365]. Specifically, the ESL plays a 
central role in preventing blood clotting on the inside surfaces of healthy blood vessels. The 
negatively charged surface of the ESL acts as a barrier that limits the access of certain components, 
such as leucocytes, platelets, and some proteins to the endothelium [51,366]. Moreover, this highly 
hydrated layer reduces nonspecific blood protein adsorption [367]. The ESL is also responsible for 
binding several serine protease inhibitors (serpins), enhancing its anticoagulant activity [368,369]. 
When coagulation is not necessary, ATIII, and heparin cofactor II (two important anticoagulant 
proteins) bind to the GAGs through specific binding sequences to inhibit thrombin and FXa [369]. 
Therefore, mimicking the endothelial glycocalyx on a biomaterial surface is a potential strategy 
for development of blood-compatible surfaces. To this end, GAGs have been used as surface 
modifications to improve the blood-compatibility of surfaces [370,371]. Fabrication of heparin 
coatings for improving blood compatibility is one of the well-known applications of GAGs in the 
realm of designing blood-compatible surfaces, which was discussed earlier. In this section we 
highlight the strategies used to mimic the ESL on biomaterials to improve antifouling and blood-
compatibility of surfaces. 
Several studies with different GAGs have been conducted to understand blood protein, 
platelet, and whole blood interactions with glycocalyx-like surfaces. Glycocalyx-like surfaces 
73 
 
have been prepared by a variety of techniques to immobilize GAG-rich sulfated materials, 
including  oligosaccharides and polysaccharides [367,372–376]. These studies reported reduced 
blood protein adsorption and/or platelet adhesion and activation, and in one case reduced the 
inflammatory responses compared to unmodified substrates. In a study by Ham et al. inspired by 
glycoproteins present in the ESL, glycopeptoids were grafted to TiO2 substrate to make 
glycocalyx-mimetic peptoids [377]. The interfacial saccharide residues of glycopeptoids formed a 
biomimetic shielding layer that dramatically reduced nonspecific blood protein adsorption, 
fibroblast, and bacterial cell attachment compared to unmodified substrate. The fouling resistance 
of the fabricated layer was attributed to both a water barrier effect due to high number of hydrogen 
bonds with water molecules, as well as steric hindrance from the 20-mer N-methoxyethyl peptoid 
linker of the glycopeptoid. In another study, CS was covalently grafted to primary amine-rich 
plasma-polymerized films to compare antifouling ability and blood compatibility to PEG-grafted 
and carboxymethylated dextran-grafted (CMD-grafted) surfaces [378]. CS was shown to be as 
effective as PEG in reducing fibrinogen and BSA adsorption, although CMD reduced fibrinogen 
adsorption more than both of the other surfaces. PEG-, CMD-, and CS-grafted surfaces drastically 
decreased platelet adhesion and activation compared to unmodified PET surfaces in a study with 
whole blood for 15 min. Interestingly, CS-grafted surfaces exhibited much better endothelial cell 
adhesion and growth compared to PEG and CMD surfaces. In addition to interfering with blood 
coagulation, the CS-grafted surface could therefore promote the more complete restoration of a 
stable endothelium. In another study, PTFE vascular grafts were coated with perlecan (a major 
heparan sulfate-containing proteoglycan) and tested in an ovine carotid interposition model for a 
6-week period [379]. Reduced thrombus formation was the result of both reduced platelet adhesion 
and aggregation and enhanced endothelialization compared to the uncoated surface. It was shown 
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also that perlecan is resistant to platelet adhesion as long as it possesses heparan sulfate side chains. 
Once the GAGs were removed, platelet adhesion and aggregation were supported. This result 
shows the importance of GAGs in improving blood compatibility and promoting endothelial cell 
proliferation.  
Most of the current research in glycocalyx-mimics has addressed mimicking the surface 
chemistry of the ESL on biomaterials to improve antifouling properties of surfaces and ultimately 
enhance blood-compatibility. However, in addition to the chemistry of the ESL, mechanical 
properties and topography of the ESL are also important to thoroughly mimic this layer. Hedayati 
et al. developed a technique to mimic bush-like structures found in the ESL based on the LbL 
assembly of polyelectrolyte multilayers (PEMs) and their subsequent modification with 
polyelectrolyte complex nanoparticles (PCNs), to make PEM+PCN surfaces [380]. The 
polyelectrolytes used are all polysaccharides, and include polyanionic GAGs, like those found in 
the glycocalyx. The PEMs provide a uniform surface for deposition of the GAG-rich PCNs, and 
the PCNs provide supermolecular assembly of the GAGs into bush-like structures similar, to those 
reported by Rostgaard and Qvortrup for the endothelial glycocalyx [381]. The fabricated 
glycocalyx-mimetic surfaces present dense GAG-rich regions that swell when hydrated, and have 
higher Young’s modulus than the underlying PEM with height features from 100 to 150 nm high 
(Figure 1.19). They later showed that these glycocalyx-mimetic nanostructures suppress 
nonspecific blood protein adsorption compared to unmodified glass and PEM surfaces [382]. More 
interestingly, once they added thrombin to the fibrinogen solution in the absence of ATIII, a 
network of fibrin fibers were formed on PEM surfaces terminated with either chitosan, CS or 
heparin. Therefore, coating the surface with GAGs such as heparin or CS does not suppress fibrin 
polymerization on the surface or fibrin fiber adsorption from solution onto the surface. Strikingly, 
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in the cases of glycocalyx-mimetic nanostructures (PEM+PCNs) no fibrin fibers are observed on 
the surfaces (Figure 1.19). They concluded that both chemistry and surface topography of the 
glycocalyx-mimetic layer are required to inhibit fibrin fiber and fibrin network formation. In 
another study [37], titania nanotubes with high surface area were coated with heparin-chitosan 
PEMs to provide GAG functionalization. Then chitosan was modified with a NO-donor chemistry 
to provide an important antithrombotic small-molecule signal. Combination of surface 
nanotopography, GAG-based surfaces, with NO-donor chemistry demonstrated substantial 
reduction in platelet adhesion and activation compared to unmodified TiO2 surfaces (Figure 1.3).  
 
Figure 1.19. (a) Sketch of endothelial surface layer (not to scale) showing core protein 
arrangement and spacing of scattering centers along core proteins and their relationship to the actin 
cortical cytoskeleton. Reproduced with permission from [383], copyright 2003, National Academy 
of Sciences. (b) Electron micrographs of capillary from small intestine. Bush-like structures are 
indicated by the arrows. The capillary lumen is labeled “L”. Scale bars: (top) 1.0 μm; (bottom) 
0.5 μm. Reproduced with permission from Molecular Sieve Plugs in Capillary Fenestrae, 
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copyright 1997, Elsevier. (c and d) Surface chemistries and structures of glycocalyx-mimetic 
surfaces (PEM19+PCNs) inhibit both the surface-mediated polymerization of fibrin and the 
adsorption of fibrin fibers from solution. (c) Representative 5 μm × 5 μm AFM topographic images 
of PEM19 (19-layer chitosan/hyaluronan), PEM19 + CS (chondroitin sulfate-terminated PEM), 
PEM19 + HEP (heparin-terminated PEM) and PEM19 + PCN (CS-CHI and HEP-CHI) taken in 
liquid. (d) Total internal reflection fluorescence (TIRF) microscopy images of fluorescently 
labeled fibrin fibers, polymerized from physiologic concentration of fibrinogen (0.75 mg mL−1), 
in the presence of thrombin (1 NIH U mL−1) on PEMs. The structure of the glycocalyx-mimetic 
surfaces (PEM19+PCNs) samples does not prevent the adsorption of fibrin(ogen) monomers, but 
it completely prevents adsorption of fibrin fibers and fibrin polymerization on the surface. 
Reproduced with permission from [382], copyright 2018, American Chemical Society.  
Since the inside surfaces of healthy blood vessels are the only surface known to be 
completely compatible with flowing whole blood for long-term contact, strategically mimicking 
key features of the endothelial glycocalyx is a rational approach to developing blood compatible 
materials.  Although this emerging approach is still in its infancy, some studies have shown that 
such biomimetic surfaces suppress blood protein adsorption, platelet adhesion and activation, 
bacterial adhesion and ultimately improve blood compatibility in short-term experiments. These 
evidences indicate that surfaces that mimic the chemistry and structure of the ESL have the 
potential to be developed as a new class of improved blood-contacting biomaterials. One challenge 
to this approach is that the vascular endothelium is a multicomponent surface, with many 
biological functions. Further mechanistic studies should be aimed at elucidating which chemical 
and structural features of the ESL impart important biological functions critical to blood 
compatibility, and how these features can be tuned to optimize performance for specific 
applications. Another challenge to this biomimetic strategy is that both the blood and the blood 
vessel wall are alive. Endothelial cells lining the blood vessel wall can expend energy and consume 
nutrients to continuously alter the presentation of the glycocalyx, for example, in response to 
mechanical stimuli, and can repair damage to the glycocalyx. A durable and robust glycocalyx 
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mimic must be designed to maintain its various functions in the challenging and dynamic 
environment represented by flowing whole blood. 
While mimicking the nanoscale and macromolecular assembly of some components of the 
vascular endothelium is a promising strategy, these are not the only features that impart blood 
compatibility to blood vessel walls. Endothelial cells lining the blood vessel wall also produce an 
important antithrombotic signal, NO. NO delivery can also be exploited to improve the blood 
compatibility of surfaces, as discussed in the next section. 
1.4.6 Delivery of the small molecule NO 
Over 40 years ago Ferid Murad proposed that NO was a molecule responsible for activation 
of an enzyme, guanylate cyclase, involved in vasodilation [384,385]. Over the subsequent decade, 
Luis J. Ignarro and Robert F. Furchgott contributed to elucidating a biological source and modes 
of action of NO. Ignarro and others showed that NO activates the enzyme guanylate cyclase, which 
synthesizes 3',5'-cyclic guanosine monophosphate (cGMP) from guanosine triphosphate (GTP) 
[386]. The subsequent increase in cGMP levels triggers relaxation of the vascular smooth muscle 
cells, in addition to inhibiting platelet adhesion and activation that can lead to thrombosis [387]. 
Furchgott and others discovered that vasodilation was achieved through the action of a factor 
produced by endothelial cells [388,389]. Ignarro and co-workers later showed that the endothelial-
derived molecule responsible was NO [390,391]. Consequently, Furchgott, Ignarro, and Murad 
received the 1998 Nobel Prize in Physiology or Medicine for their identification of NO as a 
signaling molecule in the cardiovascular system. Mechanisms of NO signaling are still being 
discovered [392]. Nonetheless, what is currently known about the potency of NO and its 
importance in signaling in the cardiovascular system have made NO delivery an important strategy 
for the development of blood-compatible materials. 
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1.4.6.1 NO in the cardiovascular system 
NO is continuously produced by healthy endothelial cells at a basal level and in response 
to physiological stimuli. For example, Rubanyi et al. proposed, and others later confirmed, that 
NO release from endothelial cells is triggered by increased pulsatile flow [393–395].  Today, the 
bioactivity of NO is well established and encompasses cardiovascular regulation, 
neurotransmission, promotion of wound healing, and antibacterial effects [396–398]. Biologically, 
NO reacts with metal centers or other radicals, the latter resulting in the production of RNS. NO 
has direct effects due to chemical interactions between a receptor biomolecule and NO itself, such 
as the binding of NO to the Fe2+ of the heme moiety to form a metal nitrosyl adduct (Figure 1.20, 
top) [399]. Indirect effects involve the production of RNS such as peroxynitrite (ONOO-), nitrate 
(NO3-), nitrite (NO2-), dinitrogen trioxide (N2O3) and dinitrogen tetroxide (N2O4), which form 
through the reactions of NO with oxygen [399,400]. These RNS species proceed to target specific 
functions without the direct participation of NO. Vasodilation, inhibition of platelet activation, and 
various wound healing functions are typically attributed to direct effects of NO, while indirect 




Figure 1.20. Top.  Examples of the reactivity of NO to form RNS under physiological conditions. 
Bottom. Reactions to form diazeniumdiolates and S-nitrosothiols followed by the subsequent 
release of NO.   
Three different isoforms of the NO synthase enzyme (NOS) are responsible for NO 
production in mammalian biology; these enzymes are neuronal NOS (NOS I or nNOS), inducible 
NOS (NOS II or iNOS) and endothelial NOS (NOS III or eNOS) [401].  NO generation can also 
occur in a NOS-independent manner in the nitrate-nitrite-NO pathway, which involves the 
reduction of nitrate or nitrite to NO [402]. The nitrate-nitrite-NO pathway activity increases under 
low oxygen conditions (hypoxia) when the classical oxygen-dependent mechanism of NO 
synthesis is inhibited. During this process, bacteria, hemoglobin, myoglobin, and certain enzymes 
such as xanthine oxidase can reduce nitrate and nitrite to NO. Notably this pathway can be fueled 
by exogenous nitrate and nitrite sources in our diet that can produce therapeutic effects particularly 
for the treatment of cardiovascular disease [403,404].  
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Plasma thiols are likely precursors for natural NO generation in the endothelium, and 
participate in the activation of nitrosovasodilators. Stamler et al. were the first to demonstrate that 
the majority of S-nitroso adducts occur as S-nitrosoalbumin (SNO-albumin) through nitrosation of 
the lone cysteine residue [405]. The balance was proposed to consist of S-nitrosothiols (RSNOs) 
derived from low-molecular weight thiols, such as S-nitrosoglutathione (GSNO). Scharfstein and 
colleagues later speculated that transnitrosation occurs in vivo between SNO-albumin and low-
molecular weight thiols [406]. Subsequent studies have shown several mechanisms whereby SNO-
albumin may serve as a biological reservoir from which low-molecular weight thiols are nitrosated, 
and other mechanisms of RSNO formation [407–410].  
NO produced by endothelial cells has regulatory effects on the cardiovascular system, 
largely through NO-induced formation of cGMP and its influence on a variety of receptors. NO 
prevents platelet adhesion and aggregation along the endothelium by increasing the intracellular 
concentration of cGMP. The presence of cGMP then decreases the intracellular concentration of 
Ca2+, a key regulatory promoter of platelet activation [394,395,411,412]. Another route through 
which NO prevents platelet adhesion and activation is via inhibition of thromboxane A2 (TXA2), 
a signaling molecule produced by activated platelets with prothrombotic properties. Previous 
research has shown that cGMP can directly inhibit TXA2 activity, thereby reducing platelet 
adhesion and activation [110].  
Understanding the relationship between NO concentration and biological activity has been 
the target of substantial research efforts. The effective therapeutic dose of NO for medical 
applications depends upon the desired effect (Table 1.2). At low concentrations (1-30 nM), NO 
exhibits regulation such as vasodilation and formation of new blood vessels (angiogenesis) [413]. 
An increased NO concentration of approximately 100 nM results in protective effects towards cell 
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apoptosis (anti-inflammatory and wound healing), whereas concentrations above 400 nM induce 
cellular apoptosis [413]. Higher concentrations have proven to be beneficial for anticancer and 
antibacterial applications [414]. From a clinical perspective, the varied biological effects of NO 
illustrates the need for fine control over NO release kinetics when developing materials for NO 
delivery.  
Table 1.2. Concentration ranges of NO and corresponding physiological activities [413]. 
 [NO] physiological results 
cell 
protection 
1-30 nM proliferative and protective effects (vasodilation, angiogenesis) 
30-60 nM apoptosis protection (antioxidant) 
100 nM tissue injury protection (anti-inflammatory, wound healing) 
cell 
damage 
400 nM apoptosis induction (antibacterial and anticancer) 
1 μM full cell cycle arrest (toxicity) 
 
The healthy endothelium is estimated to release NO with a surface flux of 0.5-4.0 × 10-10 
mol NO cm-2 min-1. Therefore, materials for blood-contacting applications should fall within this 
target range [415]. Due to its reactivity, localized surface delivery of NO is desirable for 
antithrombotic applications without the systemic effects, such as hemorrhaging, which may occur 
from use of anticoagulants. However, the applicability of therapeutic NO is limited by the overall 
reactivity of the molecule. Several factors can influence the consumption of NO within the body, 
including the availability of oxygen and hemoglobin. In aqueous solution, the rate of NO 
consumption with oxygen and hemoglobin is proportional to the square of NO concentration and 
follows second order kinetics [416]. The half-life of NO in extravascular tissue is reported to fall 
within the range of 0.09 s to > 2 s, depending on the concentration of oxygen present [417]. 
82 
 
However, the half-life of NO in whole blood has been calculated to be much smaller (1.8 × 10-3 s) 
and is correlated to the concentration of red blood cells [418]. In blood, an additional route of NO 
consumption is through the reaction of NO with oxyhemoglobin or heme-bound iron of the heme 
proteins to yield iron(III)-peroxynitrite species [419]. This very short half-life of NO in blood 
necessitates strategies to stabilize NO. To increase the availability of NO materials have been 
developed that contain much more stable NO-donor chemistries. The next sections discuss 
materials that carry NO-donor chemistries or that can catalytically generate NO from endogenous 
NO precursors in the bloodstream. 
1.4.6.2 Materials with NO-donating groups 
Since NO inhibits platelet activity in the healthy endothelium, strategies incorporating an 
exogenous supply of NO for blood contacting devices have been widely explored as a method for 
inhibiting thrombus formation [420–422]. Given the fleeting nature of NO in the presence of the 
reactive components of blood, chemical functional groups that decompose to release NO have 
been proposed to function as NO carriers that can stabilize NO within a biomaterial or at a surface. 
Both RSNOs and N-diazeniumdiolates (NONOates) (Figure 1.20, bottom) have been proposed as 
NO-donor groups for the controlled delivery of NO from materials. NONOates are synthetic 
molecules formed through nitrosation of secondary and primary amines. NONOates exhibit 
spontaneous decomposition, generating two molecules of NO per NONOate molecule [420–422]. 
RSNOs, on the other hand, occur in both natural and synthetic forms, and can be prepared through 
nitrosation of the sulfur atom of the thiol (Figure 1.21) [420–422]. RSNOs decompose in response 
to heat, light, copper ions, and changes in pH, to release one molecule of NO per RSNO. Recently, 
Lutkze et al. demonstrated that other metal ions, such as indium, also facilitate the release of NO 
from RSNOs [423]. This discovery may lead to additional systems that can be engineered to 
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produce NO from RSNOs. Some RSNOs are naturally occurring within the blood, and likely serve 
as the endogenous substrates for NO production by endothelial cells [424]. Both NONOates and 
RSNOs have demonstrated their ability as potent antiplatelet agents and vasodilators and are 
therefore very promising for blood-contacting applications [421]. While there are numerous 
reports related to small-molecule and polymeric NO donors, only a few will be discussed in this 
section. 
Figure 1.21. Example S-nitrosothiols that serve as natural or synthetic NO donors. 
An early report observed that S-nitroso-N-acetylcysteine can inhibit fibrinogen binding to 
activated platelets in a dose-dependent manner. Fibrinogen inhibition was correlated with a 
corresponding increase in platelet cGMP levels [425]. This fibrinogen inhibition is potentially 
related in part to cGMP inhibition of phosphoinositide 3-kinase (PI3-K) receptors, which activate 
the GPIIb-IIIa receptors on platelets that bind to fibrinogen. This mode of action could therefore 
be exploited to reduce platelet adhesion, activation, and aggregation, as these processes are 
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promoted by fibrin(ogen)-GP binding, as described above. The influence of NO on fibrinogen has 
been further investigated by the Reynolds group. Here, it was observed that  NO-releasing polymer 
films increase fibrinogen deposition onto surfaces once the critical flux of NO is achieved [426].  
The fibrinogen adsorbed in the presence of NO, however, does not bind to platelets, thus 
demonstrating an alternative mechanism for NO to act as an anti-clotting agent [427].  
To achieve targeted and controllable release, NO donors are often incorporated into a 
polymer scaffold.  Two commonly used approaches include covalently bound NO-releasing 
polymers and direct blending of the NO donors through physical encapsulation in the polymer 
[420–422]. Towards this end, NO donors have been incorporated into PVC, hydrogels, PU, PEG, 
silicone rubbers, polymethacrylates, sol-gels, chitosan, polyphosphazenes, and PEO to name a few 
materials [420–422]. As an example, one of the first reports to incorporate NONOates into a blood-
contacting polymer used vascular grafts coated with cross-linked PEI, containing covalently 
attached NONOates [428]. To determine the effect of the NO-releasing polymer on platelet 
function, the vascular grafts were implanted in segments of artery-vein shunts in baboons. When 
compared to the control (PEI-coated vascular grafts without the NONOate chemistry) the NO-
releasing grafts had substantially less platelet deposition after 1 hour. The incorporation of 
NONOates into polymers has proven to be a versatile strategy; a variety of materials platforms 
have been fabricated to incorporate these NONOates including silica particles, sol-gels, xerogels, 
dendrimers, electrospun fibers and polymer blends [429–436]. However, the utilization of these 
materials may ultimately be hindered by the formation of carcinogenic products (nitrosamine).  
The covalent attachment of RSNOs to polymer blends for blood-contacting surfaces has 
been investigated [437]. In this work, polynitrosated polyester/poly(methyl methacrylate) 
(PE/PMMA) blends were synthesized, which released NO at a rate of 1.8 ± 0.1 nmol g-1 h-1 for up 
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to 24 h. Platelet adhesion experiments showed that the use of polynitrosated PE/PMMA blends 
resulted in complete inhibition of platelet deposition, demonstrating their potential as a blood-
contacting surface with local antiplatelet activity. Despite the availability of alternative NO donor 
species such as NONOates, RSNOs exhibit significant advantages that include limited toxicity, 
and a diverse selection of environmental triggers.  
Recently sustained NO release by covalently attaching S-nitrosoacetylpenicillamine 
(SNAP) to PDMS was achieved [438]. The NO donor chemistry resulted in a measurable NO 
surface flux in the range of 0.5 to 8.35 × 10-10 mol cm-2 min-1 for 38 days, with no leaching of the 
NO-donor. After that, the materials continued to release measurable amounts of NO for as long as 
125 days, though at a level below the target minimum physiological flux (0.5 × 10-10 mol cm-2 min-
1). The materials were tested in blood flow circuits. In the control circuits, platelet concentrations 
were observed to drop below 55% of baseline levels. Comparatively, the NO-releasing circuits 
maintained platelet levels of 75% compared to baseline after 4 hours (Figure 1.22). Evaluation of 
the circuits both qualitatively and quantitatively, revealed that the SNAP-PDMS coated circuits 
displayed a 78% reduction in thrombus formation compared to control circuits (Figure 1.22). In 
an additional report, the same group evaluated controlling NO release from SNAP through 
covalent attachment to PVC (SNAP-PVC) [439]. Both photointiated and metal ion-induced NO 




Figure 1.22. Hemocompatibility measurements of SNAP−PDMS-coated tubing for ECC testing. 
(A) Time-dependent effects of NO release from the ECC on platelet count over the course of the 
4 h study (n = 3). (B) Quantification of clot mass obtained from the thrombogenicity chamber. (C) 
Visual representation of the clotting that occurred in PDMS-coated controls (left) and 
SNAP−PDMS-coated circuits (right). p < 0.05 was used for comparison. Error bars represent 
standard deviation. Reproduced with permission from [438], copyright 2018, American Chemical 
Society. 
Xu et al. assessed SNAP-doped, textured PU as a dual-functional surface to mimic the 
inner surface of blood vessels for inhibiting platelet and bacterial adhesion (Figure 1.23, top) [440].  
Plasma coagulation properties of SNAP-doped PU were evaluated by assessment of FXII 
activation to FXIIa. In comparison to textured films, smooth PU displayed the highest amount of 
FXIIa at a yield of 0.64 ± 0.08 ng mm-2. SNAP loading (either 5 or 10%) further reduced FXIIa 
yields to one third of the amount produced on smooth PU (Figure 1.23, top). Furthermore 
evaluation of platelet adhesion and activation on the polymer surfaces by optical imaging 
suggested that SNAP-doped, textured PU significantly reduced both platelet adhesion and 
activation when compared to smooth PU (Figure 1.23, top).  
In another report, catheters were fabricated from a SNAP-doped CarboSil system. The 
ability of the material to prevent thrombus formation was evaluated in an in vivo model by placing 
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catheters into the external jugular veins of rabbits for 7 h [441]. After removal, digital images of 
the catheter surfaces demonstrated that thrombus formation was significantly reduced on the 
SNAP-doped CarboSil catheters compared to the control (Figure 1.23, bottom). Furthermore, 
evaluation of the NO release properties demonstrated that SNAP-doped CarboSil films can 
generate NO fluxes above 0.5 × 10-10 mol cm-2 min-1 (which is at the low end of the physiological 
range of the endothelial surface flux) for greater than three weeks (Figure 1.23, bottom). 
 
Figure 1.23. Top. (a) Textured polyurethane (PU) is impregnated with SNAP. The combination 
of surface texturing and NO release mimics the inner surface of blood vessels and inhibits platelet 
and bacterial adhesion. (b) FXII contact activation in contact with polymers for 60 min. Statistical 
analysis was performed to compare the smooth PU films without SNAP. (Statistical symbols, **: 
p < 0.01; ***: p < 0.001). Representative images of platelets adhered on surface of (c) 10% SNAP 
impregnated 700/700 nm and (d) smooth PU films without SNAP impregnation, showing different 
platelet morphologies. Scale bar = 10 µm. Reproduced with permission from [440], copyright 
2019, Elsevier. Bottom. (e) Five cm of the catheters (left of the dash line) were inserted into the 
rabbit external jugular veins for 7 h. Representative pictures of thrombus formation on the 
SNAP/CarboSil and control catheters after removal from veins. (f) Two-dimensional 
representation of clot area (cm2) on SNAP/CarboSil and control catheters in rabbit veins for 7 h, 
as quantitated using ImageJ software from NIH. Data are mean ± SEM (n = 3). * = p < 0.05, 
SNAP/CarboSil vs control catheters. (g) NO flux from 10 wt % SNAP-doped CarboSil films with 
SR topcoats in PBS at 37 °C for 22 days. Data are mean ± SEM (n = 3). Reproduced with 
permission from [441], copyright 2015, American Chemical Society. 
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For the long-term application of blood-contacting materials, NO-donor chemistries have a 
distinct disadvantage: the NO release decays with time, and is eventually depleted. One strategy 
to overcome this challenge is to develop materials that can catalyze the generation of NO directly 
from endogenous RSNOs. This strategy is discussed in the next section. 
1.4.6.3 Catalytic generation of NO 
The use of exogenous NO donors to produce NO-releasing medical implants for long-term 
applications is limited by a finite reservoir of the NO-donating group. Once the donor species is 
depleted of its NO release capability, the direct on-going therapeutic effects from the action of NO 
are arrested. In the majority of cases, this depletion occurs within hours, days, or weeks. To 
transcend this limitation, alternative routes have proposed the generation of NO directly from 
endogenous substrates. Materials that harness this concept have included polymer-immobilized 
organotellurium and selenium catalysts, as well as copper nanoparticles and complexes [442–453].  
The Meyerhoff group has pioneered the generation of NO from RSNOs that occur naturally in 
blood. The use of catalysts developed from the Group 16 elements selenium and tellurium was 
inspired by a biomimetic approach that sought to reproduce the biological activity of glutathione 
peroxidase, a selenium-containing enzyme that generates NO from RSNOs through a catalytic 
reaction [454]. While selenide-based and telluride-based materials successfully generated NO 
from RSNOs such as GSNO and S-nitrosocystein (CysNO), the addition of thiol was necessary to 
maintain the catalytic cycle [443–446]. Other approaches have used copper species to induce the 
catalytic generation of NO from both RSNOs and nitrite [447–453,455]. However, many of these 
approaches proceed through the intentional generation and release of copper ions into solution, 
which depletes the activity of the material, and could cause potential toxicity [448–453].  
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The ability of 1,4,7,10-tetraazacyclododecane complexes [Cu(II)-cyclen] to generate NO 
from both GSNO and CysNO has been investigated, following covalent attachment to cross-linked 
PHEMA [452]. NO release experiments demonstrated that immersion of Cu(II)-cyclen/PHEMA 
films into solutions containing RSNOs could produce steady NO surface fluxes in the range of 2.5 
× 10-10 mol cm-2 min-1, a value that is within the range observed for NO release from healthy 
endothelial cells. Unfortunately, substantial copper leaching occurred (approximately 40%) after 
soaking the materials in PBS with GSNO/GSH over 15 days. Subsequent evaluation of catalytic 
activity showed a resulting decrease in NO generation by 25-50% [456].   
In another report the catalytic properties of Cu(II)-cyclen complexes covalently attached 
to a hydrophillic PU were investigated [453]. While this material generated an NO flux between 
1-3 × 10-10 mol cm-2 min-1, the material lost 25% of the copper, due to leaching, within the first 24 
h, with an additional 25% within a week. These subsequent findings of copper leaching 
demonstrate that the initial materials were not catalytic in function.  
Major et al. incorporated 1, 5, and 10 wt.% copper nanoparticles into a hydrophilic PU to 
develop a material which mimicked the tubing of an extracorporeal circulation device [448]. This 
approach was based on the slow corrosion of Cu0 to generate catalytically active Cu2+ ions. 
Addition of 1 µM GSNO resulted in NO flux measurements of 5, 10 and 12×10-10 mol cm-2 min-1, 
using different weight percentages of copper nanoparticles. Experiments with blood showed that 
the plasma copper concentration increased by a factor of 1-1.3 after 4 hours, suggesting some 
copper leaching [448]. Meyerhoff and coworkers have also demonstrated the ability to 
electrochemically generate NO in the presence of nitrite through a Cu+-mediated pathway. 
Generation of Cu+ proceeded either through the reduction of a Cu2+ or through the oxidation of 
Cu0 wire. The materials were able to generate NO in the range of 0.5-3.5×10-10 mol cm-2 min-1, 
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corresponding to physiologically produced levels [457–459]. Catheters designed using this 
strategy resulted in substantial reductions in thrombus formation, when implanted into rabbit veins 
for 7 h, and they also exhibited substantial antibacterial activity against S. aureus and E. coli [458]. 
Other reports described the incorporation of a copper dibenzol [e,k]-2,3,8,9-tetraphenyl-
1,4,7,10-tetraaza-cyclododeca-1,3,7,9-tetraene complex (CuDTTCT) into polymers for the 
catalytic generation of NO from nitrite [447,455]. By incorporating CuDTTCT species into PVC, 
NO could be produced from nitrite using ascorbic acid as the reducing agent. More recently, the 
same group reported on an iron-based complex which was capable of facilitating the redox cycle 
for catalytic generation of NO from nitrite in the presence of the copper species [455]. In both 
reports, less than 1% of the copper was leached after three days of incubation with nitrifying 
bacteria [455]. While these studies hold merit for medical applications, the ability to generate NO 
from nitrite becomes more relevant for antibacterial applications, because nitrite is an established 
product of bacterial metabolism [447,455].  
While immobilized copper-based species generate NO from the decomposition of RSNOs, 
limitations arise with respect to long-term medical devices due to gradual loss of the catalytic 
materials and subsequent toxicity related to copper leaching. As such, research has progressed 
towards the development of a material in which the copper sites remain immobilized within the 
structural framework under physiological conditions, which is extremely desirable for medical 
applications. In particular, a promising alternative involves the use of metal–organic frameworks 
(MOFs) for NO generation. In MOFs, the immobilization of the metals within the extended 
framework can result in their enhanced stability over other copper complexes, reducing the copper 
leaching. Two copper-based MOFs have been investigated for their NO-generating activity in the 
presence of certain NO donors. These include the copper-carboxylate based MOF, copper 
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benzene-1,3,5-tricarboxylate (CuBTC, Figure 1.24) and the copper triazoleate-based MOF,  
H3[Cu4Cl)3(BTTri)8(H2O)12]•72H2O, where BTTri is 1,3,5-tris(1H-1,2,3-triazol-5-yl)benzene 
(CuBTTri, Figure 1.25) [460,461].  
CuBTC forms face-centered cubic crystals composed of dimeric copper(II) ions at the 
vertices and four trimesate ligands, which form a paddle-wheel-type configuration (Figure 1.24) 
[462]. CuBTC has remained the subject of ongoing study and has been proposed for numerous 
applications. In particular, Harding et al. evaluated the ability of CuBTC to generate NO from the 
NO donor, CysNO. Experiments performed in reagent alcohol in the presence of CysNO and 
cysteine (CysH), showed that CuBTC recovered nearly 100% of theoretical NO upon the addition 
of 2, 10, and 15-fold excesses of CysNO relative to theoretical copper sites in CuBTC, with no 




Figure 1.24. Structure of CuBTC (a) as viewed along the a-axis (b) viewed along the (110) plane 
(c) local environment around the copper centers which forms the SBUs. Image on the left illustrates 
the copper centers upon dehydration with two possible binding sites. Image on the right illustrates 
the hydrated version. Carbon atoms are represented in black, oxygen in red and copper in blue. 
Hydrogen atoms have been omitted for clarity. 
The robust, cubic sodalite-type MOF, CuBTTri, featuring open Cu(II) coordination sites 
has been synthesized (Figure 1.25) [463]. CuBTTri has enhanced water stability compared to 
CuBTC [463]. The catalytic production of NO from S-nitrosocysteamine by both CuBTTri itself 
and a CuBTTri/polymer blend (PU) has been demonstrated [461]. The presence of CuBTTri 
93 
 
resulted in enhanced NO generation when compared to the baseline decomposition of the RSNO. 
The inclusion of CuBTTri into a polymer gave an 8-fold reduction in the rate of NO generation, 
demonstrating that incorporation into a polymeric material can impact NO generation due to 
diffusion limitation of the RSNO [461]. 
 
Figure 1.25. Components of the CuBTTri MOF (a) structure of the BTTri ligand that binds with 
six different copper species (b) SBU with square planar geometry (c) viewed along the a-axis (d) 
view along the (110) plane. 
The concept of localizing the MOF to the surfaces of polymers and metals has been 
investigated [464,465]. The direct growth of CuBTC on carboxymethylated cotton fabric was 
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demonstrated using LbL methodology [464]. Evaluation of the coated fabric indicated that the 
material was able to induce NO formation from S-nitrosocysteamine at rates comparable to 
unsupported CuBTC particles. Overall, this work demonstrated that CuBTC can be deposited onto 
a flexible polymeric material with excellent surface coverage, and that NO release can be catalyzed 
at therapeutically-relevant levels. Further work by Neufeld et al. incorporated CuBTTri into films 
made from PVC, a polymer used to fabricate the tubing used to transport blood in extra corporeal 
circuits [466]. The ability of CuBTTri to enhance the rate of NO generation from SNAP was 
retained following incorporation within PVC. Following exposure to SNAP at ambient 
temperature and physiological pH, it was observed that CuBTTri/PVC films were able to generate 
NO at a level frequently associated with antithrombogenic surfaces. However, until recently, the 
absence of definitive evidence that either CuBTC or CuBTTri could initiate the decomposition of 
the physiological RSNO reservoir (which is largely composed of S-nitrosoalbumin and GSNO) 
remained a significant obstacle to further development. Further efforts toward increasing catalytic 
NO-generation have transitioned to inclusion into polymer formulations with increased 
hydrophilic character, such as chitosan and poly(vinyl alcohol) (PVA) [467,468]. These reports 
first demonstrated MOF-induced NO generation from GSNO, the most abundant small-molecule 
RSNO, at physiologically relevant concentrations. In particular, upon incorporation into PVA, NO 
release occurred at a surface flux that falls within the range associated with the natural 
endothelium.  
Biomaterials that include CuBTTri possess significant clinical potential due to the ability 
of the MOF to modulate biological processes such as clotting. These MOF materials have been 
shown to maintain platelet function.  In a recent report by the Batchinsky and Reynolds groups, 
exposure of blood to a MOF decreased clot strength and accelerated fibrinolysis at 30 min and 60 
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min post- clot strength detection in the ex vivo preparation, demonstrating the antiplatelet function 
of the MOF material [469]. This observation of reduced clot strength and accelerated clot lysis 
was hypothesized to result from NO through inhibition of platelet aggregation and promotion of 
clot dissolution.  
The development of MOFs for biomedical applications is at an early stage, with no current 
use in patient care. An understanding of the biodegradability, stability, and toxicity of MOFs is an 
undeveloped field with information regarding these critical factors limited to only a handful of 
publications. In regards to the use of MOFs for biomedical applications, the majority of reports 
have focused their attention specifically on MOF particles. However, potential applications will 
remain limited unless the materials are incorporated within a polymeric support. Towards this end, 
MOFs are fabricated into thin films or membranes through two generalized approaches: the direct 
blending of the MOF within the polymer matrix and chemical attachment of MOFs to a substrate 
via in situ growth. Direct incorporation of MOF particles into commercially available polymeric 
materials allows the potential to maintain properties of the parent material while adding the desired 
properties of the MOF. MOF incorporation to various metal or polymer substances and the amount 
of RSNOs available near the device site remain as challenges to the manufacturability of these 
materials. For example, medical devices made from materials that are not easily modified and need 
thin polymer layers are not as accessible as the materials that can be easily extruded or surface 
modified, like heparin-bonded surfaces through EDC modifications. PU, polymethacrylates and 
PVC are easily surface modified, whereas materials like poly(methyl pentene) are more difficult 
to pre-treat in a manner similar to heparin coatings. Excitingly, given the potential for sustained 
activity, the manufacturability of the MOF materials, the ability to combine them with other 
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technologies and the safety profile of these materials, on-going research efforts in this area are 
likely to produce a translational pathway to the clinic. 
When developing materials specifically for blood-contacting applications, NO release 
function is a well-established, promising approach to preventing thrombus formation. As 
polymeric encapsulation can significantly influence NO generation using MOFs, another 
challenge involves identification of polymers that optimize the productive, NO-forming 
interaction between aqueous-phase RSNOs and the encapsulated MOF. The future investigation 
and assessment of their in vivo activity will aid in the refinement and advancement of these 
promising systems for medical applications.  
1.5. Summary and outlook for future research 
The robustness with which blood is able to respond to foreign materials—particularly 
through clotting and inflammatory responses—represents many challenges in the quest for blood-
compatible materials. While the risks presented by these physiological responses can be mitigated 
through drugs, the long-term systemic administration of drugs to alleviate risks associated with 
cardiovascular implants and extracorporeal blood circuits is not ideal, and is insufficient to prevent 
device failure. To address this need, materials scientists and engineers have taken up the grand 
challenge of developing blood-compatible materials that locally reduce or prevent negative blood-
material interactions.  
The design of blood-compatible materials requires an understanding of the physiological 
mechanisms that give rise to undesirable blood-material interactions, such as blood clotting and 
inflammation. For example, the early focus on preventing nonspecific protein adsorption is 
gradually being supplanted by more informed approaches, which seek to optimize protein stability, 
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and the interactions of surfaces with specific proteins. Surfaces with features that drive or control 
cellular responses, such as platelet activation and macrophage polarization, either indirectly (by 
selective protein adsorption and stabilization) or directly (by presentation of specific signals) also 
show promise for improving blood-material interactions. By understanding the underlying 
mechanisms driving the physiological responses of the blood to materials, the impacts of the 
physical, chemical, and structural properties of the material on these processes can be elucidated. 
Only then can useful design principles for blood-compatible materials be developed.  
Within the several approaches reviewed here, perhaps the predominant recurring challenge 
is the stability or durability of the material and its blood-compatible properties. Blood contains 
many proteins and living cells, and the cardiovascular system is a dynamic environment. There are 
many chemical and physical processes that can alter the surface features of even the most 
intricately tuned material, ultimately altering its blood-compatibility. One strategy to overcome 
this challenge is develop materials which synergistically combine multiple blood-compatibilizing 
properties, so that as the blood has multiple mechanisms of responding, the material likewise has 
multiple mechanisms of compatibilization.  
The biochemical and cellular mechanisms giving rise to blood-clotting and inflammation 
are robust, containing redundant mechanisms and positive feedback. Therefore, multiple functions 
and features may be required to ultimately suppress these mechanisms in long-term applications. 
For some applications (e.g. stents), the promotion of re-endothelialization is recognized as the best 
clinical outcome, so that in the long term, the blood does not contact the implanted material at all, 
but instead interacts with a living, multifunctional endothelial surface. This outcome may not be 
realizable for all blood-contacting applications, however. One particularly promising related 
approach that can be used to develop multifunctional blood compatible materials is strategic 
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biomimicry. In this approach, some features of the healthy vascular endothelium are strategically 
selected and combined to produce a surface with multiple features that impart blood-compatibility 
(e.g. surface nanostructure, protein stabilization, anti-coagulant chemistry, and NO release).  
Despite advances in biomimetic materials and the remarkable advances made via this and 
other strategies reviewed here, few of the materials developed by these approaches have been 
translated to clinical use. The translation of materials to clinically used devices is a slow process.  
Several thousand new materials are reported each year, focused on improving the biocompatibility 
of devices, yet very few enter a product development pathway. One reason for this may be 
differences in research objectives for discovery-based research versus commercialization-based 
research. Discovery-based research often aims to elucidate how new approaches can be optimized 
with respect to a particular blood-material interaction. Commercialization requires far more in-
depth demonstration of safety and efficacy, as well development of reproducible manufacturing 
methods that can be scaled to production. Materials used in FDA-approved devices have to be 
manufactured using industry standards, sterilized using hospital protocols, packaged and stored 
under appropriate conditions and demonstrated to be safe following ISO-10993. From a materials 
science perspective, however, materials are often designed to address one problem associated with 
interactions with the blood over time scales that are not clinically translatable.  This review 
provided a sampling of hundreds of papers in the past few years addressing proteins, platelets and 
inflammation. The term “biocompatibility” is used in many of these reports, yet when taken as a 
whole, very few of these reports focus on the safety of the material from a clinical perspective; 
rather the focus is often on the aspects related to thrombus formation and the kinetics of the blood-
material interactions.    
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New materials that focus on the dynamic and changing interface between the blood and 
material will likely provide the most rapid progress towards the truly biocompatible surface. At 
the same time, our in vitro testing methods should be expanded to move beyond short-term (e.g. a 
2-hour time point) experiments to long-term (e.g. a time-scale that more closely matches both the 
long-term effects at the blood-material interface and the ultimate end use).  Finally, discussion 
between clinicians and materials scientists and engineers needs to occur more frequently, to 
facilitate a better pairing between the end user (physicians) and the new materials. As long as 
materials researchers and clinicians do not engage in fruitful, tangible discussion, then we are 
unlikely to move more materials from the bench to clinic.  
The recent advances in blood-compatible materials reviewed here collectively demonstrate 
several promising avenues for future research. Materials science and engineering is offering many 
new technologies based on the ability to tune chemistry and structure of materials to achieve 
durable and robust biological functions. Some of the most promising recent avenues of research 
reviewed here are those which establish performance limits and relevant design criteria for new 
blood-compatible materials. While these pursuits have not yet produced the ‘holy grail’ of an ideal 
blood-contacting material, they have yielded substantial improvements in our understanding of the 
mechanisms governing blood compatibility, and exciting new approaches which expand the 
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Chapter 2: ATOMIC FORCE MICROSCOPY OF ADSORBED PROTEOGLYCAN 






Blood vessels present a dense, non-uniform, polysaccharide-rich layer, called the 
endothelial glycocalyx. The polysaccharides in the glycocalyx include polyanionic 
glycosaminoglycans (GAGs). This polysaccharide-rich surface has excellent and unique blood 
compatibility. We report new methods for preparing and characterizing dense GAG surfaces that 
can serve as models of the vascular endothelial glycocalyx. The GAG-rich surfaces are prepared 
by adsorbing heparin and chondroitin sulfate-containing polyelectrolyte complex nanoparticles 
(PCNs) to chitosan-hyaluronan polyelectrolyte multilayers (PEMs). The surfaces are characterized 
by PeakForce tapping atomic force microscopy, both in air and in aqueous pH 7.4 buffer, and by 
PeakForce quantitative nanomechanics (PF-QNM) mode with high spatial resolution. These new 
surfaces provide access to heparin-rich or chondroitin sulfate-rich coatings that mimic both 
composition and nanoscale structural features of the vascular endothelial glycocalyx.  
2.1. Introduction 
Despite the widespread need of blood-compatible materials for medical devices and 
decades of research in this area, obstacles to designing blood-compatible surfaces remain. The 
inside surface of healthy blood vessels is the only known material that is blood-compatible when 
                                                            
1 This work was published in Carbohydrate Polymers and is reproduced in modified form here with permission [1]. 
M. Hedayati was responsible for designing and conducting experiments, managing data, and preparing the manuscript. 
M.J. Kipper conceived of the research, advised and oversaw the experimental work, and edited the manuscript. 
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in long-term contact with flowing whole blood [2]. Blood vessel walls are lined with a layer of 
endothelial cells, which present a network of membrane-bound proteoglycans and glycoproteins 
known as the endothelial glycocalyx [3,4]. The thickness of the endothelial glycocalyx varies 
throughout the vasculature, with reported glycocalyx thickness ranging from 200 to 2000 nm [3,5]. 
The composition of the glycocalyx also varies, as a dynamic equilibrium exists between this layer 
and the soluble components in the flowing plasma [3].  
Proteoglycans and glycoproteins connect the endothelial glycocalyx to the endothelium 
[6]. Proteoglycans are composed of a core protein chain with glycosaminoglycan (GAG) side 
chains connected to them. The most common GAG in the endothelial glycocalyx is heparan 
sulfate, followed by chondroitin sulfate and dermatan sulfate [3]. The glycocalyx plays an 
important role in the anticoagulant activity of the endothelium. The negative charge of the GAGs 
repels circulating platelets [3,5], and some anticoagulant mediators can bind to the glycocalyx to 
enhance their anticoagulant activity [7–9]. 
The structure of the endothelial glycocalyx arising from the organization of proteoglycans 
has been investigated to better understand structure-function relationships. This structure is 
illustrated in Figure 2.1 [10,11]. Rostgaard and Qvortrup show electron microscopy of renal 
capillaries with features they describe as (gooseberry) bush-like spherical features about 300-400 
nm in diameter, composed of smaller filaments [10]. Foundational work by Squire et al. provided 
a detailed structural analysis of Fourier transformed electron micrographs of frog capillaries [12]. 
Their analysis resulted in a structural model in which clusters or “tufts” of glycoproteins about 100 
nm in diameter are organized into a quasi-hexagonal lattice, with thicknesses between about 100 
and 200 nm [12]. Within these clusters organized into 100-nm domains, glycoproteins are further 
clustered into features with approximately 20-nm spacing [12]. Squire et al. proposed that the 
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regular spacing of these “tufts” or “bushes” is consistent with a proposed model in which the 
proteoglycans are organized by anchoring foci in the underlying actin cortical cytoskeleton 
[12,13]. Subsequent improvements to experimental techniques have improved estimates of the 
glycocalyx thickness [14]. However, for 20 years, this general description has persisted as the 
dominant basis for structural and mechanical models of the endothelial glycocalyx [6,15,16]. In 
the present work, we aim to develop and characterize model surfaces that have similar bush-like 
organization of GAGs, as those found in the endothelial glycocalyx, shown in Figure 2.1.  
 
Figure 2.1. (a) Sketch of endothelial surface layer (not to scale) showing core protein arrangement 
and spacing of scattering centers along core proteins and their relationship to the actin cortical 
cytoskeleton as proposed in [12], from [11], copyright 2003, National Academy of Sciences. (b 
and c) Electron micrographs of capillary from small intestine. Bush-like structures are indicated 
by the arrows. The capillary lumen in b and c is labeled “L”. Bars: (b) 1.0 μm; (c) 0.5 μm. (b and 
c) are Reprinted from Microvascular Research, 53, Jørgen Rostgaard and Klaus Qvortrup, Electron 
Microscopic Demonstrations of Filamentous. Molecular Sieve Plugs in Capillary Fenestrae, 1-13, 
Copyright (1997), with permission from Elsevier. 
The structures illustrated in Figure 2.1 are determined using electron microscopy on 
prepared tissue samples. The endothelial glycocalyx has also been characterized by atomic force 
microscopy (AFM) techniques to measure and map its mechanical properties, both on endothelial 
cell cultures and on tissue samples [17–19]. In all three of these reports the AFM imaging and 
mechanical property mapping is conducted at a resolution that is too low to observe the sub-micron 
features described by electron microscopy (Figure 2.1). Nonetheless, these previous publications 
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establish that the mechanical properties of the endothelial glycocalyx can be characterized by 
AFM, and provide possible benchmark for the mechanical properties of glycocalyx mimics.   
Glycocalyx-mimetic surfaces should present a high density of saccharide residues. In 
particular, heparin-containing polyelectrolyte multilayers can modulate cell-surface interactions 
and improve the blood compatibility of surfaces [20–23]. Saccharide-modified surfaces can be 
prepared by a variety of techniques, including self-assembled monolayers containing saccharides 
(“glyco-SAMs”) [24,25], glycopolymers containing monosaccharide or oligosaccharide pendant 
groups [26–30], and brushes formed from polysaccharides, graft copolymers, or dendrimers [31–
34]. These approaches are often described as “glycocalyx mimics” or “glycocalyx substitutes”. 
These surfaces offer control over surface chemistry for protein binding studies. In some cases they 
have been used to modify cell-surface and protein-surface interactions. However, these examples 
primarily use neutral saccharide residues (e.g. glucose and mannose), and the resultant surfaces 
have thicknesses limited to about 20 nm or less, and therefore do not present structures similar to 
those in Figure 2.1. The recent work by Goren et al., grafting dextran to an azide-modified surface 
is a notable exception to this surface thickness limitation [34]. These approaches provide platforms 
for studying biomolecule interactions with ultrathin glyco-coatings on surfaces that may mimic 
some features of cell surfaces that have a very thin glycocalyx. Nonetheless, the formation of dense 
GAG-rich surfaces with composition, negatively charged functional groups, and structural features 
similar to that of the much thicker vascular endothelial glycocalyx shown in Figure 2.1 has not 
been demonstrated by these techniques. 
In this work we demonstrate a new method for preparing surfaces that mimic the structure 
and composition of the endothelial glycocalyx. This method is based on the layer-by-layer (LbL) 
assembly of polyelectrolyte multilayers (PEMs) and their subsequent modification with 
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polyelectrolyte complex nanoparticles (PCNs). The polyelectrolytes used are polyanionic 
polysaccharides, like those found in the glycocalyx. The PEMs provide a uniform surface for 
deposition of the PCNs, and the PCNs provide the bush-like structures with dimensions 
(approximately 100 to 200 nm diameter) similar to those shown in Figure 2.1.  
Here we report initial characterization of these GAG-rich surfaces prepared via LbL 
assembly of PEMs containing PCNs by atomic force microscopy. We used the hyaluronan (HA) 
as a polyanion and chitosan (CHI) as a polycationic polysaccharide (Scheme 2.1) for PEM 
construction. PEM formation is monitored using in-situ Fourier-transform surface plasmon 
resonance (FT-SPR), and surface chemistry is confirmed using X-ray photoelectron spectroscopy 
(XPS). Both techniques confirm LbL adsorption of the polysaccharides. The surface structure and 
mechanical properties are characterized at high resolution using atomic force microscopy (AFM) 
and PeakForce quantitative nanomechanics (PF-QNM). In this work, we hypothesize that 
adsorption of PCNs to PEMs, illustrated in Scheme 2.1, will provide access to dense GAG-rich 
surfaces with dimensions and features approaching those of the vascular endothelial glycocalyx, 
shown in Figure 2.1. These surfaces could serve as model systems to study the structure-
composition-property relationships of glycocalyx-mimetic surfaces, providing new insights into 
the design of blood-compatible surfaces. The structure and organization of GAGs in the vascular 
endothelial glycocalyx has been reported in the literature for over 30 years. However, to the best 
of our knowledge no report in the literature has demonstrated preparation of a surface that mimics 





Scheme 2.1. Chemical structure of each polysaccharide used in this study (left). Schematic of 
GAG-rich polyelectrolyte complex nanoparticles, formed from CS and CHI or HEP and CHI, 
polyelectrolyte multilayers formed from HA and CHI, and the PEM+PCN surfaces we propose as 
mimics of the “bush-like” structures of the endothelial glycocalyx shown in Figure 2.1. 
2.2 Materials and methods 
2.2.1 Materials  
Chitosan (CHI) (Protosan UP B 90/20, 5%) was purchased from Novamatrix. Chondroitin 
sulfate sodium (CS) salt (from shark cartilage, 6% sulfur, 6-sulfate/4-sulfate = 1.24, Mw =84.3 
kDa; PDI = 1.94) and hyaluronic acid (HA) sodium salt (Mw = 743 kDa; PDI = 1.16) were 
purchased from Sigma Aldrich (St. Louis, MO). Heparin sodium (HEP) (from porcine intestinal 
mucosa, 12.5% sulfur) was purchased from Celsus Laboratories (Cincinnati, OH). 11-
Mercaptoundecanioc acid 95% (MUA), rhodamine B isothiocyanate, and fluorescein 
isothiocyanate were purchased from Sigma-Aldrich (St. Louis, MO). Glacial acetic acid and 
ethanol (200 proof 99.5+ %) were purchased from Acros Organics (Geel, Belgium). Sodium 
acetate was purchased from Fisher Scientific (Pittsburgh, PA). Phosphate buffered saline without 
calcium and magnesium (PBS) was purchased from Gibco (Grand Island, NY). A Millipore 
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Synthesis water purification unit was used to obtain 18.2 MΩ cm water, used for making all 
aqueous solutions. 
2.2.2. PCN preparation and characterization by dynamic light scattering (DLS) and zeta 
potential measurements  
We form PCNs, as we have reported previously, by combining a solution containing a 
polyanionic GAG (heparin or chondroitin sulfate) with a solution containing a polycation (the 
polysaccharide chitosan) (Figure 2.1), so that the negatively charged groups (sulfate and 
carboxylate) on the GAG are in stoichiometric excess relative to the positively charged groups 
(ammonium) groups on the chitosan [35–37]. Briefly, chitosan, heparin sodium, and chondroitin 
sulfate solutions were prepared at concentrations of 0.9, 0.95, and 1.9 mg mL−1, respectively, in 
each of three acetate buffer solutions (0.1 M sodium acetate and acetic acid at pH 4.6, 5.0, and 
5.4). Solutions were filtered using 0.22 μm syringe filters (PVDF, Fisher Scientific). To prepare 
chondroitin sulfate PCNs (CS-CHI) the chondroitin sulfate solution was added to the stirring 
chitosan solution in a 6:1 volume ratio (36 mL of chondroitin sulfate solution to 6 mL of chitosan 
solution). To prepare heparin PCNs (HEP-CHI) the heparin solution was added to the stirring 
chitosan solution in a 4:1 volume ratio of heparin solution to a chitosan solution (24 mL heparin 
solution to 6 mL chitosan solution). CS-CHI and HEP-CHI PCNs were prepared at each of the 
three pH values. The mixtures were stirred for 3 h at 1100 rpm. After 3 h of stirring, all solutions 
were allowed to settle overnight to remove aggregated particles. After settling, the supernatant was 
decanted, containing the colloidally stable nanoparticles, while the aggregated particles were 
disposed of. DLS analysis demonstrated that CS-CHI nanoparticles have a reliable polydispersity 
index and do not require further separation. The HEP-CHI solution was centrifuged at 7000 × g 
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for 5 min to separate the particles from uncomplexed polymer, using an Eppendorf 5804 
centrifuge, (Eppendorf, Westbury, NY). 
A Zetasizer Nano ZS (Malvern) was used to analyze size and zeta-potential using a 633 
nm laser. All measurements were performed at a fixed angle of 175° at 25 °C. All measurements 
were performed in 0.1 M acetate buffer solution. Three measurements for each sample were taken.  
2.2.3 Layer-by-layer assembly of PEMs and PEM+PCN  
PEM structure and properties can be modulated through parameters including solution pH, 
salt concentration, polymer charge density, and number of layers deposited [38–42]. PEM were 
prepared from polysaccharides as we have described previously [41,43–46]. Gold-coated glass 
chips with 47 nm gold thickness (NanoSPR LLC, Chicago, IL) were used as a substrates for PEM 
deposition. The chips were rinsed exhaustively in ethanol. The chips were then modified with a 
monolayer of MUA by soaking the gold chip in a 1 mM MUA solution in ethanol for at least 20 
h. The MUA-modified gold chips were dried with a gentle stream of dry nitrogen. 
Polysaccharide solutions were prepared in similar acetate buffer solutions as those used for 
the PCN preparation (0.1 M sodium acetate and acetic acid at pH 4.6, 5.0, and 5.4). Chitosan (1.8 
mg mL−1) and hyaluronan (1 mg mL−1) solutions were prepared at each pH, by stirring for 2 h at 
room temperature. Solutions were clarified by filtration through 0.22 μm syringe filters for 
chitosan and 0.45 μm syringe filters for hyaluronan solution (PVDF, Fisher Scientific).   
Fourier transform surface plasmon resonance (FT-SPR) was used for measuring the 
intensity of p-polarized light reflected from the back side of the gold film on which the PEMs were 
assembled, as a function of wavenumber. MUA-modified chips were mounted in the flow cell of 
an SPR-100 module on a Thermo Electron 8700 FT-IR spectrometer. A Masterflex peristaltic 
pump (Cole-Parmer, Vernon Hills, IL) was used to pump polysaccharide and rinse solutions 
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through the FT-SPR flow cell, with a flow rate of 0.8 mL min−1. A low flow rate was used to 
ensure laminar flow over the gold chip surface. The interferometer in the FT-IR instrument was 
used to scan wavelengths at a fixed angle of incidence. In these experiments, FT-SPR was 
performed using a white light/near-infrared source with a CaF2 beam splitter at the interferometer 
and an InGaS detector. Data were collected using Omnic 7.3 software (Thermo Electron), at 8 
cm−1 resolution from 6000 to 12000 cm−1. PEMs were constructed with CHI as the polycation and 
HA as the polyanion at each of three pH values. SPR peak position at each time point was 
determined from the center of gravity method provided in the OMNIC software. First, the surface 
was exposed to an acidified water rinse (pH 4.0, acidified with acetic acid), for six minutes. The 
LbL process was conducted by alternatively flowing solutions through the flow cell in the 
following sequence: polycation (CHI), rinse, polyanion (HA), rinse. The sequence was repeated 
until a 13-layer PEM (terminating with CHI) had been adsorbed. PEM+PCN samples were 
prepared similarly. After the LbL assembly of 13-layer CHI-HA PEMs at each pH, either CS-CHI 
PCNs or HEP-CHI PCNs were adsorbed, at the same pH as the rest of the PEM assembly was 
conducted (either pH 4.6, 5.0 or 5.4). The resulting samples are referred to as PEM+PCN(CS-CHI) 
and PEM+PCN(HEP-CHI). The length of the adsorption steps was doubled to 12 minutes for the 
PCN adsorption, followed by a final acidified water rinse. 
 
2.2.4. X-ray photoelectron spectroscopy (XPS)  
The surface chemistry of PEM and PEM+PCN samples were evaluated by Physical 
Electronics 5800 spectrometer (Chanhassen, MN). This system has a monochromatic Al kα X-ray 
source (hν = 1486.6 eV), hemispherical analyzer, and multichannel detector. The binding energy 
scales for the samples were referenced to the C1s peak at 284.8 eV. High resolution spectra of the 
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N1s and S2p envelopes were acquired with 0.1 eV steps, and an X-ray spot size of 800 μm. All 
XPS analyses were performed at a photoelectron take-off angle of 45°. Peak fitting of the N1s 
envelope was performed in MultiPak (version 9.3.0.3, Ulvac-Phi, Inc.), assuming three 
Gaussian/Lorentzian peaks and a Shirley background correction. 
2.2.5 Microscopic evaluation of PEM+PCN 
To enable imaging of PEM+PCN samples by TIRF microscopy, surfaces were prepared on 
glass-bottom petri dishes (35 mm diameter WillCo Wells, Amsterdam, Netherlands). Petri dishes 
were first treated with oxygen plasma for 10 minutes, to ensure a clean, oxidized surface. 
Rhodamine-modified chitosan and fluorescein-modified chitosan were used for preparation of 
PCNs and PEMs respectively. Rhodamine- and fluorescein-modified chitosan were prepared by 
dissolving 100 mg of chitosan in 10 ml of 0.1 M acetic acid, adding 10 ml of methanol to the 
solution, adding 3.25 ml of 2 mg ml-1 rhodamine B isothiocyanate or fluorescein isothiocyanate in 
methanol, and allowing the solution to react overnight. Rhodamine- and fluorescein-modified 
chitosan were purified via dialysis, freeze dried and stored at 4 °C protected from light until use. 
LbL adsorption was conducted by exposing the glass surfaces to alternating polycation, rinse, and 
polyanion solutions, as described above, for PEM preparation on gold-coated surfaces. The PEM 
was prepared using fluorescein-labeled CHI as the polycation and HA as the polyanion. CS-CHI 
PCN were prepared as described above, using rhodamine-labeled CHI. TIRF microscopy images 
of a PEM+PCN(CS-CHI) surface were acquired using an objective-type total internal reflection 
fluorescence microscope. The microscope was home-built around an Olympus IX71 body. A 473 
nm and a 561 nm laser line with 2.5 mW of power after the objective (Olympus PlanApo 100 × 
∕1.45) were used as excitation sources. A back-illuminated electron-multiplied charge coupled 
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device (EMCCD) camera (Andor iXon DU-888) operated at −85 °C with an electronic gain of 100 
was used to collect images. 
2.2.6 Atomic force microscopy (AFM)  
AFM was performed on the surfaces prepared on the gold-coated chips used for FT-SPR. 
AFM imaging was performed in air, and in pH 7.4 PBS using a BioScope ResolveTM BIOAFM 
(Bruker). The ScanAsyst mode was used, with a V-shaped silicon nitride cantilever with a nominal 
tip radius of 20 nm, spring constant of 0.35 N m-1, and a reflective gold-coating on the back side 
(DNP-10, Bruker). For all topographical imaging the peak force setpoint was selected near 2 nN, 
and this setting was optimized by the Bruker Nanoscope software. All images were taken at room 
temperature, and the images and surface roughness are representative of at least three non-
overlapping 5 μm × 5 μm areas. Image analysis was performed using NanoScope Analysis version 
1.8 software. The mechanical surface properties of PEM and PEM+PCN samples were 
quantitatively assessed using the PeakForce quantitative nano-mechanics (PF-QNM) mode with a 
V-shaped silicon nitride cantilever with an actual tip radius of 65 nm and a spring constant of 0.098 
N m-1 (PF-QNM, Bruker). This tip is calibrated by the manufacturer. The scan rate was set to 0.5 
Hz; the peak force tapping frequency was set to 1 kHz, and the peak force set point was set to 500 
pN. The PF-QNM mode is based on force-versus-distance measurements in which the probe 
oscillates at a frequency well below the resonance frequency of cantilever f0. Once a force curve 
is obtained, it is then converted to a force versus separation plot for fitting and further analysis. 
Young’s modulus of the sample surface is extracted from the retract curve of the force-versus-
distance data using a Hertzian model for indentation of an elastic solid by a spherical indenter, 
accounting for the adhesion force using the Derjaguin−Muller−Toporov (DMT) model. In these 
experiments the indentation depth is around 10 nm, which is much less than the 65 nm tip radius. 
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This ensures that the radius of the contact area is less than the tip radius, enabling use of the 
Hertzian model. The force on the cantilever is related to the modulus, tip radius, and indentation 
depth by 𝐹𝐹 − 𝐹𝐹𝑎𝑎𝑎𝑎ℎ = 43𝐸𝐸∗�𝑅𝑅(𝑅𝑅 − 𝑅𝑅0)3         (1) 
where F – Fadh is the force on the cantilever relative to the adhesion force, R is the tip end radius, 
and d – d0 is the deformation of the sample. The result of the fit is the reduced modulus E*. The 
reduced elastic modulus E* depends on the elastic moduli of both the tip Etip and the sample Es as 
well as on their Poisson ratios νtip and νs.  
𝐸𝐸∗ = �1−𝜈𝜈𝑠𝑠2𝐸𝐸𝑠𝑠 + 1−𝜈𝜈𝑡𝑡𝑡𝑡𝑡𝑡2𝐸𝐸𝑡𝑡𝑡𝑡𝑡𝑡 �−1 ≈ 𝐸𝐸𝑠𝑠1−𝜈𝜈𝑠𝑠2          (2) 
The tip modulus Etip is assumed to be infinite, so equation 2 depends only upon the sample 
modulus and Poisson’s ratio. in this work, we assumed νs = 0.3 for all samples. 
2.3. Results 
2.3.1. PCN preparation and characterization 
The average size and zeta potential of PCNs was examined with DLS (Table 2.1). The PCN 
size is more sensitive to changes in composition (CS-CHI or HEP-CHI) than to changes in pH 
over the pH range from 4.6 to 5.4. The HEP-CHI PCNs have much smaller hydrodynamic 
diameters than the CS-CHI PCNs at all pH values. The low polydispersity indices (PDI) indicate 
a reliable distribution of diameter. Moreover, the negative zeta potential of PCNs confirms that 
negatively charged PCNs can be formed from both the CS-CHI and HEP-CHI polysaccharide 
pairs, with the polyanion in excess. Figure S1 in the Appendix A shows example size distribution 




Table 2.1. Intensity-average size, PDI, and zeta potential of PCNs 
PCN composition (pH) hydrodynamic diameter (nm) PDI zeta potential (mV) 
CS-CHI (4.6) 219 ± 2 0.12 ± 0.03 -41 ± 3 
CS-CHI (5.0) 235 ± 2 0.11 ± 0.04 -36 ± 3 
CS-CHI (5.4) 228 ± 1 0.10 ± 0.04 -33 ± 2 
HEP-CHI (4.6) 93 ± 3 0.20 ± 0.04 -28 ± 2 
HEP-CHI (5.0) 94 ± 2 0.21 ± 0.04 -23 ± 1 
HEP-CHI (5.4) 110 ± 5 0.29 ± 0.05 -24 ± 2 
 
2.3.2. Layer-by-layer assembly of PEMs and PEM+PCN 
An example of in situ FT-SPR peak position as a function of time during PEM assembly 
at pH 5.0 is shown in the Appendix A Figure S2, and an example of in situ FT-SPR data for a 
PEM+PCN sample is shown in Appendix A Figure S3. The thickness of the adsorbed PEM can be 
estimated from theoretical predictions we have published previously [39,41]. We previously 
showed that there is pH dependence of PEM thickness for HEP-CHI PEMs, when the buffer ionic 
strength is higher than the ionic strength used here, but that there is little pH dependence of PEM 
thickness when 0.1 M buffer is used [41]. The range of thickness obtained for replicate samples 
was between 16 nm and 24 nm for all three pH values used. These data confirm that all three 
conditions yield 13-layer PEMs with similar thickness. 
2.3.3. Confirmation of PCN adsorption by XPS and TIRF microscopy 
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PEM and PEM+PCN surfaces are characterized using XPS. Figure 2.2 left and right show 
high-resolution N1s and S2p envelopes, respectively, for PEM+PCN prepared at each of the three 
pH values. In the N1s envelope, three peaks can be resolved. The peak at 402.1, 400.7, and 399.6 
eV represent ammonium, amide, and amine groups, respectively. The S2p envelope shows a 
contribution from the sulfate in HEP or CS, and N-sulfonate in HEP (169 eV). There is no S2p 
signal for the surface coated with only PEMs because the surface contains only CHI and HA. Table 
S1 in the Appendix A shows the sulfur to nitrogen atom ratio (S/N ratio, calculated from the S2p 
and N1s envelopes) for the PEM+PCN surfaces formed at each pH value. At each pH, the S/N 
ratio is higher for samples with HEP-CHI PCNs, than for samples with CS-CHI PCNs. This is 
consistent with the relative S content of the GAGs (Figure 2.1). 
 
Figure 2.2. N1s envelopes (left) and S2p envelopes (right) for each of the PEM+PCN. Circles 
correspond to raw data. In the N1s envelope, thick solid line is the sum of the peaks; thin lines 
corresponds to fitted peaks for amine, amide, and ammonium contributions. 
 
Although the PEM thickness and PCN size are not strongly affected by pH, the chemistry 
of the PEM+PCN surfaces is influenced by pH. For the PEM+PCN (CS-CHI) samples, there is an 
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increase in the relative amount of ammonium as the pH is reduced. The zeta potential of the PCNs 
is also reduced when they are formed at lower pH. (Compare to Table 2.1.) Therefore, we can 
conclude that there is increased ionization of the chitosan, and increased ion pairing at lower pH, 
for the CS-CHI PCNs. Furthermore, as the pH increases, the relative intensity of the sulfur signal 
is increased. This is apparent from S/N ratio in Table S1. Therefore, preparation of PEM+PCN at 
higher pH results in an increase in the surface concentration of the sulfated polysaccharide (CS or 
HEP). 
PEM+PCN surfaces were imaged using TIRF microscopy to confirm adsorption of the 
rhodamine-labelled nanoparticles. An example of a PEM+PCN (CS-CHI) samples labelled with 
fluorescein-chitosan in the PEM and rhodamine-chitosan in the PCNs is shown in the Figure S4 in 
the Appendix A. The PEM has only green fluorescence from the fluorescein-labelled chitosan; 
whereas the PEM+PCN sample also has punctate red fluorescence, corresponding to rhodamine-
labelled PCNs, confirming adsorbed PCNs are present. 
2.3.4. Atomic force microscopy (AFM)  
AFM is used to evaluate the surface morphology and roughness of the PEM and 
PEM+PCN surfaces, in both air and liquid. AFM is also used to characterize the mechanical 
properties of both PEM and PEM+PCN samples. AFM in ScanAsyst mode provides information 
about both the surface topography, and surface homogeneity. Figure 2.3 shows representative 
three-dimensional topography images of the surfaces modified with the PEM and with PEM+PCN, 
assembled at pH 5.0, imaged in both air and PBS, with corresponding in-phase and quadrature 
channels. Additional AFM topography images of the gold-coated glass, PEM and PEM+PCN 
samples formed at pH 4.6 and at pH 5.4, acquired in air and PBS are shown in Figure S5, S6, and 
S7 in the Appendix A. 
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Figure 2.3. Representative 5 μm × 5 μm AFM topographic images acquired using the DNP tip (20 
nm radius) taken in air (left) and in PBS (right) for PEM and PEM+PCN assembled at pH 5.0. The 
corresponding in-phase (magenta) and quadrature (green) channels are shown below each height 
image. When the PEM is swollen in PBS, the features on the surface are eliminated. The 
PEM+PCN samples clearly contain 80-200 nm diameter nanoparticles on the surfaces, 
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corresponding to the PCNs. When these are swollen in PBS, the PCN features swell, and have 
different properties from the underlying PEM, as is evident by the features in the in-phase and 
quadrature channels. 
 
When the PEM surface is imaged in air (Figure 2.3 top left) it is dominated by small 
features, generally less than 100 nm in diameter and less than 30 nm in height. These features are 
polyelectrolyte complexes that form on the surface during LbL assembly of the PEMs. When the 
PEM surface is hydrated and imaged in PBS (Figure 2.3 top right), the surface roughness increases, 
and the features observed in air are no longer distinct. When PEM+PCN surfaces are imaged in 
air (Figure 2.3 middle and bottom left), the PCNs can be observed, as features that are larger than 
the features on the PEM surface. The HEP-CHI PCNs are generally over 100 nm in diameter and 
over 50 nm high. The CS-CHI PCNs are smaller in air than the HEP-CHI PCNs. When imaged in 
PBS, the PCNs on the PEM+PCN surfaces swell to 200 to 300 nm in diameter and many are 100 
to 150 nm high (Figure 2.3 middle and bottom right). These characteristic sizes are similar to the 
sizes of the PCNs measured by DLS (Table 2.1 and Figure S1). Importantly, these features are 
similar in size and GAG composition to the “bush-like” features of the glycocalyx shown in Figure 
2.1. 
The root-mean-square surface roughness, 𝑅𝑅q, is used to compare the surface roughness of 
samples prepared from different pH solutions, and imaged in air and water (Table 2.2). 𝑅𝑅q is 
defined as: 
𝑅𝑅𝑞𝑞 = �∑ (𝑍𝑍𝑡𝑡−𝑍𝑍�)2𝑡𝑡 𝑁𝑁   (3) 
Where 𝑍𝑍𝑖𝑖 is the distance of the 𝑖𝑖𝑡𝑡ℎ the pixel from the mean height, ?̅?𝑍, and 𝑁𝑁 is the number 
of pixels. The PEM+PCN samples prepared at pH 5.0 have larger feature sizes than those prepared 
at either pH 4.6 or 5.4, for both types of PCNs. 
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Table 2.2. Root-mean-square roughness, Rq (nm), for PEM and PEM+PCN samples. 
 pH = 4.6 pH = 5.0 pH = 5.4 
Surface air PBS air PBS air PBS 
PEM 3 ± 1 6 ± 3 5 ± 2 6 ± 3 4 ± 2 9 ± 3 
CS-CHI 9 ± 2 14 ± 3 11 ± 3 25 ± 1 6 ± 2 14 ± 3 
HEP-CHI 9 ± 2 18 ± 3 17 ± 3 25 ± 1 10 ± 1 18 ± 5 
 
The in-phase and quadrature channels of the AFM images are compared to the height 
images for the samples prepared at pH 5.0, in Figure 2.3. Contrast in the in-phase and quadrature 
channels is characteristic of differences in the sample composition that result in different 
mechanical properties of the surface features. The height features observed in the PEM imaged in 
air are not observed when the PEM is imaged in PBS (Figure 2.3 top row). Hydrating the sample 
causes these features to blend with the rest of the surface, indicating that these features have similar 
composition to the rest of the surface. However, the PEM+PCN samples have distinct height 
features both in air and in PBS. Unlike the PEM sample, when the PEM+PCN samples are 
hydrated in PBS, the height features are enlarged, rather than disappearing (Figure 2.3 middle and 
bottom row). Furthermore, when hydrated, these features have different surface mechanical 
properties than the surface on which they are deposited, evidenced by the contrast, particularly in 
the quadrature channel. We interpret these features as highly hydrated PCNs that present GAG-
rich surface features when hydrated similar to the bush-like “tufts” that are described as features 
of the endothelial glycocalyx (Figure 2.1 and Scheme 2.1) [10–12]. 
To further investigate the nature of the adsorbed PCNs, AFM in PF-QNM mode is used to 
measure the mechanical properties of the PCNs and the PEMs in PBS, using a larger radius (65-
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nm) tip and with a reduced peak force set point (500 pN) on PEM+PCN(CS-CHI) surfaces.  The 
PF-QNM mode provides high-resolution mapping of the mechanical properties of the surface. 
These surfaces were prepared at pH 5.0. Figure 2.4 shows the height channel and the log-modulus 
channel of a PF-QNM micrograph imaged in liquid for both the PEM and the PEM+PCN(CS-
CHI). 
Figure 2.4. Representative 5 μm × 5 μm AFM images acquired in DI water using the PF-QNM tip 
(65 nm radius, 500 pN peak force), showing the height channel (top) and log-modulus channel 
(bottom) for (A.) PEM and (B.) PEM + PCN(CS-CHI). The color scales for the height and log 
modulus channels apply to both images for comparison.  
Interestingly, the height features on the PEM correspond to regions of lower Young’s 
modulus, whereas the height features on the PEM+PCN correspond to regions of higher Young’s 
modulus. This further confirms that the proteoglycan-mimetic PCN adsorbed to the PEM have 
modified the surface structure. Figure 2.5 shows corresponding histograms of the log-modulus 
channel for the PEM and PEM+PCN(CS-CHI). Figure 2.5 also shows examples of force versus 
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distance data for representative pixels in the PEM (C.) and the PEM+PCN(CS-CHI) (D.) and (E.) 
samples. In Figure 2.5 (C.) both the extend (blue) and retract (red) curves are shown. Figure 2.5 
(D.) and (E.) show representative force curves near the means of the two distributions represented 
in the histogram (B.). In Figure 2.5 (C.), (D.) and (E.), the modulus is obtained by fitting equation 
(1) to the retract curve over the region from 30 % to 90 % of the maximum force (solid black line).  
The Young’s modulus values are compared in Table 2.4. The PEM image has an 
approximately log-normal distribution of Young’s modulus with an average modulus of about 1.51 
MPa, and a range from about [0.89 – 2.33] MPa (average ± one standard deviation). In contrast, 
the PEM+PCN sample does not have a log-normal distribution, but the distribution is fit well by 
the sum of two log-normal distributions, as shown in Figure 2.5 (B.). We interpret these two 
distributions as measurements of the PCN modulus, and measurements of the underlying PEM 
modulus in the spaces between the PCN. The distribution corresponding to the blue curve in Figure 
2.5 (B.) has a very similar average and range of modulus as the PEM distribution (Figure 2.5 (A.). 
The distribution represented by the red curve has a larger mean, 4.24 MPa, and a broader range of 
[1.16 – 9.54] MPa. This represents the Young’s modulus of the adsorbed PCNs (Table 2.3). We 
also imaged the PEM+PCN(HEP-CHI) surfaces using PF-QNM (not shown), however, the force 
curves have very high adhesion (greater than 500 pN). While the measured modulus is in a similar 
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range, less than 10 MPa, the very high adhesion force gives us less confidence in the reliability of 
the model fit to the experimental force versus distance data.   
Figure 2.5. Histograms of the log modulus channels shown in Figure 2.4 for the PEM (A.) and 
PEM+PCN (CS-CHI) (B.). The histogram of the log modulus channel for the PEM (A.) shows 
that modulus is log-normally distributed (blue curve). The histogram of the log modulus channel 
for the PEM+PCN (CS-CHI) (B.), is best described by the sum (black curve) of two log-normal 
distributions (blue and red curves). Examples of force versus distance data for representative pixels 
in the PEM (C.) and the PEM+PCN (CS-CHI) (D.) and (E.) samples. In (C.) both the extend (blue) 
and retract (red) curves are shown. (D.) and (E.) show representative force curves near the means 
of the two distributions represented in the histogram (B.). In (C.), (D.) and (E.), the modulus is 
obtained by fitting equation (1) to the retract curve over the region from 30 % to 90 % of the 








Table 2.3. Modulus of samples computed using equation (1) and (2). 
 PEM (blue curves in Figure 2.5) PCN (red curve in Figure 2.5) 
sample 𝐸𝐸𝑠𝑠,𝑎𝑎𝑎𝑎𝑎𝑎 (MPa) 𝐸𝐸𝑠𝑠,𝑎𝑎𝑎𝑎𝑎𝑎 ± 𝜎𝜎 (MPa) 𝐸𝐸𝑠𝑠,𝑎𝑎𝑎𝑎𝑎𝑎 (MPa) 𝐸𝐸𝑠𝑠,𝑎𝑎𝑎𝑎𝑎𝑎 ± 𝜎𝜎 (MPa) 
PEM 1.51 [0.89, 2.33] - - 
PEM+PCN 1.74 [1.04, 2.64] 4.24 [1.16, 9.54] 
 
2.4. Discussion 
In previous work [39], we showed that CHI-HA multilayers, like the ones used here, swell 
substantially in water, and have relatively weak degree of ion pairing between the carboxylate and 
amine groups. This may make these PEMs relatively soft. In contrast, CS-CHI and HEP-CHI 
PEMs demonstrated a higher degree of ion pairing, and reduced swelling. In the present work, we 
assume that the core of the CS-CHI and HEP-CHI PCNs are characterized by a greater degree of 
ion pairing, whereas the corona of the non-stoichiometric particles has a large number of residual 
negatively charged sulfate groups. These bind counterions, increasing the osmotic pressure of the 
PCNs, as evidenced by their swelling in buffer (Figure 2.3), and causing them to adopt “bush-like” 
conformation on the surfaces when hydrated (Scheme 2.1). This high osmotic pressure and 
electrostatic repulsion also makes them more resistant to compression by the AFM tip than the 
underlying PEM, contributing to the higher observed Young’s modulus for the PCN compared to 
the PEM (Figures 2.4 and 2.5, and Table 2.3). 
Recently, Andreeva et al. characterized similar CHI-HA PEMs, by AFM and ellipsometry, 
and also measured albumin adsorption [47]. They showed that using different small molecule ions 
in the surface preparation modulated the thickness, roughness, hydrophilicity, and Young’s 
modulus [47]. While the Young’s modulus measurements made by Andreeva et al. on their CHI-
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HA PEMs are lower than ours, their samples were characterized using a much smaller radius tip 
(< 10 nm), by force volume mapping of 10 points on the surface. Here, we demonstrate a method 
for preparing surfaces with additional heterogeneous surface features, by adsorbing the 
proteoglycan mimetic PCNs to the PEM surfaces. We also provide a much more detailed 
measurement of the surface mechanical properties by mapping the modulus and correlating 
modulus features to the adsorbed PEM and PCNs. These features may more closely mimic the 
surface organization of proteoglycans in the endothelial glycocalyx found from experimental 
characterization of real endothelia (Figure 2.1).  
The mechanical properties of the endothelial glycocalyx on live cells and tissues has been 
characterized by AFM [17–19]. In the work by O’Callaghan et al. on endothelial cell cultures and 
the work by Wiesinger et al. on aorta tissue samples, very large diameter AFM tips (17 or 10 μm) 
were used to reduce the pressure applied by the AFM probe on the cell membranes. The work by 
Bai and Wang uses a smaller AFM tip (40 nm diameter), however the AFM images reported are 
at the length scale of the cell (75 μm × 75 μm). Therefore these previous AFM experiments on cell 
and tissue samples are not capable of resolving the sub-micron the bush-like structures observed 
in electron microscopy images (Figure 2.1). In the experiments by Bai and Wang on live 
endothelial cells, the glycocalyx modulus is obtained from 200-nm indentation depth using a linear 
mechanical model that includes two moduli, a modulus of the cell and a modulus of the glycocalyx. 
Experiments were conducted before and after treatment with an enzyme to remove the glycocalyx. 
They report a modulus for the glycocalyx that is less than 1 kPa, which is far lower than the 
modulus of our surfaces [17]. Others have used a similar indentation depth with AFM of 
endothelial cells showing that the measured mechanical properties correspond to intracellular 
features [48].  O’Callaghan also report much lower modulus of endothelial cell cultures (between 
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1 and 2 kPa), than what we measure for our surfaces, also using a large indentation depth (> 200 
nm) [18]. Indentation experiments with greater than 200 nm depth are also reported by Wiesinger 
et al. on bovine aorta tissue samples and cultured endothelial cells [19]. These authors do not use 
a mechanical model to extract modulus from their indentation data. While none of these reports 
maps the mechanical properties of the cell or tissue at high resolution, these important experiments 
demonstrate that it is possible in principle to characterize the glycocalyx on live cells using AFM. 
To compare our results to measurements on live cells, however, further experiments should be 
done on live cells at higher resolution and under similar imaging conditions (lower indentation 
depth, higher indentation frequency). Nonetheless the consensus from reports in the literature is 
that the endothelial surface, including the cells and the glycocalyx, should have an elastic modulus 
in the range of kPa. While our surfaces may mimic the composition and supermolecular assembly 
(sub-micron “bush-like” structures) of the glycocalyx, they clearly do not have the same 
mechanical properties as the endothelial cell surface. As further experiments are reported in the 
literature to better characterize the mechanical properties of the endothelial glycocalyx at higher 
resolution, this information can be used to guide the development of glycocalyx mimics, like the 
surfaces we report here.  
The surface reported here have high-GAG composition and sub-micron features that mimic 
some features of the endothelial glycocalyx. This may make these model surfaces an ideal platform 
for studying how composition, supermolecular assembly, and nanoscale surface topography can 
be tuned to make surfaces more blood compatible. However, before these surfaces can be 
translated to useful applications in blood-contacting materials, their stability at physiological 
conditions, their behavior under physiological shear rates, and their interactions with blood cells 
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and blood proteins should also be investigated. These future investigations should guide the design 
of glycocalyx mimetic surfaces with improved blood compatibility. 
2.5. Conclusions 
In this study, we demonstrate that by combining LbL assembly of PEMs with GAG-rich 
PCNs, dense polysaccharide-rich surface coatings can be prepared, that have nanoscale features of 
similar dimensions to those found in the endothelial glycocalyx. AFM imaging in both air and 
liquid, combined with high-resolution mechanical property mapping by PF-QNM mode imaging 
in liquid provide details about the structure and topography of these new glycocalyx mimics. When 
proteoglycan mimetic PCNs are adsorbed to PEMs, the resulting features present dense GAG-rich 
regions that swell when hydrated, and have higher Young’s modulus than the underlying PEM. 
This surface heterogeneity is likely due to electrostatic repulsion among neighboring PCNs that 
precludes more complete surface coverage. In the regions where the proteoglycan mimetic PCNs 
are adsorbed, a dense GAG surface with high osmotic pressure is presented, with height features 
from 100 to 150 nm high, indicating stretched polymer chains. The resulting surface heterogeneity 
may mimic the structure and organization of proteoglycans presented in the vascular endothelial 
glycocalyx. These new surfaces will provide a tunable platform for studying how blood proteins 
and blood cells interact with polyanionic glycocalyx-like surfaces composed of different GAGs. 
We propose that these surfaces could provide further insights into how composition and 
micro/nanostructure of GAG-modified surfaces should be designed to improve the blood 
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CHAPTER 3: PROTEIN ADSORPTION MEASUREMENTS ON LOW FOULING AND 






Ultralow protein fouling behavior is a common target for new high-performance materials. 
Ultralow fouling is often defined based on the amount of irreversibly adsorbed protein (< 5 ng 
cm−2) measured by a surface ensemble averaging method. Protein adsorption at solid interfaces is 
a dynamic process involving multiple steps, which may include adsorption, desorption, and protein 
denaturation. In order to better optimize the performance of antifouling surfaces, it is imperative 
to fully understand how proteins interact with surfaces, including kinetics of adsorption and 
desorption, conformation, stability, and amount of adsorbed proteins. Defining ultralow fouling 
surfaces based on a measurement at or near the limit of detection of a surface-averaged 
measurement may not capture all of this behavior. Single-molecule microscopy techniques can 
resolve individual protein-surface interactions in high time and space resolution. This information 
could be used to tune the properties of surfaces to better resist protein adsorption. In this work we 
demonstrate how combining surface plasmon resonance, X-ray spectroscopy, atomic force 
microscopy, and single-molecule total internal reflection fluorescence microscopy provides a more 
complete picture of protein adsorption on ultralow fouling polyelectrolyte multilayer and polymer 
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brush surfaces, over different regimes of protein concentration. In this example comparing the 
surfaces using surface plasmon resonance alone is insufficient to rank their resistance to protein 
adsorption. However, the combination of surface ensemble averaging and single-molecule 
microscopy provides a more complete characterization of the protein adsorption phenomena. We 
propose that the definition of ultralow fouling surfaces based on a single technique should not be 
considered a gold-standard for qualifying new advanced antifouling materials. 
3.1. Introduction 
Nonspecific biomolecular adsorption on surfaces is a universal phenomenon that is 
detrimental to the functionality of materials used in medical implants, medical devices, drug 
delivery carriers, and biosensors [1]. Therefore, measuring non-specific protein adsorption on 
surfaces is important for predicting and optimizing material performance in biological 
applications. Surface ensemble-averaging techniques measure physical or chemical properties 
averaged over a surface. In controlled experiments, changes in these average properties are 
attributed to protein adsorption. For example, infrared spectroscopy or X-ray spectroscopy can be 
used to measure ensemble changes in chemical signatures due to the presence of surfaced adhered 
proteins [2,3]. Widespread techniques used to measure protein adsorption based on changes in 
physical properties include surface plasmon resonance (SPR) and quartz crystal microbalance 
(QCM) [4–8]. SPR and QCM are optical and acoustic sensors, respectively, that are used to 
quantify the amount of protein adsorption on material surfaces, and to compare and qualify non-
fouling surfaces. These techniques rely on measuring a resonant frequency of an electronic (SPR) 
or acoustic (QCM) oscillation in which physical changes on the surface lead to resonance shift of 
an evanescent wave propagating from the surface [9,10]. Since these techniques measure a mean 
property change in both the surface and the nearby solution, they cannot directly distinguish 
158 
 
between signal changes due to reversible or irreversible protein adsorption and signal changes due 
to introduction of the protein to the medium in contact with the sensor surface. For example, SPR 
can have sensitivity in the range of 10−5 - 10−6 refractive index units [11]. The refractive index 
increment of many proteins in solution is between 0.185 and 0.195 mL g−1 [12]. Hence the addition 
of protein to a solution even at concentrations below 0.1 mg mL−1 creates a significant background 
signal, regardless of whether the protein adsorbs to the surface. Therefore, although they are 
amenable to in situ measurements, these techniques also require that the surface (optical or 
acoustic) properties be compared before and after protein adsorption to quantify the amount 
adsorbed, resulting in a static measurement of irreversibly adsorbed protein. Vibrational and X-
ray spectroscopy are also surface-averaging techniques can be used to directly measure adsorbed 
proteins, but are not usually conducted in situ, and generally have lower limits of detection than 
QCM or SPR [3]. 
To rationally design advanced ultralow fouling materials, it may be even more critical to 
understand the dynamics underlying protein-surface interactions and possible changes in protein 
conformational at the solution-solid interface. Protein adsorption can result in reversible or 
irreversible adsorption [13]. Reversibly adsorbed proteins do not permanently modify the surface 
physical chemistry. Irreversible adsorption, however, is often accompanied by protein unfolding, 
which can affect the protein's biological function and ultimately modify the surface physical 
chemistry. The physical ensemble-averaging techniques (SPR and QCM), and complementary 
chemical spectroscopic techniques cannot provide direct information about the molecular 
mechanisms of protein adsorption, because they do not permit the direct observation of the 
interfacial dynamics [14]. In contrast to the surface ensemble-averaged methods, single-molecule 
microscopy with high signal-to-noise ratio provides unique spatiotemporal information on the 
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dynamic behavior of individual protein molecules [15–19]. Single-molecule total internal 
reflection fluorescence (TIRF) microscopy can specifically detect and track in real time the 
interactions of proteins directly with the surface [20–23]. In this technique, fluorescent molecules 
located near the surface (< 150 nm) or directly in contact with the surface are excited by the 
evanescent wave of the incident laser. Hence, the background signal of fluorescence from the 
protein solution is eliminated from outside the focal plane. Furthermore, freely diffusing molecules 
in solution move too rapidly to be captured by the microscopy. Therefore only surface-
immobilized protein molecules are detected. However, the TIRF experiments are so sensitive that 
they must be conducted at very low protein concentration to enable the single particle detection. 
On the other hand SPR enables measurement of protein adsorption in real time at physiologically 
relevant concentrations, without requiring protein labeling. For techniques such as QCM and SPR, 
the limit of detection is on the order of 0.1 - 2 of ng cm−2 [10,23]. Therefore ultralow fouling is 
often defined based upon a signal at or near the limit of detection of SPR or QCM, or based on 
lack of detection altogether. In contrast, TIRF microscopy can in theory be used to detect a single 
protein in a field of view of the microscope, achieving detection limits two to three orders of 
magnitude lower than what is achievable by QCM and SPR [25]. Furthermore, the detection can 
be made with both high space and time resolution to provide more detailed information about the 
dynamics of protein-surface interactions [25].   
It has already been widely acknowledged in the literature that experiments using ensemble-
averaging techniques may demonstrate ultralow fouling behavior, but that these results often do 
not predict the effects of long-term protein exposure, or exposure to complex biological media 
containing multiple proteins. Therefore, they should not be relied upon as the only techniques used 
for qualifying ultralow fouling surfaces. Here, we propose that a suite of complementary analytical 
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techniques providing a more comprehensive description of protein adsorption should include 
single-molecule techniques.   
In the present study, we combine single-molecule microscopy and ensemble-averaging 
techniques to study protein adsorption phenomenon on ultralow fouling surfaces. Both in situ SPR, 
and single-molecule TIRF microscopy were performed to measure protein adsorption. Surfaces 
are also characterized before and after protein adsorption using X-ray photoelectron spectroscopy 
(XPS) and atomic force microscopy (AFM). These techniques were uniquely combined to analyze 
the adsorption of two different proteins, bovine serum albumin and fibrinogen, on four well-
characterized low fouling or ultralow fouling surfaces: high- and low-grafting density polyethylene 
glycol (PEG) brush surfaces (PEGhg and PEGlg) and polysaccharide-based polyelectrolyte 
multilayer (PEM) surfaces with different terminal layers (PEM10 and PEM11). We show that SPR 
alone is not sufficient to characterize the antifouling properties of surfaces, and that combining 
SPR and single-molecule TIRF microscopy can paint a more complete picture of the protein 
adsorption at the solution-solid interface.   
3.2. Materials and Methods 
3.2.1. Materials 
α-Methoxy-ω-triethoxy PEG (Mw = 5,000 Da) and α-methoxy-ω-thiol PEG (Mw = 5,000 
Da) were purchased from Laysan Bio Inc. and Nanocs respectively. Chitosan (CHI) was purchased 
from Heppe Medical Chitosan, GmbH (Halle, Germany).  Hyaluronic acid (HA) sodium salt (Mw 
= 743 kDa; PDI = 1.16), bovine serum albumin (BSA), fibrinogen (FIB) from human plasma, 
thrombin from bovine plasma, 11-mercaptoundecanoic acid (MUA, 95%), sodium acetate, β-
mercaptoethanol, catalase from bovine liver, and glucose oxidase were purchased from Sigma 
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Aldrich. Glacial acetic acid and ethanol (200 proof 99.5+%) were purchased from Acros Organics. 
BSA conjugated to Alexa Fluor 647 and FIB from human plasma Alexa Fluor 647 conjugate were 
purchased from Thermo Fisher Scientific (Waltham, MA). Phosphate-buffered saline (PBS) 
without Ca2+ and Mg2+ was purchased from Gibco (Grand Island, NY). 18.2 MΩ cm water from a 
Millipore water purification unit was used for making all aqueous solutions. 
 
3.2.2. Preparation of PEG brush surfaces  
Surfaces functionalized with PEG brushes were constructed via a grafting-to approach 
[27]. The grafting density was changed by changing the solvent quality of the PEG deposition 
solution. For TIRF microscopy experiments, the underlying substrates were fused silica wafers. 
Prior to functionalization, the wafers were thoroughly washed with Micro-90 (International 
Product Corp.), ultrapure water, and piranha solution, followed by a UV/ozone treatment for 30 
min. Next, the wafers were immersed in a 1 mM solution of α-methoxy-ω-triethoxy PEG (Mw 
5,000 Da) in either 100% acetone (low grafting density PEG brushes) or 50% acetone/50% diethyl 
ether (high grafting density PEG brushes) for 15 h at 30 °C. The surface grafting reaction was 
catalyzed by N-butylamine at a 1:20 volumetric ratio of the catalyst-to-reaction mixture. Finally, 
surfaces were rinsed multiple times with acetone and water and dried with ultrapure N2. For SPR 
measurements, gold chips were used as the underlying substrate. Prior to functionalization, the 
chips were rinsed with ethanol and exposed to UV/ozone treatment for 30 min. Next, the surfaces 
were immersed in a 0.4 mM solution of α-methoxy-ω-thiol PEG (Mw = 5,000 Da) in either 100% 
acetone (low grafting density) or 100% ethanol (high grafting density) for 1 h at room temperature. 
Finally, surfaces were thoroughly washed with ethanol and water and dried with ultrapure N2. All 
surfaces were prepared in triplicate per condition in separate batches. The high grafting density 
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PEG sample (PEGhg) on the cover glass had a similar grafting density to the low grafting density 
PEG sample (PEGlg) on the gold-coated glass. 
 
3.2.3. PEG brush thickness determination 
The thickness of the dry brush was measured by ellipsometry using a J.A. Woollam 
variable angle spectroscopic ellipsometer (model VASE-VB-250). Each surface was spectrally 
scanned with an incident angle between 60-80°, in increments of 5°, over a range of 500-900 nm. 
The collected spectra were fit to a three-layer planar model of the solid surface, which accounts 
for the refractive index of air (n = 1.003), PEG (n = 1.45), silicon oxide layer (n = 1.457), and 
silicon (n = 3.881). For the gold chips, the silicon oxide layer was replaced by a gold layer (n = 
0.1810). The dry PEG brush thickness (ℎ𝑎𝑎𝑑𝑑𝑑𝑑) was obtained and subsequently related to grafting 
density (𝜎𝜎) as 𝜎𝜎 = 𝜌𝜌𝑎𝑎𝑑𝑑𝑑𝑑ℎ𝑎𝑎𝑑𝑑𝑑𝑑𝑁𝑁𝐴𝐴 𝑀𝑀𝑤𝑤⁄ , where 𝜌𝜌𝑎𝑎𝑑𝑑𝑑𝑑 is the dry density of the PEG monomer repeat 
unit (1 g/cm3), 𝑁𝑁𝐴𝐴 is Avogadro’s number, and 𝑀𝑀𝑤𝑤 is the average molecular weight of the PEG 
polymer (5 kDa). Dry thicknesses were measured on triplicate samples for each condition to 
account for sample variability. Additionally, for each sample, dry thickness was measured on three 
different spots to account for sample heterogeneity. All nine measurements were included in the 
determination of the standard deviation of the measured thickness values. 
3.2.4. Layer-by-layer surface preparation of PEM 
Polysaccharide solutions were prepared in acetate buffer solutions (0.2 M sodium acetate 
and acetic acid at pH =5.0). Chitosan (1 mg mL−1) and hyaluronan (0.5 mg mL−1) solutions were 
prepared by stirring for 1 h at room temperature. Solutions were clarified by filtration through 0.22 
μm syringe filters for CHI and 0.45 μm syringe filters for HA solution. 
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Gold-coated glass chips (47 nm gold thickness) were rinsed exhaustively in ethanol, then 
modified with a self-assembled monolayer of MUA by soaking the gold-coated glass chip in a 1 
mM MUA solution in ethanol for 24 h. First, the surface was exposed to an acidified water rinse 
(pH 4.0, acidified with acetic acid) for 4 minutes. The layer-by-layer process was conducted by 
immersing MUA-modified surfaces into an aqueous polycation (chitosan) solution (1 mg mL−1) 
for 6 min rinsing with acidified water for 4 min. Subsequently, polycation modified surfaces were 
immersed into aqueous polyanion (hyaluronan) solutions (0.5 mg mL−1) for 6 min, followed by 
acidified water rinse for another 4 min. The cycle was repeated until the desired layer number was 
reached. For TIRF microscopy experiments, the underlying substrates were fused silica wafers. 
Cover glasses were first treated with oxygen plasma for 10 min, to ensure a clean, oxidized surface. 
Then, layer-by-layer adsorption was conducted by exposing the glass surfaces to alternating 
polycation, rinse, and polyanion solutions, on an orbital shaker similar to the procedure used for 
the SPR. To confirm that the PEM surfaces prepared on MUA-modified, gold-coated glass are 
similar to those on cover glasses, examples of elemental composition from XPS and AFM images 
of the PEM11 on both substrates are shown in Table S1 and Figure S1 in the Appendix B. 
3.2.5. Protein adsorption by SPR 
Fourier Transform Surface Plasmon Resonance (FT-SPR) was used for measuring protein 
adsorption on the surface of PEMs and PEG brushes as a function of wavenumber using an SPR 
100 module on a Thermo 8700 model FT-IR spectrometer (Thermo Electron). The average limit 
of detection for wavelength changes for the instrument was estimated to be 0.1 nm. A 1 nm SPR 
wavelength shift is equivalent to a surface coverage of ~ 20 ng cm−2 adsorbed proteins. Gold chips 
coated with PEG or PEM surfaces were mounted to the base of a prism on one side of a flow cell, 
and optical contact was established between the chip and the prism using a refractive index 
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matching fluid. A Masterflex peristaltic pump was used to pump protein and PBS solutions through 
the flow cell, in contact with the PEG or PEM surfaces, with a flow rate of 0.1 mL min−1. The 
interferometer in the FT-IR instrument was used to scan wavelengths at a fixed angle of incidence. 
In these experiments, FT-SPR was performed using a white light/near-infrared source with a CaF2 
beam splitter at the interferometer and an InGaS detector. Data were collected using Omnic 7.3 
software (Thermo Electron), at 8 cm−1 resolution from 6000 to 12000 cm−1. 
 
3.2.6. Protein adsorption by XPS 
After exposing samples to either PBS or to protein solutions in PBS by SPR, XPS (Physical 
Electronics 5800 spectrometer) was performed on PEG and PEM surfaces to characterize adsorbed 
proteins. High resolution spectra were collected for the C1s, N1s, and O1s envelopes using a pass 
energy of 23.5 eV. Peak fit analysis for high resolution carbon (C1s) peak was performed using 
the Multipak software. The binding energy scales for the samples were referenced to the C1s peak 
at 284.8 eV. 
3.2.7. Protein adsorption by AFM 
After exposing samples to either PBS or protein solutions by SPR, AFM was obtained to 
observe protein adsorption on PEG and PEM surfaces. The topography scan was performed using 
a BioScope Resolve BIOAFM (Bruker) with Nanoscope V controller. The measurements were 
performed under ambient conditions at room temperature in PBS to compare the nanoscale 
morphology of the surfaces before and after exposure to protein solution. The ScanAsyst mode 
was used, with a V-shaped silicon nitride cantilever (SNL-10, Bruker, nominal tip radius of 2 nm, 
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spring constant of 0.35 N m−1). For all topographical imaging, the peak force setpoint was selected 
near 500 pN, and this setting was optimized by the Bruker NanoScope software. 
3.2.8. Protein adsorption study by single-molecule microscopy  
Individual fluorescently-labeled protein molecules at the solution-solid interface were 
imaged by total internal reflection fluorescence (TIRF) microscopy to track individual 
fluorescently labeled protein molecules as they adsorb to and desorb from the solid-liquid 
interface. Proteins in solution within the total internal reflection range diffuse too quickly to be 
detected by the camera. The microscope was home-built around an Olympus IX71 body with 638 
nm laser line as excitation source (DL638- 328 050, CrystaLaser) [14,28]. A back-illuminated 
electron-multiplied charge coupled device (EMCCD) camera (Andor iXon DU-888) liquid-cooled 
to −70 °C, with an electronic gain of 60 was used. An autofocus system (CRISP, Applied Scientific 
Instrumentation) in combination with a piezoelectric stage was used to maintain constant focus 
during imaging. To reduce photobleaching, an enzymatic oxygen scavenger system was used in 
the imaging buffer. Imaging buffer for screening protein adsorption was PBS (pH 7.4), 0.15 mg 
mL−1 glucose oxidase, 34 μg mL−1 catalase, 0.8% (w/v) glucose and 1% (v/v) β-mercaptoethanol. 
Albumin from bovine serum conjugated with Alexa Fluor 647 and fibrinogen from human plasma 
conjugated with Alexa Fluor 647 were used to observe protein adsorption on different surfaces. 
For TIRF experiments, solutions were introduced into a microfluidic flow chamber, which 
was constructed with #1.5 cover glass (~170 μm thick) modified with the PEG or PEM surfaces. 
A schematic picture of the flow cell is depicted in Figure S2. The chamber was made by adhering 
a plastic cover slip to the modified cover glass via a double-sided SecureSeal adhesive sheet 360 
μm thick (Grace Bio Labs, Bend, OR, USA). Two parallel rectangular channels of 1.6 mm width 
each were cut into the adhesive sheet, so that a channel is created. In order to introduce inlets and 
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outlets in the plastic cover, four holes 0.5 mm in diameter were drilled. A plexiglass cover, also 
with four holes was clamped onto the cover glass sandwich. The holes on each end of the flow 
channel were connected through 1/32″ outer diameter PEEK tubing (1569, IDEX Health & 
Science, Middleborough, MA, USA). A Masterflex peristaltic pump was used to pump protein and 
PBS solutions through the flow channel with a flow rate of 0.1 mL min−1. The surface shear rate 
profile across the width of the microchannel (x-direction) was calculated based on equation S1 in 
the Appendix B [29]. A wall shear rate of 50 s−1 was used for all the surfaces at 𝑥𝑥 = 0.  
3.3. Results 
3.3.1. Surface characterization 
3.3.1.1. PEG surfaces 
The resulting grafting density (σ), tether distance of PEG brush surfaces (distance between 
chains on the surface), and the measured dry brush thickness were determined by ellipsometry 
(Table 3.1). The average surface roughness was measured by AFM in PBS (Table 3.1). In this 
study, we used two different PEG brush surfaces on both gold and glass substrates. On each 
surface, the lower grafting density is referred to as PEGlg, and the higher grafting density is referred 
to as PEGhg. The grafting densities on gold are higher than the grafting densities on glass, with the 
PEGlg on gold having similar grafting density to the PEGhg on glass.  
Table 3.1. Structural parameters of PEG brush surfaces on both glass and gold. Results are 










PEGlg on glass 1.4 ± 0.1 0.16 ± 0.01 2.48 ± 0.08 -- 
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PEGhg on glass 2.9 ± 0.1 0.34 ± 0.01 1.73 ± 0.03 -- 
   PEGlg on gold 2.5 ± 0.2 0.29 ± 0.02 1.86 ± 0.06 1.2 ± 0.2 
   PEGhg on gold 7.2 ± 0.2 0.83 ± 0.02 1.10 ± 0.01 1.3 ± 0.2 
 
3.3.1.2. PEM surfaces 
We previously reported the layer-by-layer assembly of the PEMs (from CHI and HA at pH 
5.0) by in situ Fourier transform surface plasmon resonance (FT-SPR) on gold-coated glass 
substrates, modified with a self-assembled monolayer of MUA (Figure S3) [30]. The resulting dry 
and wet thickness of PEM surfaces, determined by ellipsometry and SPR is shown in Table 3.2. 
In this study, all the experiments were carried out on gold-coated glass substrates except for the 
TIRF microscopy experiments, which were performed on cover glass substrates.  
Table 3.2. Structural parameters of PEM surfaces. Results are expressed as mean values ± 








PEM10 6.4 ± 0.2 15 ± 2 6.3 ± 0.8 
PEM11 9 ± 0.8 16.5 ± 2 13 ± 2.2 
 
3.3.2. Protein adsorption study by SPR 
SPR was used to quantify the adsorption of protein on PEG and PEM surfaces. Surfaces 
were exposed to solutions (1 mg mL−1) of albumin or fibrinogen in phosphate-buffered saline 
(PBS) for 30 min. During the protein adsorption step, the plasmon resonance absorption 
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wavelength, λres, was monitored, as shown in Figure 3.1. The wavelength is expected to shift due 
to the difference in refractive index of the PBS with and without protein within the penetration 
depth of the SPR evanescent field. This change in refractive index arises due to protein adsorption 
on the surface as well as the refractive index increment of the protein in solution. In all 
experiments, the SPR signal equilibrated in approximately 10 min. The amount of irreversibly 
adsorbed protein was quantified as the difference in λres (i.e., ∆λres) in PBS before and after 
incubation with protein solution (Table 3.3). On all the surfaces, a positive change was detected in 
λres when the surfaces were exposed to protein which means both albumin and fibrinogen were 
adsorbed on all surfaces. However, for some cases the adsorbed protein desorbed entirely during 
the subsequent rinse.  
 
Figure 3.1. Protein adsorption on PEG (left) and PEM (right) surfaces from in situ SPR. 
Table 3.3. SPR response to nonspecific protein adsorption ∆λres (nm). Results are expressed as 




surface albumin fibrinogen 
PEGlg n.d. 4.0 ± 0.5 
PEGhg 7.1 ± 0.8 20 ± 1 
PEM10 n.d. 1.0 ± 0.2 
PEM11 0.5 ± 0.2 n.d. 
 
As shown in Figure 3.1, albumin adsorption on PEGlg is reversible, indicating excellent 
albumin resistance. However, on PEGhg the signal does not return to the original value upon 
washing, indicating that some of the albumin adsorption on PEGhg is irreversible, and that the 
surface is not resistant to albumin adsorption. Fibrinogen has much higher affinity with the PEGhg 
compared to the PEGlg surface. Both surfaces irreversibly adsorb fibrinogen, although the amount 
of adsorption for PEGhg is higher than that for PEGlg.  
For PEM surfaces, as shown in Figure 3.1 and Table 3.3, the amount of protein that 
irreversibly adsorbs is much lower than for PEG surfaces. The terminal PEM layer can be chosen 
to select for resistance to different proteins. PEM10 exhibits albumin resistance, as the adsorbed 
albumin on the surface is completely desorbed during subsequent rinse step. However, PEM10 does 
not completely resist irreversible adsorption of fibrinogen. PEM11 has the opposite trend with 
respect to adsorbing these two proteins. PEM11 exhibits reversible fibrinogen adsorption, with no 
detectable fibrinogen adsorbed following the rinse. However, PEM11 does adsorb some albumin 
irreversibly. Using SPR, we are able to compare the amount of irreversible protein adsorption on 
different surfaces. SPR results from albumin and fibrinogen interactions with PEG and PEM 
surfaces indicate that PEM surfaces exhibit better antifouling activity toward protein adsorption.  
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3.3.3. Protein adsorption by XPS 
Protein adsorption on different surfaces was also investigated by XPS. Surfaces exposed 
to solutions (1 mg mL−1) of albumin or fibrinogen in PBS for 30 min in the SPR study were used 
to determine how much protein was adsorbed on the surface, following the rinse. To evaluate the 
accumulation of proteins on surfaces, C1s and N1s high resolution spectra were examined.  
XPS high-resolution scans of the C1s envelopes are shown in Figure 3.2, top for PEG 
surfaces. The strong peak at 286.5 eV corresponds to the C–O bond on both PEG surfaces. 
Increasing the grafting density results in higher intensity of the C–O peak for PEGhg in comparison 
to PEGlg surfaces. Analysis of the N1s spectra on PEG surfaces indicates the presence of amino 
acids in the proteins. The N1s envelope of the PEGlg surface after albumin adsorption shows no 
detectable nitrogen, indicating no detectable protein adsorption. However, fibrinogen adsorption 
is observed by XPS on PEGlg. For PEGhg surface, albumin adsorption causes some alteration to 
the C1s envelope, but no detectable nitrogen is observed in the N1s envelope. Fibrinogen 
adsorption on PEGhg surface, however, is very obvious in Figure 3.2, top which shows a peak near 
288 eV in the C1s spectrum (N–C=O) and a sharp peak near 400 eV in N1s spectrum, due to amide 
nitrogen from the adsorbed protein. The PEGhg surface adsorbs more fibrinogen than the PEGlg 
surface.  
The high-resolution spectra in the region of the C1s and N1s envelopes for the PEM 
surfaces before and after exposure to the proteins are shown in Figure 3.2, bottom. Both surfaces 
show characteristic N1s spectra with the amine and amide group from the polysaccharides, near 
400 eV. For the PEM11, a strong ammonium contribution near 402 eV confirms the presence of 
chitosan as the terminal layer. The C1s spectra for the PEM samples have peaks near 288.2 eV 
(carboxylic acid), 286.5 (amide and alcohol), and 284.8 (aliphatic). After albumin or fibrinogen 
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adsorption to either PEM10 or PEM11, there is a significant change in the relative amount of amide 
in both the C1s and N1s envelopes. In the case of PEM10, there is no observable ammonium in the 
unmodified surface, but after exposure to the protein an ammonium peak at 401-402 eV is 
observed. On the PEM11 surface, ammonium is observed on the PEM both before and after protein 
adsorption, which is consistent with the terminal layer being chitosan. These changes are evidence 
that both proteins adsorb to each of the PEM surfaces. 
 
Figure 3.2. High-resolution XPS spectra of C1s and N1s envelopes of PEG (top) and PEM 
(bottom) surfaces before and after protein adsorption. 
3.3.4. Protein adsorption by AFM 
Protein adsorption on both PEG and PEM surfaces that were exposed to solutions (1 mg 
mL−1) of albumin or fibrinogen in PBS for 30 min in the SPR was investigated by AFM (Figure 
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3.3). AFM images of both PEG surfaces in PBS before and after protein adsorption (Figure 3.3, 
top) provide information about both the surface topography and surface homogeneity. The average 
surface roughness for both surfaces before the protein adsorption is provided in Table 3.1. PEG 
samples represent smooth and homogeneous surfaces when imaged with AFM. Therefore, 
topographical variation upon exposure to the protein solution could be interpreted as protein 
adsorption. Albumin adsorption on PEGhg changes the topography of the surface (evidenced by an 
increase of surface roughness by 1 nm), and this change is more pronounced than on the PEGlg 
surface (0.6 nm), indicating greater albumin adsorption on the PEGhg surface. Fibrinogen 
adsorption on the PEGlg can be observed as individual features that lead to a rougher surface 
(evidenced by an increase of surface roughness by 1.3 nm). For the PEGhg, fibrinogen adsorption 
leads to substantial topographical changes, with the surface roughness increasing by 1.6 nm, 
indicating more apparent fibrinogen adsorption on PEGhg than on PEGlg. Assuming that an 
increase in roughness and height is associated with the amount of protein adsorption, AFM 
suggests that for both proteins, PEGlg has lower nonspecific protein adsorption than PEGhg.  
AFM images of both PEM surfaces in PBS before and after protein adsorption are shown 
in Figure 3.3, bottom. Surface features from LbL deposition of CHI and HA are apparent, and 
average surface roughness before protein adsorption is provided in Table 3.2. These surfaces have 
increased roughness compared to the PEG samples. Moreover, when the PEM surfaces are 
hydrated, the thickness increases. The PEM10 surface shows topographical changes following both 
albumin and fibrinogen adsorption with surface roughness increasing by 4 and 6 nm, respectively. 
The PEM11 surface is rough prior to the protein adsorption, and the surfaces following protein 
adsorption have slightly reduced roughness (evidenced by 3 and 2 nm reductions in surface 




Figure 3.3. Representative 5 μm × 5 μm AFM topographic images of PEG (top) and PEM 
(bottom) surfaces before and after protein adsorption taken in PBS. 
3.3.5. Protein adsorption by TIRF microscopy 
Single-molecule adsorption experiments with fluorescently labeled albumin and fibrinogen 
were also used to evaluate the resistance of each surface to protein adsorption. Labeled proteins 
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were diluted to 10 nM in PBS to enable single-molecule detection. Since the labeled protein was 
diluted substantially to enable single-molecule detection, two sets of experiments were conducted 
for each protein-surface pair. In the first experiment only diluted labeled protein was used (10 nM). 
In the second set of experiments, 10 nM labeled protein was combined with concentrated (1 mg 
mL−1) non-labeled protein, to match the concentration of protein used in the SPR experiments. The 
protein-surface interactions were assessed by exposing the surfaces to protein solution under very 
low shear rate (50 s−1 that corresponds to a flow rate Q = 0.1 mL min−1) in a microfluidic flow 
channel as described in the Experimental Section and the Appendix B. First, PEG or PEM surfaces 
were exposed to flowing PBS for 5 min. Then PBS was switched to labeled protein solution and 
time-lapse imaging was started (0.5 frames s−1). Protein solution was flowed for at least 30 minutes 
for the PEM surfaces, and at least 40 minutes for the PEG surfaces. The surfaces were then rinsed 
with PBS at the same shear rate, for at least 20 minutes. Figure 3.4 and Figure 3.5 show microscopy 
images of PEG and PEM surfaces in contact with the dilute (10 nM) labeled protein solutions at 
different times.   
At the very beginning of these experiments on PEG surfaces, both proteins adsorbed and 
desorbed, with a low total protein number on the surface. This observation demonstrates that the 
adsorption of albumin and fibrinogen on PEG are initially reversible. The number of adsorbed 
protein molecules increases over time eventually reaching a steady-state. The amount of both 
proteins adsorbed at the beginning of the experiment on the PEGhg is higher than the amount 
adsorbed on the PEGlg surface (evidenced by higher average intensity, Figure 3.4). Following 
surface rinsing with PBS, most of the protein molecules are removed, indicating that proteins are 
primarily adsorbed through weak, reversible physical interactions. A minor subpopulation of 
protein molecules are adsorbed irreversibly through stronger affinity interactions with the surface.  
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These irreversibly adsorbed molecules do not leave the surface, even after the rinsing step. This 
phenomenon could be the result of the aggregation of denatured protein molecules, which 
presumably may be retained on the surface irreversibly.  
 
 Figure 3.4. Representative TIRF micrographs during protein adsorption experiments on PEG 
surfaces (left). Scale bar = 5 μm. Average intensity of fluorescently labeled protein in the TIRF 
microscopy images (right). The error bars represent standard deviations (n = 3 independent 
experiments for each condition).    
To better compare the results from single-molecule microscopy and SPR experiments, 
TIRF microscopy was also conducted with the same concentration of protein used in the SPR 
study. Both albumin and fibrinogen were mixed at a final concentrations of 1 mg mL−1 with labeled 
protein at a final concentration of 10 nM in PBS. The results, which are shown in Figure S4, are 
strikingly different from what we observe with low protein concentration. The experiments were 
conducted for two hours. During this time, individual labeled proteins were observed to interact 
dynamically with the surface, but these events are rare, and the molecules persist for only a few 
frames (corresponding to less than 1 minute dwell time). Even after two hours of continuous 
exposure to the concentrated protein solution, no irreversibly adsorbed molecules were observed 
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on PEG surfaces, in any of the three replicates for both proteins on both PEGlg and PEGhg. This 
could be the result of higher diffusive flux of proteins to the surface at higher protein concentration 
in the solution. It has previously been proposed that when the local concentration of proteins at or 
near the surface is high, there is competition for surface sites, leading to crowding, which 
effectively reduces the ability of proteins to denature [31,32]. As the protein conformation is 
stabilized and denaturation is blocked by crowding, the protein has higher rates of reversible 
adsorption and desorption [32]. This crowding effect is apparent for both proteins on both PEG 
surfaces.    
For PEM surfaces, very different results are observed in the TRIF microscopy. When low 
protein concentration (10 nM) is used, both PEM surfaces adsorb albumin and fibrinogen very fast 
at the very beginning of the experiment as shown in Figure 3.5. Albumin adsorption, however, is 
primarily irreversible for both PEM surfaces; after rinsing albumin molecules are still observed to 
adhere to the surface with high affinity (evidenced by approximately 6 times higher average 
intensity compared to the beginning of the experiment, Figure 3.5). This may arise due to albumin 
denaturing on the surface, leading to irreversible protein-surface interactions. Fibrinogen 
adsorption is more reversible on PEM surfaces than albumin adsorption. Nonetheless a fraction of 




Figure 3.5. Representative TIRF micrographs during protein adsorption experiments on PEM 
surfaces (left). Scale bar = 5 μm. Average intensity of fluorescently labeled protein in the TIRF 
microscopy images (right). The error bars represent standard deviations (n = 3 independent 
experiments for each condition). 
At high protein concentration (1 mg mL−1 unlabeled protein mixed with 10 nM labeled 
protein), the observed albumin interactions with the surface are similar to the observations made 
at low protein concentration, as shown in Figure S4. The crowding effect observed at high protein 
concentration on the PEG surfaces was not observed on the PEM surfaces. Therefore, albumin has 
very high affinity for the PEM surfaces, and even at high concentration, albumin molecules are 
able to adsorb and denature on the surface. Fibrinogen interaction at high concentration with PEM 
surfaces is different from the albumin interaction. At high concentration, the crowding effect is 
more obvious, as fewer labeled fibrinogen molecules adsorb to the surfaces (in comparison to the 
low concentration experiment) and a fraction of them desorb during the subsequent rinse step.  
The kinetics of protein adsorption was quantified on both PEG and PEM surfaces with 10 
nM concentration for both proteins. The measured adsorption rate coefficient, kads, is defined as 
the number of newly adsorbed molecules per second per µm2, normalized to the concentration of 
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the protein in the bulk solution. This adsorption rate coefficient is based on tracking at least 104 
protein molecules on the surface, starting from t = 0 (when the protein solution is first introduced 
to the surface). When protein solution was flowed over the surface, the rate of adsorption was 
found to increase over time. As a result, the reported adsorption rate coefficient in Figure 3.6 is in 
a non-equilibrium state. For the PEG surfaces, the albumin adsorption rate is more than two times 
higher on PEGhg than on PEGlg. For fibrinogen, however, the adsorption rate is similar on PEGhg 
and PEGlg. Remarkably, for the PEM surfaces, the albumin adsorption rate increased 
approximately 6 times compared to the PEGlg and 3 times compared to the PEGhg. The fibrinogen 
adsorption rate was also higher for the PEM surfaces compared to the PEG surfaces.
  
Figure 3.6. Average adsorption rate coefficients of albumin (left) and fibrinogen (right) under 
continuous flow (50 s−1 shear rate) on PEG and PEM surfaces. Error bars represent the standard 
deviation (n = 3, independent experiments for each condition).   
Single-molecule results from albumin and fibrinogen interactions with PEG and PEM 
surfaces indicate that, at both low and high protein concentrations, PEG surfaces demonstrate 
better resistance to protein adsorption than the PEM. At high concentration (1 mg mL−1), we did 
not observe any adsorption of labeled protein, even after 2 h of exposure of PEG surfaces to protein 
solutions. However, at low protein concentration, protein adsorption is observed on PEG surfaces, 
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and this adsorbed protein is removed from the surface upon rinsing. PEM surfaces show much 
higher affinity for both proteins at both low and high concentrations, which indicates that these 
surfaces were not resistant to protein adsorption. The PEM surfaces adsorb much less fibrinogen 
than albumin at high protein concentration. 
3.4. Discussion 
When artificial materials are introduced into complex biological media such as blood, 
nonspecific protein adsorption is the first surface-mediated event impacting later biological 
processes [33]. This nonspecific protein adsorption determines the subsequent series of 
interactions that can lead to surface biofouling and device failure [34,35]. Thus, a significant 
amount of research effort has been invested in developing low fouling and ultralow fouling 
surfaces. 
Understanding the nature of protein-surface interactions beyond measuring the amount of 
adsorbed protein may be critical to developing advanced ultralow fouling and non-fouling 
surfaces. Many reports have developed surfaces that strongly reduce protein adsorption. 
Zwitterionic and PEG interfaces are among gold standard biofouling resistant surfaces [36–40]. 
Layer-by-Layer assembly of PEM surfaces by alternating deposition of a polycation and a 
polyanion, is another popular surface functionalization method that has been used to reduce 
biofouling [41–45]. Even small amounts of irreversibly adsorbed protein on low fouling surfaces 
may permanently modify the nature of the material and cause subsequent significant adverse 
biological responses. Therefore, it is necessary to use very high-sensitivity techniques, such as 
single-molecule TIRF microscopy, to understand the mechanisms of protein interactions with 
materials to better characterize very small amounts of protein adsorption [24].  
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In this study, we used four different well-characterized surfaces and protein adsorption 
phenomena were investigated using ensemble-averaging and single-molecule methods. SPR and 
single-molecule TIRF microscopy can both be used in situ to sensitively detect protein adsorption 
on model synthetic surfaces. SPR can be conducted at physiologically relevant protein 
concentrations, but it is not sensitive enough to detect very rare protein adsorption events. The 
sensitivity of SPR requires > 0.1 ng cm−2 of protein adsorbed. In contrast, single-molecule TIRF 
microscopy can provide much more detail about individual protein surface interactions, but must 
be conducted at much lower protein concentration. The two techniques provide complementary 
information about protein-surface interactions at two very different concentration regimes.  
At the concentrations used for SPR, the PEM surfaces studied here have resistance to 
nonspecific irreversible protein adsorption that is superior to both PEG surfaces, for both proteins. 
However, our single-molecule TIRF microscopy results at very low protein concentration tell a 
different story. The rate of protein adsorption to the PEG surfaces is lower than the rate of protein 
adsorption on either of the PEM surfaces. More interestingly, we observe a lower rate of albumin 
adsorption for the PEGlg surface compared to the PEGhg surface. In contrast, the rate of fibrinogen 
adsorption was similar on both PEG surfaces. This is evidence that individual proteins interact 
differently from one another, and that a single-protein assay may not be generalized to other protein 
behaviors on synthetic surfaces.  
XPS and AFM experiments can sensitively discern changes in the surface chemistry and 
topography, respectively, only when there is not background interference from the surface of 
interest. These techniques provide limited information about the proteins adsorbed to the PEG and 
PEM surfaces. Fibrinogen adsorption on both PEG and PEM surfaces can be observed with XPS. 
For albumin, the XPS confirms surface chemistry changes on the PEMs, but does not show any 
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conclusive evidence of adsorption on PEG. AFM images also provide qualitative information 
regarding both protein adsorption from changes of the surface topography and roughness on PEG 
surfaces. On PEM surfaces, roughness increases after protein adsorption on PEM10, but decreases 
after protein adsorption on PEM11. The high roughness of the original surfaces would make the 
use of AFM alone difficult for quantifying protein adsorption on PEM surfaces. 
3.5. Conclusions 
The use of ensemble averaging methods that measure a physical or optical change, 
averaged over a surface, have been widely proliferated for measuring protein adsorption on low 
fouling and ultralow fouling surfaces. These methods are common enough that ultralow fouling 
has come to be understood as a quality of a surface that adsorbs protein below a particular threshold 
in such experiments. When designing low fouling and ultralow fouling surfaces, we propose that 
results challenging the limits of detection of the commonly used techniques (e.g. SPR) should not 
be used as a benchmark to qualify such surfaces. Our experiments show that PEM surfaces, which 
would qualify as ultralow fouling by this criterion, do not completely prevent protein adsorption, 
as observed using single-molecule TIRF microscopy. Furthermore, extremely sensitive surface 
spectroscopy and atomic force microscopy may also be inconclusive. In contrast, PEG surfaces, 
which do irreversibly adsorb measureable amounts of protein by SPR, exhibit 
adsorption/desorption steady-state in dilute single-molecule measurements. At high protein 
concentration, the single-molecule TIRF microscopy results suggest that proteins may be 
stabilized by a crowding effect on PEG surfaces. As a complement to surface ensemble averaging 
techniques, single-molecule microscopy is capable of sensitively detecting individual protein 
adsorption events, in both concentrated and very dilute protein solutions. In the case of dilute 
protein experiments, single-molecule microscopy enables measurement of the protein adsorption 
182 
 
rate, which cannot be directly obtained from SPR. Furthermore, both adsorption and desorption 
events can be precisely quantified using single-molecule methods, provided that the labeled protein 
is at sufficiently low concentrations. A more detailed description of protein-surface interactions 
enabled by single-molecule microscopy should lead to improved design of fouling-resistant 
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Chapter 4: NANOSTRUCTURED SURFACES THAT MIMIC THE VASCULAR 
ENDOTHELIAL GLYCOCALYX REDUCE BLOOD PROTEIN ADSORPTION AND 





Blood-contacting materials are critical in many applications where long-term performance 
is desired. However, there are currently no engineered materials used in cardiovascular implants 
and devices that completely prevent clotting when in long-term contact with whole blood. The 
most common approach to developing next-generation blood-compatible materials is to design 
surface chemistries and structures that reduce or eliminate protein adsorption to prevent blood 
clotting. This work proposes a new paradigm for controlling protein-surface interactions by 
strategically mimicking key features of the glycocalyx lining the interior surfaces of blood vessels: 
negatively charged glycosaminoglycans organized into a polymer brush with nanoscale domains. 
The interactions of two important proteins from blood (albumin and fibrinogen) with these new 
glycocalyx mimics are revealed in detail using surface plasmon resonance and single-molecule 
microscopy. Surface plasmon resonance shows that these blood proteins interact reversibly with 
the glycocalyx mimics, but have no irreversible adsorption above the limit of detection. Single-
molecule microscopy is used to compare albumin and fibrinogen interactions on surfaces with and 
without glycocalyx-mimetic nanostructures. Microscopy videos reveal a new mechanism whereby 
                                                 
1 This work was published in ACS Applied Materials & Interfaces and is reproduced in modified form here with 
permission [1]. M. Hedayati was responsible for designing and conducting experiments, managing data, and preparing 
the manuscript. M.J. Kipper, D. Krapf, and M.M. Reynolds conceived of the research, advised and oversaw the 
experimental work, and edited the manuscript. 
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the glycocalyx-mimetic nanostructures eliminate the formation of fibrin networks on the surfaces. 
This approach shows for the first time that the nanoscale structure and organization of 
glycosaminoglycans in the glycocalyx are essential to (i) reduce protein adsorption, (ii) reversibly 
bind fibrin(ogen), and (iii) inhibit fibrin network formation on surfaces. The insights gained from 
this work suggest new design principles for blood-compatible surfaces. New surfaces developed 
using these design principles could reduce risk of catastrophic failures of blood-contacting medical 
devices. 
4.1. Introduction  
Clotting on blood-contacting medical devices is a persistent problem, leading to 
catastrophic failure of cardiovascular implants and extracorporeal blood circulation devices [2]. 
This necessitates antiplatelet and antithrombogenic therapies for patients with devices like stents, 
heart valves, and shunts, and those undergoing hemodialysis and membrane oxygenation [3]. The 
interior surface of healthy blood vessels is the only known surface that continuously prevents blood 
clotting while in constant contact with flowing whole blood [4,5].  
When a biomaterial comes into contact with blood it rapidly becomes covered with a layer 
of nonspecifically adsorbed proteins. This protein layer mediates the subsequent platelet adhesion, 
activation, and aggregation; blood coagulation is initiated and fibrinogen is converted to fibrin 
monomers. These monomers subsequently polymerize into protofibrils, and eventually form a 
crosslinked network of fibrin fibers. The resulting fibrin network supports platelet aggregates and 
traps red cells in a thrombus, or blood clot. Protein adsorption from blood is recognized as the first 
key event leading to surface-induced blood clotting. Consequently, new blood-contacting 
materials are developed with a focus on the protein adsorption behavior at the surface [4,6].  
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The surface of blood vessels prevents blood clotting by several mechanisms. Importantly, 
this surface stabilizes plasma proteins and acts as a barrier that blocks proteins from reaching the 
endothelium [7,8]. The endothelial cells lining this surface present a layer, the endothelial 
glycocalyx, which is rich in proteoglycans bearing glycosaminoglycan side chains (GAGs) [7,8]. 
These cells expend energy to organize the membrane-bound proteoglycans in the glycocalyx, 
containing strong polyanionic GAGs, into nanoscale “bush-like” structures, 100-200 nm in 
diameter [9,10]. These macromolecular assemblies are organized by the underlying actin cortical 
cytoskeleton into domains with 100-200 nm spacing [9,10]. We recently proposed a new method 
for preparing surfaces that mimic these structural features of the endothelial glycocalyx, and 
elucidated how the preparation conditions affect the resulting structure [11]. In this work we show 
that the nanoscale structure of these new surfaces suppresses non-specific protein adsorption. Most 
importantly, these surfaces inhibit the formation of a fibrin network, by preventing both surface-
mediated polymerization and adsorption of fibrin fibers from solution.   
Heparan sulfate, chondroitin sulfate, and hyaluronan are the dominant GAGs found in the 
vascular endothelial glycocalyx. The current gold standard for preventing blood from clotting on 
surfaces of medical devices such as blood tubing, catheters, and other blood-contacting 
biomaterials, is to coat the surface with the GAG heparin (closely related to heparan sulfate) [12]. 
Over 40 years ago, Olsson and co-workers began investigating the interactions of blood 
components with heparinized surfaces. They showed that heparinized surfaces could reduce 
platelet adhesion [13,14]. Surface-bound heparin can also inhibit thrombosis by potentiating the 
activity of antithrombin III and platelet factor 4 [13–18]. Others have shown that heparinized 
surfaces may reduce fibrinogen adsorption, and alter the adsorption of other blood proteins [19]. 
This has led to the extensive use of heparinized surfaces to improve blood compatibility of blood-
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contacting devices, such as dialysis membranes, venous implants, arterial shunts, microfluidic 
channels, vascular grafts, and arterial stents [20–30]. More recent approaches have included 
synthetic chemistries and superhydrophobic surfaces with nanoscale structures to prevent blood 
protein adsorption [2,12,31–37]. 
Despite these advances, the challenges of blood clotting on biomedical material surfaces 
remains, in part because the mechanisms regulating blood clotting in blood-surface interactions 
are not completely understood [12]. We propose that by mimicking the supermolecular assembly 
of GAGs in the endothelial glycocalyx, we can design surfaces that reveal how blood proteins 
interact with the glycocalyx, and how these interactions prevent clotting. Materials that prevent 
blood clotting would improve outcomes and reduce risks for patients using extracorporeal blood 
circuits and for patients receiving cardiovascular implants.  
The supermolecular assembly of highly sulfated, strong polyanions, such as heparin and 
chondroitin sulfate, into polymer brushes or the dense bush-like structures of the endothelial 
glycocalyx is energetically unfavorable due to electrostatic repulsion. We developed a technique 
to mimic these features on a surface and to overcome the electrostatic repulsion by polyelectrolyte 
complexation of polyanions with polycations, keeping the polyanions in excess [11]. We prepared 
polyelectrolyte multilayers (PEMs) from hyaluronan (a polyanionic GAG) and chitosan (a 
structurally similar, but polycationic polysaccharide) (Scheme 1). Adjusting the pH, molarity, 
number of layers, and chemistry of the terminal layer can enable fine control over the PEM 
composition, thickness, and physical chemistry [38,39]. We also formed polyelectrolyte complex 
nanoparticles (PCNs) containing heparin (HEP) or chondroitin sulfate (CS) as the polyanion, and 
chitosan (CHI) as the polycation (Scheme 1). When the polyanion was in excess, these particles 
formed with a collapsed core of neutralized charges, surrounded by a corona of pendent excess 
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polyanion chains (Scheme 1). The size, zeta potential and composition of these PCNs can be tuned 
by altering the charge mixing ratio of the constituent polysaccharides [40,41]. We then adsorbed 
CS-CHI and HEP-CHI PCNs to the PEMs to form PEM+PCN surfaces [11,42]. As we have 
recently reported, these PEM+PCN surfaces have 100-200 nm hemispherical bush-like domains 
presenting a high density of HEP or CS glycosaminoglycan chains, which mimic nanostructures 
in the endothelial glycocalyx [11]. In this previous work we determined how the pH of the 
adsorption process affects the PCN coverage on 13-layer PEMs.  
 
Scheme 4.1. Preparation of glycocalyx mimics from GAG-terminated PEMs and from PEMs 
combined with GAG-containing PCNs. 
The outlined PEM+PCN strategy provides a new glycocalyx mimetic surface from which 
the effects of nanostructure on protein adsorption can be elucidated. In this work we study in detail 
the interactions of specific blood proteins with these glycocalyx mimics. We hypothesize that these 
new PEM+PCN surfaces can reduce the adsorption of two important blood proteins, serum 
albumin (BSA) and fibrinogen (FIB), and that fibrin fiber network formation is modulated by the 
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GAG-rich bush-like structures. Albumin is the most abundant protein in blood. It is amphiphilic, 
and its adsorption to surfaces has been promoted as a strategy for preventing platelet adhesion, 
since it does not contain adhesive peptide sequences. However, Latour et al. demonstrated that 
when albumin denatures beyond a critical degree on a surface it can promote platelet adhesion, 
which could lead to thrombosis [43]. Fibrinogen, a glycoprotein from blood plasma, is activated 
by the enzyme thrombin to form fibrin, which polymerizes to form fibers that stabilize blood clots 
[44–46]. Fibrin adsorption and polymerization can also be affected by surface chemistry and the 
orientation of the adsorbed proteins [45,47]. Therefore, controlling the specific interactions of 
albumin and fibrinogen with a surface may be more effective than attempting to prevent the protein 
adsorption altogether. To the best of our knowledge, we show for the first time that the structure 
of the PCNs on a surface inhibits the adsorption and formation of fibrin fibers on a surface, a key 
step in blood clot formation, even in the absence of the important inhibitor of fibrin polymerization, 
antithrombin III. This is a new mechanism of preventing blood clotting. Furthermore, these new 
surfaces serve as useful models for studying the structure-function relationships of the nanoscale 
features of the endothelial glycocalyx, and provide a new strategy for designing blood-contacting 
materials.  
4.2. Experimental section 
4.2.1. Materials 
Chitosan (CHI) was purchased from MP Biomedicals. Chondroitin sulfate sodium (CS) 
salt (from shark cartilage, 6% sulfur, 6-sulfate/4-sulfate = 1.24, Mw =84.3 kDa; PDI = 1.94), 
hyaluronic acid (HA) sodium salt (Mw = 743 kDa; PDI = 1.16), bovine serum albumin (BSA), 
fibrinogen from human plasma (FIB), thrombin from bovine plasma, 11-mercaptoundecanoic acid  
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95% (MUA), sodium acetate, β-mercaptoethanol, catalase from bovine liver, and glucose oxidase, 
were purchased from Sigma Aldrich. Heparin sodium (HEP) (from porcine intestinal mucosa, 
12.5% sulfur) was purchased from Celsus Laboratories (Cincinnati, OH). Glacial acetic acid and 
ethanol (200 proof 99.5+ %) were purchased from Acros Organics (Geel, Belgium). BSA 
conjugated to Alexa Fluor 647 and FIB from human plasma Alexa Fluor 647 conjugate were 
purchased from Thermo Fisher Scientific (Waltham, MA). Phosphate-buffered saline without Ca2+ 
and Mg2+ (PBS) was purchased from Gibco (Grand Island, NY). A Millipore water purification 
unit was used to obtain 18.2 MΩ cm water, used for making all aqueous solutions (Millipore, 
Billerica, MA). 
4.2.2. PCN Preparation and Characterization 
PCNs formed from chitosan and GAGs were made as previously described [40–42,48]. 
Briefly, chitosan, heparin sodium, and chondroitin sulfate solutions were prepared at 
concentrations of 1, 1.5, and 2.8 mg mL−1, respectively, in acetate buffer solutions (0.2 M sodium 
acetate and acetic acid at pH 5.0). Solutions were filtered using 0.22-μm syringe filters. To prepare 
chondroitin sulfate-based PCNs (CS-CHI) the chondroitin sulfate solution was added to the stirring 
chitosan solution in a 6:1 volume ratio (36 mL of chondroitin sulfate solution to 6 mL of chitosan 
solution). To prepare heparin-based PCNs (HEP-CHI), the heparin solution was added to the 
stirring chitosan solution in a 4:1 volume ratio of heparin solution to a chitosan solution (24 mL 
heparin solution to 6 mL chitosan solution). The mixtures were stirred for 3 h at 1100 rpm. After 
3 hours of stirring, all solutions were allowed to settle overnight to remove aggregated particles. 
After settling, the supernatant was decanted, containing the colloidally stable nanoparticles. The 
aggregated particles were discarded. DLS confirmed that CS-CHI nanoparticles have a reliable 
polydispersity index and do not require further separation. The HEP-CHI solution was centrifuged 
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at 3000 × g for 5 min to separate the particles from uncomplexed polymer, using an Eppendorf 
5804 centrifuge. A Zetasizer Nano ZS (Malvern) was used to analyze hydrodynamic diameter 
using a 633 nm laser. All measurements were performed at a fixed angle of 175° at 25 °C. All 
measurements were performed in 0.2 M acetate buffer solution. Three measurements were made 
on each of three separate samples for each composition. The mean ± standard deviation are 
reported for the hydrodynamic diameter. 
4.2.3. Layer-by-Layer Surface Modification and Protein Adsorption by SPR 
Polysaccharide solutions were prepared in similar acetate buffer solutions as those used for 
the PCN preparation (0.2 M sodium acetate and acetic acid at 5.0). This pH was selected based on 
our previous work [11]. Chitosan (1.33 mg mL−1) and hyaluronan (0.66 mg mL−1) solutions were 
prepared by stirring for 2 h at room temperature. Solutions were clarified by filtration through 0.22 
μm syringe filters for CHI and 0.45 μm syringe filters for HA solution.  
Fourier transform surface plasmon resonance (FT-SPR) was used for measuring the 
intensity of p-polarized light reflected from the back side of the gold film on which the samples 
were assembled, as a function of wavenumber, as we have described previously, using an SPR 100 
module on a Thermo 8700 model FT-IR spectrometer (Thermo Electron) [39,49,50]. Briefly, gold-
coated SF-10 glass chips (47 nm gold thickness, NanoSPR LLC, Chicago, IL) were rinsed 
exhaustively in ethanol, then modified with a self-assembled monolayer of MUA by soaking the 
gold-coated glass chip in a 1 mM MUA solution in ethanol for at least 20 h. The MUA-modified 
surfaces were dried with a gentle stream of dry nitrogen. MUA-modified chips were mounted to 
the base of a prism on one side of a flow cell, and optical contact was established between the chip 
and the prism using a refractive index matching fluid. A Masterflex peristaltic pump was used to 
pump polysaccharide and rinse solutions through the flow cell, in contact with the MUA-coated 
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surface, with a flow rate of 0.5 mL min−1. A low flow rate was used to ensure laminar flow over 
the gold chip surface. The interferometer in the FT-IR instrument was used to scan wavelengths at 
a fixed angle of incidence. In these experiments, FT-SPR was performed using a white light/near-
infrared source with a CaF2 beam splitter at the interferometer and an InGaS detector. Data were 
collected using Omnic 7.3 software (Thermo Electron), at 8 cm−1 resolution from 6000 to 12000 
cm−1. PEMs were constructed with CHI as the polycation and HA as the polyanion at pH 5.0 in 
the solutions described above. First, the surface was exposed to an acidified water rinse (pH 4.0, 
acidified with acetic acid), for six minutes. The layer-by-layer process was conducted by 
alternatively flowing solutions through the flow cell in the following sequence: polycation (CHI), 
rinse, polyanion (HA), rinse. The sequence was repeated until a seven-layer, 13-layer, or 19-layer 
PEM (terminating with CHI) had been adsorbed. PEM+PCN samples were prepared similarly. 
After the layer-by-layer assembly of 19-layer CHI-HA PEMs, either CS-CHI PCNs or HEP-CHI 
PCNs were adsorbed. The resulting samples are referred to as PEM19+PCN(CS-CHI) and 
PEM19+PCN(HEP-CHI). The length of the adsorption steps was doubled to 12 minutes for the 
PCN adsorption, followed by a final acidified water rinse. The layer-by-layer process was 
monitored by detecting the change in the plasmon resonance absorption wavenumber, caused by 
adsorption of each layer. Here the resonance peak position in wavenumber in converted to 
wavelength, λres. The thickness of these PEM and PEM19+PCN samples is well within the range 
of sensitivity of the SPR, evidenced by changes in λres when the rinse solution is changed. 
Once the PEM and PEM19+PCN samples were prepared, protein adsorption was also 
monitored by FT-SPR. Each sample was exposed to PBS for 40 minutes to equilibrate the surface 
with the ions in the buffer solution. The experiment was continued by replacing the PBS buffer 
with 0.75 mg mL−1 BSA or FIB solution (approximately 12 µM for BSA and 3.5 µM for FIB) in 
195 
 
PBS for 30 minutes. During protein adsorption the plasmon resonance absorption wavelength 
shifts due to the difference in refractive index of the medium at the sensor surface, within the 
penetration depth of the SPR evanescent wave. This change in refractive index arises due to both 
protein deposition on the gold surface and due to the refractive index increment of the protein in 
solution. After reaching a steady-state value of λres, BSA or FIB solution was replaced with PBS. 
The amount of irreversibly adsorbed BSA and FIB was quantified as the difference in λres measured 
in PBS before and after incubation with BSA or FIB solution. This difference is the Δλres. The 
average limit of quantitation (LOQ) for our instrument was estimated to be 0.1 nm, which 
corresponds to approximately 20 pg of deposit per mm2.  
4.2.4. AFM Measurements in PeakForce QNM Mode 
The PeakForce QNM AFM study was done using a BioScope Resolve BIOAFM (Bruker) 
with Nanoscope V controller. The measurements were performed under ambient conditions at 
room temperature in deionized water to characterize the morphology and the mechanical properties 
of the sample at the nanoscale. The calibrated probe PF-QNM-LC-CAL with a tip radius of 65 nm 
was used, and deflection sensitivity was measured against a hard surface. The scan size was 
typically 5 × 5 µm2, with a digital resolution of 512 px × 512 px and a scanning rate of 0.5 Hz 
(lines per second). The oscillation frequency of the probe was set to 1 kHz, and the peak force set 
point was 500 pN. For every experiment, three measurements on three different samples were 
acquired. Image analysis was performed using NanoScope Analysis (version 1.8). 
To enable imaging of PEM and PEM19+PCN samples by AFM in liquid, samples were 
prepared on glass-bottom petri dishes (30 mm Pelco petri dishes, Willco Wells, Amsterdam) and 
mounted on the AFM stage. Petri dishes were first treated with oxygen plasma for 10 minutes, to 
ensure a clean, oxidized surface. Then layer-by-layer adsorption was conducted by exposing the 
196 
 
glass surfaces to alternating polycation, rinse, and polyanion solutions, on an orbital shaker. The 
surfaces prepared on glass bottom petri dishes were prepared using a similar procedure as that used 
for the FT-SPR, listed above (polysaccharide solutions and adsorption times). 
4.2.5. X-ray Photoelectron Spectroscopy 
The surface chemistry of PEM19 and PEM19+PCNs surfaces prepared on glass-bottom petri 
dishes was evaluated by X-ray photoelectron spectroscopy (XPS). Spectra were obtained with a 
monochromatic Al Kα X-ray source (hν = 1486.6 eV), a hemispherical analyzer, and multichannel 
detector. High-resolution spectra were obtained using a 23.5 eV analyzer pass energy with 0.1 eV 
steps and an X-ray spot of 800 µm2. All spectra were obtained with a photoelectron takeoff angle 
of 45°.The binding energy scales for the samples were referenced to the C1s peak at 284.8 eV. 
Spectra curve fitting was done using Phi Electronics Multipak version 9.3. Elemental compositions 
were computed according to the atom sensitivities. 
4.2.6. Single-Molecule Microscopy Evaluation of Protein Adsorption and Fibrin Network 
Formation 
For high-sensitivity detection of protein adsorption and fibrin network formation at solid-
liquid interfaces, an objective-type TIRF microscope was used as previously described [51,52]. 
Specifically, the excitation was performed in oblique illumination mode for measuring protein 
adsorption, and in TIRF mode for characterizing fibrin network formation. The samples were 
prepared on glass-bottom petri dishes as described above for the AFM characterization. The 
microscope was home-built around an Olympus IX71 body with 638 nm laser line as excitation 
source (DL638- 328  050, CrystaLaser, Reno, NV). A back-illuminated electron-multiplied charge 
coupled device (EMCCD) camera (Andor iXon DU-888) liquid-cooled to −70 °C, with an 
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electronic gain of 60 was used. In order to maintain constant focus during the whole imaging time 
we employed an autofocus system (CRISP, Applied Scientific Instrumentation, Eugene, OR) in 
combination with a piezoelectric stage (Z-100, Mad City Labs, Madison, WI). To reduce 
photobleaching, an enzymatic oxygen scavenger system was used in the imaging buffer. Imaging 
buffer for screening protein adsorption was 50 mM Tris-HCl (pH 8.0), 10 mM NaCl, 10% glucose, 
0.15 mg ml−1 glucose oxidase, 34 µg ml−1 catalase, 10% glucose and 1% β-mercaptoethanol [53]. 
Fibrinogen from human plasma conjugated with Alexa Fluor 647 and albumin from bovine serum 
conjugated with Alexa Fluor 647 were used to observe protein adsorption on different surfaces. 
The perfusion chamber was filled with the solution containing the labeled protein, and after an 
incubation period of 10 minutes, with no subsequent rinse step, 105 seconds of microscopy videos 
were acquired at a frame rate of 9.5 frames/s, using a 100×/1.4 oil immersion objective. For each 
experimental condition, three independent replicates on three different samples were conducted. 
The protein adsorption data are reported as the mean fluorescence intensity ± standard deviation.  
Fibrin polymerization was studied by mixing fibrinogen (at a final concentrations of 0.75 
mg mL−1), Alexa Fluor 647-conjugated fibrinogen (at a final concentration of 5 nM), and thrombin 
(at 1 NIH U mL−1) in Tris-buffered saline (10 mM Tris, 150 mM NaCl, pH 7.4) with 5 mM CaCl2, 
to activate thrombin at room temperature. TIRF videos were taken on at least five different regions 
of three different samples and one representative image is shown here for PEM19, PEM+CS, 
PEM+HEP, PEM19+PCN(CS-CHI), and PEM19+PCN(HEP-CHI). A video of these 
fibrin/thrombin experiments is shown in the Appendix C. 
4.3. Results 
4.3.1. AFM of PEM and PEM19+PCN Surfaces 
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Atomic force micrographs (AFM) obtained in fluid with peak-force quantitative 
nanomechanical property mapping (PF-QNM) of the PEM and PEM19+PCN surfaces, prepared on 
glass-bottom petri dishes (Figure 4.1) show that the surface roughness increases as the number of 
PEM layers increases. The RMS surface roughness, Rq, calculated from 5 µm × 5 µm AFM images 
performed on triplicate (n = 3) samples for each condition, is reported in Table S.1 in the Appendix 
C. The apparent Young’s modulus of the surface is also reduced as the layer number is increased. 
Furthermore, when the nanoparticles are adsorbed, they appear as approximately 200 nm-diameter 
domains densely covering the surface. These features are similar to the sizes of the PCNs obtained 
by dynamic light scattering (DLS) when the PCNs are in solution (Table 4.1). Notably, these 
features have similar dimensions and spacing to the dominant GAG structures found in the 
endothelial glycocalyx [9–11]. Furthermore, the negative zeta potential of the PCNs (Table 4.1) 
confirms that these are enriched in the polyanionic GAGs, HEP and CS. The AFM images also 
confirm the aqueous stability of the PEM and PEM+PCN coatings, as multiple AFM images were 
collected in DI water over the span of several hours, for each sample type. 
 




diameter (nm)  
PDI zeta potential 
(mV) 
CS-CHI 238 ± 2 0.10 ± 0.02 -30 ± 3 






Figure 4.1. (top) Representative 5 μm × 5 μm AFM topographic images of PEMs and 
PEM19+PCN(CS-CHI) taken in liquid. (bottom) Young’s modulus (calculated using the DMT 
model) of representative samples shown in logarithmic scale. 
4.3.2. XPS of PEM and PEM19+PCN Surfaces 
To further confirm the adsorption of PCNs, X-ray photoelectron spectroscopy was 
performed on PEM and PEM19+PCN surfaces. The high-resolution scans of the N1s and S2p 
envelopes are shown in Figure 4.2. All samples show characteristic N1s spectra with the amine 
and amide group from the polysaccharides, near 400 eV, and a strong ammonium contribution 
between 402 eV and 402.5 eV. The ammonium contribution confirms the presence of chitosan 
within the PEM and PCNs as we have reported previously [38,48,54,55]. The addition of the PCN 
is confirmed by the strong sulfate signal in the S2p envelope. While the PEMs composed of CHI 
and HA contain no sulfate, adsorption of the CS- and HEP-containing PCNs results in a sulfur 
signal from the surface. The elemental compositions (C, O, N, and S) of these surfaces are reported 
in the Appendix C (Table S.2).  To confirm that the PEM surfaces prepared on MUA-modified, 
gold-coated glass are similar to those on glass-bottom petri dishes, examples of XPS and AFM of 
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the PEM13 and the PEM19+PCN(CS-CHI) on both substrates are shown in Figures S.1 and S.2 in 
the Appendix C. 
 
Figure 4.2. High resolution XPS spectra of the PEM19 and PEM19+PCN samples in the region of 
the N1s and S2p envelopes confirms that all of the samples contain chitosan electrostatically 
complexed with the polyanions (evidenced by the ammonium peak) and that the PEM19+PCN 
samples contain the sulfated CS and HEP (evidenced by the characteristic sulfate signal in the S2p 
envelope).  
4.3.3. LbL Assembly of PEMs and Protein Adsorption by FT-SPR  
The layer-by-layer assembly of the PEMs, the adsorption of PCNs, and subsequent 
adsorption of plasma proteins was monitored by in situ Fourier-transform surface plasmon 
resonance (FT-SPR). Layer-by-layer assembly was conducted on gold-coated glass substrates, 
modified with a self-assembled monolayer of MUA, as previously reported [38,39,49]. The FT-
SPR data during the last steps of construction of a 19-layer chitosan-hyaluronan PEM (PEM19), 
followed by CS-CHI PCN adsorption are shown in Figure 4.3 (a). During each polyelectrolyte 
adsorption step, the plasmon resonance absorbance wavelength, λres, increases by about 35 to 50 
201 
 
nm, due to surface adsorption and to changes in the refractive index between the rinse and 
polyelectrolyte solutions. Then, during the subsequent rinse step, λres, is reduced. The net change 
in λres measured during the rinses before and after each adsorption step is proportional to the 
changes in the surface thickness and refractive index, corresponding to the amount of irreversibly 
adsorbed polyelectrolyte at each step.  
 
Figure 4.3. LbL assembly of PEM and protein adsorption from in situ FT-SPR. (a) Example of in 
situ FT-SPR data confirming the last 7 layers of CHI-HA PEM assembly. These data show PCN 
adsorption, a subsequent rinse with PBS, and a 30-minute BSA adsorption step. There is no 
measurable difference in wavelength before and after BSA adsorption. (b) BSA and FIB 
adsorption steps from in situ FT-SPR experiments. Irreversible protein adsorption is detected for 
both BSA and FIB on the control (gold-coated glass, modified with MUA self-assembled 
monolayer), but no irreversible adsorption of BSA or FIB adsorption is detected on any of the 
PEM or PEM19+PCN surfaces. 
To evaluate protein adsorption on the PEM and PEM19+PCN surfaces, we exposed the 
surfaces to solutions (0.75 mg mL−1) of BSA or FIB in phosphate-buffered saline (PBS) for 30 
minutes. During the protein adsorption step, the plasmon resonance absorption wavelength, λres, 
was monitored, as shown in Figure 4.3 (b). The wavelength is expected to shift due to the 
difference in refractive index of the medium at the sensor surface, within the penetration depth of 
the SPR evanescent field. This change in refractive index arises due to changes in the surface (e.g. 
protein deposition) and due to the refractive index increment of the protein in solution. After 
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reaching a steady-state value of λres, BSA or FIB solution was replaced with PBS. The amount of 
irreversibly adsorbed BSA and FIB was quantified as the difference in λres measured in PBS before 
and after incubation with BSA or FIB solution. This difference is Δλres. The average limit of 
quantitation for our instrument was estimated to be 0.1 nm, which corresponds to approximately 
20 pg mm-2 of deposit.  On control surfaces (gold-coated glass modified with a self-assembled 
monolayer of MUA), we detected 2.2 ng mm-2 of BSA adsorption, and 3.8 ng mm-2 of FIB 
adsorption. On all of the experimental PEM and PEM19+PCN surfaces we detected a positive 
change in λres when the surfaces were exposed to protein (between 0.5 nm and 2.5 nm, 
corresponding to 0.1 to 0.5 ng mm-2), which was completely reversed during the subsequent rinse. 
The values of Δλres were either below the limit of detection or were slightly negative, indicating 
that the wavelength change is due to some other change on the surface. The positive change in λres 
during exposure to the protein solution likely indicates reversible protein adsorption, however no 
irreversible adsorption of either BSA or FIB is detected on PEM and PEM19+PCN surfaces. This 
confirms that all of the experimental surfaces are comparable to ultra-low fouling surfaces [56,57]. 
Moreover, the inability to detect protein adsorption on PEM and PEM19+PCN samples cannot be 
attributed to the thickness of the coatings. These coatings are within the evanescent field sensitivity 
of the SPR, evidenced by the change in the signal when the rinse solution is changed to PBS.  
Although SPR shows that there is no irreversible adsorption on our PEM and PEM19+PCN 
surfaces, the SPR signal does change during the protein adsorption and subsequent rinse steps. 
SPR is extremely sensitive for detecting changes in both the thickness and the refractive index of 
the surface. Therefore any change in the surface structure during protein adsorption, such as release 
of water and counterions, or desorption of polysaccharides may mask the detection of protein 
adsorption. Furthermore, the SPR technique requires that the surface be rinsed following 
203 
 
adsorption, so that surface changes can be compared using the same refractive index background. 
To precisely quantify protein adsorption, a technique that distinguishes protein adsorption from 
these other phenomena, while the surface is exposed to protein solution, is required. 
4.3.4. Protein Adsorption by Single-Molecule Fluorescence Microscopy  
To better quantify protein adsorption on bare glass (control), PEM7, PEM13, PEM19, 
PEM19+PCN(CS-CHI), and PEM19+PCN(HEP-CHI), we conducted single-molecule fluorescence 
microscopy using fluorescently-labeled BSA and FIB. (In these experiments, bare glass must be 
used as a control because the gold-coated glass control used for SPR cannot be used in TIRF 
microscopy.) To enable single-molecule detection, proteins were diluted to very low 
concentrations (100 pM, 500 pM, 1 nM, and 3 nM) in pH 8.0 imaging buffer, as described in the 
Experimental Section. Imaging conditions (laser power, excitation angle, exposure time, etc.) were 
the same across all concentrations and surfaces. The lowest concentration of protein (100 pM) was 
allowed to equilibrate with each surface for 10 minutes. Then microscopy videos were collected 
for 105 seconds (1000 frames) using oblique illumination to reduce background fluorescence. 
Subsequently, the protein solution concentration was incremented to the next concentration in the 
series (namely, 500 pM, 1 nM, and 3 nM), and the surface was again allowed to equilibrate for 10 
minutes, before collecting 105 seconds of video. Separate surfaces were prepared for BSA and 
FIB. Figure 4.4 (a) shows representative images obtained by averaging 1000 frames under oblique 
illumination during protein adsorption from the BSA and FIB solutions at 1 nM, after 10 minutes 
of incubation with the fluorescently-labeled protein solution. Figures 4.4 (b) and (c) also show the 
mean fluorescence intensity of the adsorbed BSA and FIB on the surface of each experimental 
sample and the glass control, after 10 minutes of incubation with protein solution at different 
concentrations. When protein concentration is increased, the amount of adsorbed protein increases 
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for all surface types. The clean glass control surface exhibits a measurable adsorption of BSA and 
FIB at all tested concentrations, as expected. When the glass is modified with chitosan-terminated 
PEM, the surface adsorbs more BSA than the glass, but the FIB adsorption is substantially reduced. 
For both proteins the amount adsorbed decreases as the number of PEM layers increases for PEM7, 
PEM13, and PEM19, as others have reported for polysaccharide-based PEMs [36]. Adding either 
the CS-CHI or HEP-CHI PCNs to make PEM19+PCN(CS-CHI) and PEM19+PCN(HEP-CHI) 
surfaces results in a substantial reduction in BSA adsorption (Figure 4.4), even though these 
surfaces have higher surface area (Figure 4.1). Interestingly, there is a significant difference 
between the CS-CHI and the HEP-CHI PCNs, with respect to FIB adsorption. At higher FIB 
concentrations (1 nM and 3 nM), the HEP-CHI PCN surface adsorbs more FIB than the CS-CHI 
PCN. This effect could be due to specific binding between heparin and FIB, as FIB is a heparin-
binding protein [58]. The reduction in surface protein adsorption as the layer number increases, 
suggests that neither protein diffuses into the PEM. Rather, both proteins adsorb only on the 
surfaces. If the proteins were diffusing into the PEMs, then the amount of protein would increase 





Figure 4.4. (a) Single-molecule fluorescence detection of BSA and FIB adsorption  from 1 nM 
protein solutions on glass (control), 7-layer, 13-layer, 19-layer PEMs, and PEM19+PCN(CS-CHI) 
and PEM19+PCN(HEP-CHI) surfaces. (Scale bar is 5 µm). (b-c) Average fluorescence intensity 
from single-molecule fluorescence microscopy experiments at different protein concentrations. In 
(b) and (c) error bars represent standard deviation from experiments on 3 replicate surfaces (n = 
3). Insets in (b) and (c) show the data without the PEM samples (b) and without the glass control 
samples (c), so that the very low-intensity signals can be compared. 
4.3.5. Fibrin Network Formation on Surfaces by Single Molecule Fluorescence Microscopy 
While the PCN-modified surfaces attract FIB, fibrin network formation is completely 
inhibited by the PCN structure. CHI-, CS-, and HEP-terminated PEMs and PEM19+PCN surfaces 
were exposed to a solution containing physiologic concentration of fibrinogen solutions (0.75 
mg/mL), thrombin (at 1 NIH U mL-1), and fluorescently labeled fibrinogen (5 nM). Thrombin 
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converts FIB to the polymerizable fibrin, which then forms polymerized fibrin fibers. On the 
experimental surfaces, the first evidence of polymerized fibrin fibers appears after 30 min. (See 
Figure S.3 in Appendix C). After 40 minutes of incubation, total internal reflection fluorescence 
(TIRF) microscopy videos were collected on chitosan-terminated PEMs (PEM19) (control), HEP-
terminated PEMs (PEM+HEP), CS-terminated PEMs (PEM+CS), and PCN-terminated surfaces 
[PEM19+PCN(CS-CHI) and PEM19+PCN(HEP-CHI)]. TIRF videos were taken on a minimum of 
five different regions of three different surfaces and one representative image is shown here for 
each surface type. In Figure 4.5 each image shows the average of 1500 frames after 40 minutes of 
incubation with the mixture of FIB and thrombin. These are the same fields of view shown in 
Figure S.3 in Appendix C). A video of fibrin(ogen) interaction with PEM surfaces is also available 
in the Appendix C.  
On the PEM19 surface (Figure 4.5), intersecting fibers suggest that a network of fibrin is 
formed on the control surface before 40 minutes, evidenced by visible intersecting fibers 
incorporating the fluorescently labeled fibrin(ogen). Similar fibrin networks are also observed on 
the PEM surfaces terminated with CS and HEP (PEM+CS and PEM+HEP). Therefore, coating the 
surface with heparin or chondroitin sulfate does not suppress fibrin polymerization on the surface 
or fibrin fiber adsorption from solution onto the surface. The formation of fibrin fibers and a 
crosslinked fibrin network is expected in these experiments, because the only coagulation proteins 
present are fibrinogen and thrombin (e.g. there is no antithrombin III). Strikingly, in the case of 
PEM19+PCN(CS-CHI) and PEM19+PCN(HEP-CHI) no fibrin fibers are observed on the surfaces, 
even after 40 minutes (Figure 4.5). For both types of PEM19+PCN surfaces, only sparse single 
molecules of fibrin(ogen) are adsorbed on the surface. Therefore, the PEM19+PCN surfaces must 
be inhibiting both fibrin fiber adsorption from solution, and polymerization of fibrin on the 
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surfaces. To further demonstrate the capacity of PEM19+PCN surfaces to inhibit fibrin network 
formation, a PEM19+PCN(CS-CHI) surface was incubated for 2 hours with the same FIB/thrombin 
mixture. No fibers were observed on the surface even after 2 hours. (See Figure S.3 in the 
Appendix C). This is remarkable since the PEM19, PEM+CS and PEM19+HEP surfaces all have 
obvious fiber formation after 30 minutes, and show intersecting fibers characteristic of fibrin 
networks, after only 40 minutes. 
 
Figure 4.5. TIRF microscopy images of fluorescently-labeled fibrin fibers, polymerized from 
physiologic concentration of fibrinogen (0.75 mg/mL), in the presence of thrombin (1 NIH U/mL) 
on PEMs. The structure of the PEM19+PCN samples does not prevent the adsorption of 
fibrin(ogen) monomers, but it completely prevents adsorption of fibrin fibers and fibrin 
polymerization on the surface. 
4.4. Discussion 
While some superhydrophobic surfaces, polymer brushes, and other surface chemistries 
can reduce protein adsorption to very low levels, no surface can completely eliminate all protein 
adsorption from a complex solution, containing many proteins, fats, sugars, cells, and polyvalent 
ions, such as blood [35,37,56,57,59]. When any biomaterial comes in contact with blood, a layer 
of nonspecifically adsorbed proteins will eventually form. Fibrin(ogen) and denatured albumin can 
bind platelets, promoting their attachment onto a biomaterial surface, ultimately leading to 
thrombus (blood clot) formation [4,43,60,61]. Fibrinogen on the surface of biomaterials can be 
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converted to insoluble fibrin through thrombin-mediated cleavage of small fibrinopeptides A and 
B from the N-termini of the Aα and Bβ chains [44–46]. Activated fibrin molecules then polymerize 
into branched fibers, forming an elastic network, which traps red blood cells and ultimately forms 
a thrombus. On the inside surface of blood vessels, thrombin activity is inhibited by antithrombin 
III, which binds to sulfated glycosaminoglycans in the glycocalyx [15]. In this work we show that 
in the absence of antithrombin III, sulfated GAGs (PEM19+PCNs) can inhibit fibrin network 
formation through a nanostructure-dependent mechanism, when they are presented in glycocalyx 
mimetic bush-like domains formed by the PCNs.  
SPR is widely used to characterize protein adsorption when developing high-performance, 
ultra-low fouling surfaces [56,57]. The PEM and glycocalyx-mimetic PEM+PCN surfaces 
proposed here are complex, multicomponent surfaces that can undergo multiple changes when 
exposed to different solution conditions, complicating interpretation of very small SPR signal 
changes. To overcome this limitation, we use single-molecule fluorescence microscopy to directly 
observe the interactions of blood proteins with PEM and glycocalyx-mimetic PEM+PCN surfaces. 
Like SPR, single-molecule fluorescence microscopy can be performed in real time. However, 
unlike SPR, the microscopy technique provides microscopic resolution of the protein interactions 
with the surface and distinguishes differences between PEM and PEM19+PCN surfaces. 
Furthermore, the SPR experiments also require a rinse step, so that the refractive index of the 
solution background is the same before and after protein adsorption. But in a long-term blood-
contacting application, there is no periodic rinsing of the surface. Since the single-molecule 
fluorescence microscopy technique does not require that the surfaces be rinsed, these experiments 
provide detail about how proteins interact with the surface in a context that is more similar to a 
proposed blood-contacting application than the SPR experiments.  
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Single-molecule fluorescence microscopy also affords the ability to directly observe the 
formation of fibrin(ogen) fibers and fiber networks on the surfaces. The PEM19 surface has very 
low fibrinogen adsorption (Figure 4.4). However single-molecule microscopy reveals that a fibrin 
fiber network still forms before 40 minutes on this surface when fibrinogen and thrombin are 
combined. The introduction of heparin or chondroitin sulfate on the surface (PEM+HEP and 
PEM+CS, Figure 4.4) is also not sufficient to prevent this fibrin network formation. However, 
PEM19+PCN have similarly low fibrinogen adsorption and also completely inhibit the fibrin 
network formation.  The fibers and networks observed on the PEM19, PEM19+HEP, and 
PEM19+CS are most likely a combination of fibers that polymerize from surface-adsorbed 
fibrin(ogen) and fibers formed in solution that subsequently adsorb. Neither of these phenomena 
occur on the PEM19+PCN surfaces. Polymerization of surface-bound fibrin(ogen) could be 
inhibited by PCNs on PEM19+PCN surfaces if the PCNs bind and isolate single fibrin(ogen) 
molecules, thereby suppressing their assembly to form fibers. In the TIRF videos (see Appendix 
C) some sparse fibrin(ogen) molecules appear to be irreversibly bound while others appear and 
disappear from the TIRF plane of view, indicating adsorption and desorption. The adsorption of 
fibrin fibers from solution onto the PEM19+PCN surfaces may be inhibited by the surface 
topography introduced by the PCNs. The surface roughness of the PEM19+PCN, characterized by 
high Rq and the 100-200 nm diameter hemispherical domains observed in the AFM images may 
restrict the relatively stiff fibrin fibers from conforming to the surface to form multiple adhesive 
contacts, thereby inhibiting adsorption.  
The modification of surfaces with polysaccharide-based PEMs is a rapid, low-cost, and 
scalable process. Our group and others have demonstrated PEM modification of metals, polymers, 
composites (including bone tissue), and conformal coating of nanostructured materials [5,48–
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50,54,55]. Therefore, this simple strategy could be generalized to many blood-contacting medical 
devices to control the interactions of blood proteins with surfaces. We envision adapting these 
surfaces for materials for long-term blood contacting applications, such as cardiovascular implants 
and extracorporeal blood circuits.  
4.5. Conclusions 
Protein adsorption from blood is the initiating event in surface-induced blood clotting. 
Therefore, many researchers have proposed that ideal blood-contacting materials should be 
developed with a focus on reducing protein adsorption at the surface to prevent blood clotting 
[4,6]. The inside surface of blood vessels has overcome protein adsorption by developing a barrier 
on the endothelial cells, the endothelial glycocalyx, to maintain blood compatibility of the 
intravascular luminal wall. Rather than attempting to completely eliminate protein adsorption, we 
propose that mimicking the endothelial glycocalyx layer on the surface of biomaterials has the 
potential to suppress nonspecific blood protein adsorption. This approach represents a new 
paradigm in preventing blood clotting on biomedical device surfaces.  
The glycocalyx-mimetic surfaces proposed here have no irreversible adsorption of BSA 
and FIB above the limit of detection of SPR. Single-molecule TIRF microscopy experiments show 
that the PCN in the PEM19+PCN surfaces inhibit both the surface-mediated polymerization of 
fibrin and the adsorption of fibrin fibers from solution, in the presence of thrombin. Further 
detailed investigation of how the structure and composition of these surfaces control protein-
surface interactions in more complex protein solutions will enable elucidation of design principles 
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CHAPTER 5: SINGLE-MOLECULE MICROSCOPY REVEALS THE DYNAMICS OF 






Understanding the mechanism of protein interaction on surfaces is critical to a range of 
biomaterials applications. Here, we investigate the long-term albumin and fibrinogen adsorption 
on ultralow fouling and low fouling surfaces using single-molecule tracking methods to directly 
measure protein adsorption and desorption. These long-term experiments reveal two regimes of 
behavior for protein interactions at surfaces. In regime I, dynamic pseudo-equilibrium of proteins 
is observed for a limited time. In regime II, irreversible protein adsorption occurs that leads to 
protein accumulation on all surfaces. This work reveals that in long-term contact with protein 
solutions, all experimental surfaces investigated here eventually foul, indicating that the short-term 
measurements of protein adsorption using ensemble averaging methods may not be sufficient for 
designing antifouling materials.     
 
                                                            







In this project, we developed surfaces that mimic the endothelial glycocalyx layer. We 
showed that these surfaces substantially reduce nonspecific blood protein adsorption as a first step 
in the coagulation cascade on biomaterials surfaces. Moreover, it was shown that the topography 
and chemistry of these mimetic materials inhibit both the surface-mediated polymerization of 
fibrin and the adsorption of fibrin fibers from solution, in the presence of thrombin. 
Furthermore, we demonstrated how combining surface plasmon resonance, X-ray 
spectroscopy, atomic force microscopy, and single-molecule total internal reflection fluorescence 
microscopy provides a more complete picture of protein adsorption on low fouling surfaces instead 
of just using one technique. With single-molecule TIRF microscopy both adsorption and 
desorption events were precisely quantified to provide a detailed description of protein surface 
interactions.  
Finally, by using high-throughput single-molecule tracking methods we showed the long-
term protein interactions with several biomaterials surfaces. Two regimes of protein adsorption 
were observed on all surfaces for two different blood proteins. In addition, a new mathematical 
model for protein adsorption was proposed to predict the long-term behavior of protein interactions 
on surfaces.  
Further detailed investigation of how the structure and composition of these surfaces 
control protein-surface interactions in more complex protein solutions will enable elucidation of 
design principles for a new class of improved blood-contacting biomaterials based on mimics of 
the endothelial glycocalyx.  
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To combat thrombus formation on artificial blood-contacting surfaces various strategies 
such as incorporation of hydrophilic polymers, bioactive components, bioinspired surfaces, 
surface endothelialization, and NO release have been proposed. These strategies can be 
incorporated to glycocalyx-mimetic materials to reduce protein adsorption, control coagulation, 
and mitigate platelet adhesion and activation, and inflammation. Strategies to reduce protein 
adsorption have received the greatest amount of attention in this field; studies aimed at 





APPENDIX A: ATOMIC FORCE MICROSCOPY OF ADSORBED PROTEOGLYCAN 





In situ FT-SPR for PEM+PCN(HEP-CHI) sample pH 5.4.  
PEM were constructed with CHI as the polycation and HA as the polyanion. During the last 12 
min of the experiment, the PEM surface was exposed to the PCN(HEP-CHI). PCN do not interact 
the same with the surface as a polymer layer, as a result the rinse following PCN adsorption takes 
more time to equilibrate. 
 
Figure S1. Representative kinetics of PEM+PCN(HEP-CHI) assembly from in situ FT-SPR for 
the PEM+PCN assembled at pH 5.4. Arrows represent the beginning of acidified water rinse 
(blue), chitosan adsorption (green), hyaluronan adsorption (red), and PCN adsorption (black). The 









Microscopic evaluation of PEM+PCN 
PEM+PCN (CS-CHI) surface was imaged using TIRF microscopy with different laser line over 
an area of 5 μm × 5 μm.   
Figure S2. TIRF microscopy image for CS-CHI. A. Taken by 473 nm laser line. B. Taken by 561 
nm laser line and C. Both of the laser lines at the same time.  
 
AFM topographic images for gold-coated glass, PEM, and PEM+PCN assembled at pH 4.6 
and 5.4 in air and PBS  
 





Figure S4. 5 µm × 5 µm AFM topography images in air and in PBS of PEM and PEM+PCN 





Figure S5. 5 µm × 5 µm AFM topography images in air and in PBS of PEM and PEM+PCN 










APPENDIX B: PROTEIN ADSORPTION MEASUREMENTS ON LOW FOULING AND 





For comparison of PEM surfaces on gold and gold-coated glass, XPS and AFM was used to 
compare the chemistry and topography of the surfaces.  The elemental compositions of the PEM 
surfaces on gold and glass substrate were determined by XPS and are shown in Table S1. Both 
PEM10 and PEM11 surfaces represent similar elemental compositions (atom % values are all within 
5 %).  
Table S1. Elemental composition from X-ray photoelectron spectroscopy. 
 Atom % 
Surface   C   O   N 
PEM10 (on Au) 55% 40.8% 4.2% 
PEM10 (on glass) 51.2% 43.5% 5.3% 
PEM11 (on Au) 58.2% 34.9% 6.9% 
PEM11 (on glass) 53.4% 41.3% 5.3% 
 
5 µm × 5 μm AFM scans of the surfaces on glass and gold substrates in PBS show similar surface 
features. Although they are not identical, but polyelectrolyte feature complexes which form on the 
surface during LbL assembly of the PEMs are very similar. This confirms similarity of PEM 




Figure. S1.5 µm × 5 µm AFM topography images in PBS of PEM11 on MUA-modified gold-
coated glass (left) and glass (right). 
 
Schematic of flow channel used in TIRF microscopy experiment. 
 
Figure. S2. Schematic diagram showing the multilayer structure of the flow channel used in TIRF 
microscopy. 
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Where 𝛾𝛾 is the shear rate, 𝑄𝑄 is the volumetric flow rate, ℎ is height, and 𝑤𝑤 is width of the channel. 
In situ FT-SPR for PEM construction on the gold chip. 
PEM surfaces were constructed with CHI as the polycation and HA as the polyanion. Figure. S3 
represents PEM build-up with FT-SPR. The first 6 min (blue arrow) represents an acidified water 
rinse on the gold-coated glass chip modified with MUA. The green and red arrows respectively 
indicate the CHI and HA adsorption during LbL assembly. The difference between the FT-SPR 
peak position during the first and second rinse steps is due to the adsorption of CHI. Similarly, the 
difference between the peak position during the second and third rinse steps is due to the adsorption 
of HA on top of the CHI layer.  The LbL process was repeated until a 10-layer PEM (terminating 
with HA for PEM10 surface) and 11-layer PEM (terminating with CHI for PEM11 surface) had 
been constructed. The approximate wet thickness of the PEM surfaces from theoretical predictions 




Figure. S3. Representative kinetics of PEM11 assembly from in situ FT-SPR for the PEMs 
assembled at pH 5.0. Arrows represent the beginning of acidified water rinse (blue), chitosan 
adsorption (green), and hyaluronan adsorption (red) steps. 
Protein adsorption study at high concentration by TIRF microscopy. 
TIRF microscopy was conducted with the same concentration of protein used in the SPR study. 
Albumin or fibrinogen were mixed at a final concentrations of 1 mg mL−1 with labeled protein at 
a final concentration of 10 nM in PBS. 
 
Figure. S4. Representative TIRF micrographs during protein adsorption at a concentrations of 1 
mg mL−1 with labeled protein at a final concentration of 10 nM in PBS on PEG brush surfaces 




APPENDIX C: NANOSTRUCTURED SURFACES THAT MIMIC THE VASCULAR 
ENDOTHELIAL GLYCOCALYX REDUCE BLOOD PROTEIN ADSORPTION AND 




Theoretical background for PeakForce QNM mode. The mechanical surface properties of 
PEMs and PEM+PCNs were quantitatively assessed using the PeakForce QNM mode. In 
PeakForce QNM mode, the tip oscillates at a frequency (f) well below the resonance frequency of 
cantilever (f0), so that the cantilever follows the sinusoidal movement of the cantilever base. This 
mode is based on force-versus-distance measurements that are collected with a high acquisition 
rate, typically 1 to 2 kHz. During scanning, the maximum normal force applied to the surface (peak 
force) is controlled by the feedback mechanism of the AFM at each pixel. This enables the 
acquisition of force-distance data at each pixel. These force-distance data can be analyzed to 
provide information about modulus, deformation, adhesion, and dissipation, at the AFM image 
resolution 
To obtain the elastic properties, the force-distance data must be interpreted with respect to a 
model describing the material properties and the tip-surface interaction mechanisms. The 
Derjaguin-Muller-Toporov (DMT) model is used to calculate the modulus. This model assumes 
spherical contact shape of the tip and is valid when the indentation depth is less than the tip radius. 
The DMT model also assumes that the force on the cantilever is ths sum of the stress on the material 
integrated over the inteaction area and some adhesion force between the tip and the surface. To 
calcualte the modulus of the material, the adhesion force is subtracted from the net force on the 
cantilever. By definition, the DMT model fits the equation (1) 
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𝐹𝐹 − 𝐹𝐹𝑎𝑎𝑎𝑎ℎ = 43𝐸𝐸∗√𝑅𝑅𝑅𝑅3                                                                                             (1) 
Where F is the force on the tip, Fadh is the adhesion force, R is the tip radius, d is the sample 
deformation and E* is the reduced modulus. This model is fit to the retract curve of the force-
distance data over the region from 30% to 90% of the peak force. The result of the fit is the reduced 
modulus E*. The reduced modulus E* depends on the elastic moduli of both the tip Etip and the 
sample Es as well as on their Poisson ratios νtip and νs.  
𝐸𝐸∗ = �1−𝜈𝜈𝑠𝑠2𝐸𝐸𝑠𝑠 + 1−𝜈𝜈𝑡𝑡𝑡𝑡𝑡𝑡2𝐸𝐸𝑡𝑡𝑡𝑡𝑡𝑡 �−1 ≈ 𝐸𝐸𝑠𝑠1−𝜈𝜈𝑠𝑠2                                                                                 (2) 
In these experiments, the tip is made of silicon with modulus > 10 GPa so Etip is assumed to be 
infinite, and calculation of the sample modulus is achieved by assuming a Poisson’s ratio for the 
sample. Since the value of νs is not known for the most samples studied in this work, we assumed 
νs = 0.3 for all samples.  
Surface Roughness Calculated from the AFM Images in Figure 1. The root-mean-square 
surface roughness, Rq, is used to compare the surface roughness of PEM7, PEM13, PEM19, and 
PEM19+PCN(CS-CHI) , imaged in deionized water (Table S.1). Rq is defined as: 
𝑅𝑅𝑞𝑞 = �∑ (𝑍𝑍𝑡𝑡−𝑍𝑍�)2𝑡𝑡 𝑁𝑁                                                                                    (3) 
where 𝑍𝑍𝑖𝑖 − ?̅?𝑍 is the difference between the height of the ith the pixel from the mean height, and N 
is the number of pixels. 
Table S.1.  RMS roughness of surfaces from Figure 1. 
Surface PEM7 PEM13 PEM19 PEM19+PCN(CS-CHI) 




Composition and Structure of Surfaces. The elemental compositions of the PEM13, PEM19, 
PEM19+PCN(CS-CHI), and PEM19+PCN(HEP-CHI) surfaces on glass determined from X-ray 
photoelectron spectroscopy are reported in Table S.2. For comparison, the elemental composition 
of the PEM13 surface obtained on the MUA-modified gold-coated glass chip is also shown in Table 
S.2. 
Table S.2. Elemental composition from X-ray photoelectron spectroscopy. 
 Atom % 
Surface C O N S 
PEM13 (on Au) 59.9% 34.6% 5.5%    0% 
PEM13 (on glass) 58.4% 36.1% 5.5%    0% 
PEM19 (on glass) 54.7% 39.6% 5.7%    0% 
PEM19+PCN(CS-CHI) (on glass) 52.7% 40.2% 5.2% 1.9% 
PEM19+PCN(HEP-CHI) (on glass) 51.6% 42.1% 4.2% 2.1% 
 
 
The elemental compositions of the PEM13 samples on glass and on MUA-modified gold-coated 
glass are similar (atom % values are all within 2 %). Figure S.1 shows the high-resolution XPS 
spectra of the O1s, N1s, C1s, and S2p envelopes of the PEM13 samples on glass and gold-coated 
glass, as well as 5 µm × 5 µm AFM scans of the surfaces. Both surfaces have strong signals from 
–OH, between 532.5 eV and 532.9 eV, with smaller contributions from amide and carboxylic acids 
at lower binding energy (between 351eV and 532 eV). The N1s envelope is dominated by amide 
and amine nitrogen at (between 399 eV and 400 eV), with a smaller contribution from ammonium 
nitrogen (above 400 eV). The dominant peak in the C1s envelope is from the C-OH at 286.5 eV 
to 286.7 eV. The signal at 288 eV is from C=O. The primary difference between the two spectra 
is the amount of aliphatic carbon (284.8 eV), which is primarily adventitious and not from these 
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samples. No S is detected on either of these samples, as expected. The AFM scans of the surfaces 
on glass and MUA-modified gold-coated glass show similar surface roughness with features 
generally less than 100 nm in height.   
 
Figure S.1 High-resolution XPS spectra of the PEM13 samples on MUA-modified gold-coated 
glass (top) and glass (bottom), with corresponding 5 µm × 5 µm AFM height images. 
Addition of the PCNs to PEMs is achieved whether the PCNs are prepared on MUA-modified 
gold-coated glass or glass. Figure S.2 shows the high-resolution XPS spectra of the O1s, N1s, C1s, 
and S2p envelopes of PEM19+PCN(CS-CHI) surfaces prepared on both substrates, as well as 
corresponding 5 µm × 5 µm AFM scans. Addition of PCNs results in appearance of the sulfate in 
the S2p envelope at 168.5 eV (corresponding to 1.8 to 1.9 atom %), broadening of the O1s peak 




Figure S.2 High-resolution XPS spectra of the PEM19+PCN(CS-CHI) samples on MUA-modified 
gold-coated glass (top) and glass (bottom), with corresponding 5 µm × 5 µm AFM height images. 
Fibrin(ogen) Adsorption on Surfaces in the Presence of Thrombin. Experimental surfaces  
were incubated with fibrinogen (at a final concentrations of 0.75 mg/mL), thrombin (at 1 NIH 
U/mL), and Alexa Fluor 647-conjugated fibrinogen (at a final concentration of 5 nM), in Tris-
buffered saline (10 mM Tris, 150 mM NaCl, pH 7.4) with 5 mM CaCl2, to activate thrombin at 
room temperature. TIRF microscopy of PEM19, PEM+CS, and PEM+HEP at 30 minutes shows 
the onset of fibrin fiber formation on the surfaces. The PEM+PCN(CS-CHI) sample was incubated 
for two hours, under similar conditions. After a 2 hour incubation, there are still no apparent fibrin 
fibers or fibrin network formation on the PEM+PCN(CS-CHI) surface (Figure S.3).  
 
Figure S.3. TIRF microscopy images of fluorescently labeled fibron(ogen) after 30 minutes of 
incubation with thrombin on PEM19, PEM19+HEP, PEM19+CS, and after 120 minutes of 
incubation on PEM19+PCN(CS-CHI). These are the same fields of view shown at 40 minutes in 
Figure 5 of the main text. The PEM19, PEM19+HEP, PEM19+CS show the onset of fibrin(ogen) 
fiber formation on the surfaces after only 30 minutes. However the PEM19+PCN(CS-CHI) shows 
only single protein molecules with no fibrin(ogen) fiber formation after 120 minutes. Each image 
shows the average of 1500 frames from a microscopy video. 
 
Video from Single-Molecule TIRF Microscopy of Thrombin and Fluorescently-Labeled 
Fibrin(ogen) on Glycocalyx Mimetic Surfaces. A video showing the formation of fibrin fibers 
and a fiber network on PEM, PEM+CS, and PEM+HEP, and showing no fiber or network 
formation on PEM+PCN(CS-CHI) and PEM+PCN(HEP-CHI) surfaces is available. 
PEM+HEP 
30 min 
PEM19 
30 min 
PEM+CS 
30 min 
PEM19+(CS-CHI) 
120 min 
